0,1,2,3,4
NCT00004984,Inclusion,"individuals 3-45 years old who have an immediate family member with type 1 diabetes (such as a child, parent or sibling)","individuals <VML Logic=greater_equal Unit=years>3</VML> - <VML Logic=lower_equal Unit=years>45</VML> <VL Label=Age Source=DK>old</VL> who have an immediate family member with type 1 diabetes ( such as a child, parent or sibling ) ","[['Age', '>=', 3.0, 'years'], ['Age', '<=', 45.0, 'years']]"
NCT00004984,Inclusion,"individuals 3-20 years old who have an extended family member with type 1 diabetes (such as a cousin, niece, nephew, aunt, uncle, grandparent or half-sibling)","individuals <VML Logic=greater_equal Unit=years>3</VML> - <VML Logic=lower_equal Unit=years>20</VML> <VL Label=Age Source=DK>old</VL> who have an extended family member with type 1 diabetes ( such as a cousin, niece, nephew, aunt, uncle, grandparent or half-sibling ) ","[['Age', '>=', 3.0, 'years'], ['Age', '<=', 20.0, 'years']]"
NCT00005665,Exclusion,patients below the age of 3 or over 25.,patients below the <VL Label=Age Source=DK>age</VL> of <VML Logic=equal Unit=>3</VML> or <VML Logic=greater Unit=>25</VML> .,"[['Age', '=', 3.0, 'years'], ['Age', '>', 25.0, 'years']]"
NCT00021788,Inclusion,candidates must be between the ages of 18 and 65,candidates must be between the <VL Label=Age Source=DK>ages</VL> <VML Logic=greater_equal Unit=>18</VML> - <VML Logic=lower_equal Unit=>65</VML> ,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 65.0, 'years']]"
NCT00021788,Inclusion,candidates must have had iddm for at least 5 years and been under physician care for at least 6 months prior to enrollment in trial.,<VL Label=candidates must have had iddm Source=ngram>candidates must have had iddm</VL> for <VML Logic=greater_equal Unit=years>5</VML> and been under physician care for <VML Logic=greater_equal Unit=months>6</VML> prior to enrollment in trial.,"[['candidates must have had iddm', '>=', '5', 'years'], ['candidates must have had iddm', '>=', '6', 'months']]"
NCT00021788,Inclusion,these symptoms can include episodes of hypoglycemic unawareness (failure to recognize blood glucose levels < 54 mg/dl) or episodes requiring the assistance of others.,these symptoms can include episodes of hypoglycemic unawareness ( failure to recognize <VL Label=finding of blood glucose level Source=UMLS>blood glucose levels</VL> <VML Logic=lower Unit=mg/dl>54</VML> ) or episodes requiring the assistance of others.,"[['finding of blood glucose level', '<', '54', 'mg/dl']]"
NCT00021788,Inclusion,candidates may have poor diabetes control despite intensive insulin therapy (hba1c > 8.0%).,candidates may have poor diabetes control despite intensive insulin therapy ( <VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=%>8.0</VML> ) .,"[['HBA1C', '>', 8.0, '%']]"
NCT00021788,Inclusion,creatinine clearance should be > 60 ml/min),<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> should be <VML Logic=greater Unit=ml/min>60</VML> ) ,"[['Creatinine clearance', '>', 60.0, 'ml/min']]"
NCT00021788,Inclusion,body mass index should be less than 26,<VL Label=BMI Source=DK>body mass index</VL> should be <VML Logic=lower Unit=>26</VML> ,"[['BMI', '<', 26.0, 'kg/m2']]"
NCT00021788,Exclusion,"unstable cardiovascular status, including positive stress echocardiography (if > age 35)","unstable cardiovascular status, including positive stress echocardiography ( if > <VL Label=Age Source=DK>age</VL> <VML Logic=equal Unit=>35</VML> ) ","[['Age', '=', 35.0, 'years']]"
NCT00021788,Exclusion,presence of panel reactive antibodies > 20%,<VL Label=presence of panel reactive antibodies Source=ngram>presence of panel reactive antibodies</VL> <VML Logic=greater Unit=%>20</VML>,"[['presence of panel reactive antibodies', '>', '20', '%']]"
NCT00021788,Exclusion,creatinine clearance < 60 ml/min,<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=lower Unit=ml/min>60</VML>,"[['Creatinine clearance', '<', 60.0, 'ml/min']]"
NCT00021788,Exclusion,hba1c 12%,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=equal Unit=%>12</VML>,"[['HBA1C', '=', 12.0, '%']]"
NCT00021788,Exclusion,anemia (hemoglobin < 12.0),anemia ( <VL Label=hemoglobin Source=ngram>hemoglobin</VL> <VML Logic=lower Unit=>12.0</VML> ) ,"[['hemoglobin', '<', '12.0', '']]"
NCT00021788,Exclusion,psa > 4 in males,<VL Label=psa Source=ngram>psa</VL> <VML Logic=greater Unit=>4</VML> in males,"[['psa', '>', '4', '']]"
NCT00021801,Inclusion,candidates must be between the ages of 18 and 50.,candidates must be between the <VL Label=Age Source=DK>ages</VL> <VML Logic=greater_equal Unit=>18</VML> - <VML Logic=lower_equal Unit=>50</VML> .,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 50.0, 'years']]"
NCT00021801,Inclusion,candidates must have had insulin-dependent diabetes mellitus (iddm) for at least 5 years and been under physician care for at least 6 months prior to enrollment in trial.,<VL Label=candidates must have had insulin-dependent diabetes mellitus Source=ngram>candidates must have had insulin-dependent diabetes mellitus</VL> ( iddm ) for <VML Logic=greater_equal Unit=years>5</VML> and been under physician care for <VML Logic=greater_equal Unit=months>6</VML> prior to enrollment in trial.,"[['candidates must have had insulin-dependent diabetes mellitus', '>=', '5', 'years'], ['candidates must have had insulin-dependent diabetes mellitus', '>=', '6', 'months']]"
NCT00021801,Inclusion,these symptoms can include episodes of hypoglycemic unawareness (failure to recognize blood glucose levels < 54 mg/dl) or episodes requiring the assistance of others.,these symptoms can include episodes of hypoglycemic unawareness ( failure to recognize <VL Label=finding of blood glucose level Source=UMLS>blood glucose levels</VL> <VML Logic=lower Unit=mg/dl>54</VML> ) or episodes requiring the assistance of others.,"[['finding of blood glucose level', '<', '54', 'mg/dl']]"
NCT00021801,Inclusion,candidates may have poor diabetes control despite intensive insulin therapy (hba1c > 8.0%).,candidates may have poor diabetes control despite intensive insulin therapy ( <VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=%>8.0</VML> ) .,"[['HBA1C', '>', 8.0, '%']]"
NCT00021801,Inclusion,creatinine clearance should be > 60 ml/min),<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> should be <VML Logic=greater Unit=ml/min>60</VML> ) ,"[['Creatinine clearance', '>', 60.0, 'ml/min']]"
NCT00021801,Inclusion,body mass index should be less than 26,<VL Label=BMI Source=DK>body mass index</VL> should be <VML Logic=lower Unit=>26</VML> ,"[['BMI', '<', 26.0, 'kg/m2']]"
NCT00021801,Exclusion,"unstable cardiovascular status, including positive stress echocardiography (if > age 35)","unstable cardiovascular status, including positive stress echocardiography ( if > <VL Label=Age Source=DK>age</VL> <VML Logic=equal Unit=>35</VML> ) ","[['Age', '=', 35.0, 'years']]"
NCT00021801,Exclusion,presence of panel reactive antibodies > 20%,<VL Label=presence of panel reactive antibodies Source=ngram>presence of panel reactive antibodies</VL> <VML Logic=greater Unit=%>20</VML>,"[['presence of panel reactive antibodies', '>', '20', '%']]"
NCT00021801,Exclusion,creatinine clearance < 60 ml/min,<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=lower Unit=ml/min>60</VML>,"[['Creatinine clearance', '<', 60.0, 'ml/min']]"
NCT00021801,Exclusion,hba1c > 12%,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=%>12</VML>,"[['HBA1C', '>', 12.0, '%']]"
NCT00021801,Exclusion,anemia (hemoglobin < 12.0),anemia ( <VL Label=hemoglobin Source=ngram>hemoglobin</VL> <VML Logic=lower Unit=>12.0</VML> ) ,"[['hemoglobin', '<', '12.0', '']]"
NCT00021801,Exclusion,psa > 4 in males,<VL Label=psa Source=ngram>psa</VL> <VML Logic=greater Unit=>4</VML> in males,"[['psa', '>', '4', '']]"
NCT00034255,Inclusion,"male and female patients with, type 1 diabetes mellitus that are 18 through 70 years of age or type 2 diabetes mellitus that are 30 through 70 years of age.","male and female patients with, type 1 diabetes mellitus that are <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>70</VML> of <VL Label=Age Source=DK>age</VL> or type 2 diabetes mellitus that are <VML Logic=greater_equal Unit=years>30</VML> - <VML Logic=lower_equal Unit=years>70</VML> of <VL Label=Age Source=DK>age</VL>.","[['Age', '>=', 18.0, 'years'], ['Age', '<=', 70.0, 'years'], ['Age', '>=', 30.0, 'years'], ['Age', '<=', 70.0, 'years']]"
NCT00034255,Exclusion,patients who have received any investigational product within 30 days of admission into the study.,<VL Label=patients who have received any investigational product Source=ngram>patients who have received any investigational product</VL> <VML Logic=lower Unit=days>30</VML> of admission into the study.,"[['patients who have received any investigational product', '<', '30', 'days']]"
NCT00042458,Inclusion,hba1c value between 7.5-9%,<VL Label=HBA1C Source=DK>hba1c value</VL> <VML Logic=greater_equal Unit=%>7.5</VML> - <VML Logic=lower_equal Unit=%>9</VML>,"[['HBA1C', '>=', 7.5, '%'], ['HBA1C', '<=', 9.0, '%']]"
NCT00042471,Inclusion,hba1c value between 6-12%,<VL Label=HBA1C Source=DK>hba1c value</VL> <VML Logic=greater_equal Unit=%>6</VML> - <VML Logic=lower_equal Unit=%>12</VML>,"[['HBA1C', '>=', 6.0, '%'], ['HBA1C', '<=', 12.0, '%']]"
NCT00042471,Inclusion,bmi <= 27 kg/m2 or bmi >=30 to <= 45 kg/m2,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=lower_equal Unit=kg/m2>27</VML> or <VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater_equal Unit=kg/m2>30</VML> - <VML Logic=lower_equal Unit=kg/m2>45</VML>,"[['BMI', '<=', 27.0, 'kg/m2'], ['BMI', '>=', 30.0, 'kg/m2'], ['BMI', '<=', 45.0, 'kg/m2']]"
NCT00042601,Inclusion,bmi >=20 to <=25kg/m2 or >=30 to <=40 kg/m2,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater_equal Unit=kg/m2>20</VML> - <VML Logic=lower_equal Unit=kg/m2>25</VML> or <VML Logic=greater_equal Unit=kg/m2>30</VML> - <VML Logic=lower_equal Unit=kg/m2>40</VML>,"[['BMI', '>=', 20.0, 'kg/m2'], ['BMI', '<=', 25.0, 'kg/m2'], ['BMI', '>=', 30.0, 'kg/m2'], ['BMI', '<=', 40.0, 'kg/m2']]"
NCT00042601,Inclusion,hba1c value between 6.5-10% inclusive,<VL Label=HBA1C Source=DK>hba1c value</VL> <VML Logic=greater_equal Unit=%>6.5</VML> - <VML Logic=lower_equal Unit=%>10</VML> inclusive,"[['HBA1C', '>=', 6.5, '%'], ['HBA1C', '<=', 10.0, '%']]"
NCT00042601,Inclusion,bmi between 20-40kg/m2,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater_equal Unit=kg/m2>20</VML> - <VML Logic=lower_equal Unit=kg/m2>40</VML>,"[['BMI', '>=', 20.0, 'kg/m2'], ['BMI', '<=', 40.0, 'kg/m2']]"
NCT00046150,Inclusion,men and women above the age of 18.,men and women above the <VL Label=Age Source=DK>age</VL> of <VML Logic=equal Unit=>18</VML> .,"[['Age', '=', 18.0, 'years']]"
NCT00046150,Inclusion,women are either not of childbearing potential (surgically sterile or postmenopausal for more than 2 years) or are not pregnant and agree to use a reliable contraceptive measure for the duration of the study,women are either not of childbearing potential ( surgically sterile or postmenopausal for <VML Logic=greater Unit=years>2</VML> ) or are not <VL Label=Pregnant Source=DK>pregnant</VL> and agree to use a reliable contraceptive measure for the duration of the study,"[['Pregnant', '>', 2.0, 'years']]"
NCT00046150,Inclusion,type 1 diabetes mellitus as established in the medical history (for the purpose of this protocol: onset of diabetes under the age of 40 and has required continuous insulin therapy since diagnosis).,type 1 diabetes mellitus as established in the medical history ( for the purpose of this protocol: onset of diabetes under the <VL Label=Age Source=DK>age</VL> of <VML Logic=equal Unit=>40</VML> and has required continuous <VL Label=Insulin Source=DK>insulin</VL> therapy since diagnosis ) .,"[['Age', '=', 40.0, 'years']]"
NCT00046150,Inclusion,use of the same type of external insulin pump (minimed programmable pump or disetronic pump type h tron plus v 100 or d tron) for at least 3 months prior to study entry.,use of the same type of external <VL Label=Insulin Source=DK>insulin</VL> pump ( minimed programmable pump or disetronic pump type h tron plus v <VML Logic=equal Unit=or d>100</VML> tron ) for <VML Logic=greater_equal Unit=months>3</VML> prior to <VL Label=Study entry Source=DK>study entry</VL>.,"[['Insulin', '=', 100.0, 'or d']]"
NCT00046150,Inclusion,hba1c <8.5% measured at visit 1.,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=lower Unit=%>8.5</VML> measured at visit 1 .,"[['HBA1C', '<', 8.5, '%']]"
NCT00046150,Exclusion,"active proliferative diabetic retinopathy, as defined by the application of focal or panretinal photocoagulation or vitrectomy, in the 6 months prior to visit 1 or any other unstable (rapidly progressing) retinopathy that may require surgical treatment (including laser photocoagulation) during the study.","active proliferative diabetic retinopathy, as <VL Label=defined by the application of focal or panretinal photocoagulation or vitrectomy Source=ngram>defined by the application of focal or panretinal photocoagulation or vitrectomy</VL>, <VML Logic=lower_equal Unit=months>6</VML> prior to visit 1 or any other unstable ( rapidly progressing ) retinopathy that may require surgical treatment ( including laser photocoagulation ) during the study.","[['defined by the application of focal or panretinal photocoagulation or vitrectomy', '<=', '6', 'months']]"
NCT00046150,Exclusion,history of serious ketosis episode requiring hospitalization in the 3 previous months.,<VL Label=history of serious ketosis episode requiring hospitalization Source=ngram>history of serious ketosis episode requiring hospitalization</VL> <VML Logic=lower_equal Unit=previous months>3</VML>.,"[['history of serious ketosis episode requiring hospitalization', '<=', '3', 'previous months']]"
NCT00046150,Exclusion,history of abscess at the infusion site in the previous 3 months.,<VL Label=history of abscess at the infusion site Source=ngram>history of abscess at the infusion site</VL> <VML Logic=lower_equal Unit=previous months>3</VML>.,"[['history of abscess at the infusion site', '<=', '3', 'previous months']]"
NCT00046150,Exclusion,"impaired renal function, as shown by but not limited to serum creatinine >177 micromol/l (>2.0 mg/dl) measured at visit 1.","impaired renal function, as shown by but not limited to <VL Label=Creatinine Source=DK>serum creatinine</VL> <VML Logic=greater Unit=micromol/l>177</VML> ( <VML Logic=greater Unit=mg/dl>2.0</VML> ) measured at visit 1 .","[['Creatinine', '>', 2.0, 'mg/dl'], ['Creatinine', '>', 2.0, 'mg/dl']]"
NCT00063128,Inclusion,you are at least 18 years old.,you are <VML Logic=greater_equal Unit=years>18</VML> <VL Label=Age Source=DK>old</VL>.,"[['Age', '>=', 18.0, 'years']]"
NCT00063128,Inclusion,you have had type 1 diabetes for at least 2 years.,you have had <VL Label=type 1 diabetes Source=ngram>type 1 diabetes</VL> for <VML Logic=greater_equal Unit=years>2</VML>.,"[['type 1 diabetes', '>=', '2', 'years']]"
NCT00063128,Inclusion,you have not smoked for at least 1 year and you agree not to smoke or use smokeless tobacco during the study.,you have not <VL Label=smoked Source=ngram>smoked</VL> for <VML Logic=greater_equal Unit=year>1</VML> and you agree not to smoke or use smokeless tobacco during the study.,"[['smoked', '>=', '1', 'year']]"
NCT00063128,Exclusion,you have used an experimental drug during the last 30 days or have ever taken part in a study of any type of inhaled insulin.,you have used an experimental drug <VML Logic=lower_equal Unit=last days>30</VML> or have ever taken part in a study of any type of inhaled <VL Label=Insulin Source=DK>insulin</VL>.,"[['Insulin', '<=', 30.0, 'last days']]"
NCT00071448,Inclusion,hba1c less than 12%,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=lower Unit=%>12</VML>,"[['HBA1C', '<', 12.0, '%']]"
NCT00071448,Inclusion,"willing to administer at least 3 injections per day,","<VL Label=willing to administer Source=ngram>willing to administer</VL> <VML Logic=greater_equal Unit=>3</VML> injections per day,","[['willing to administer', '>=', '3', '']]"
NCT00071448,Inclusion,"willing to perform self monitored blood glucose (smbg) at least 4 times per day, includes subject and/or parent/guardian, as necessary","willing to perform self monitored blood <VL Label=Glucose Source=DK>glucose</VL> ( smbg ) <VML Logic=greater_equal Unit=times/day>4</VML>, includes subject and / or parent / guardian, as necessary","[['Glucose', '>=', 4.0, 'times/day']]"
NCT00095082,Inclusion,type 1 diabetes for at least 12 months,<VL Label=type 1 diabetes Source=ngram>type 1 diabetes</VL> for <VML Logic=greater_equal Unit=months>12</VML>,"[['type 1 diabetes', '>=', '12', 'months']]"
NCT00095082,Inclusion,hba1c less than or equal to 11.0%,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=lower_equal Unit=%>11.0</VML>,"[['HBA1C', '<=', 11.0, '%']]"
NCT00097292,Inclusion,"individuals 1 to 45 years old who have an immediate family member with type 1 diabetes (such as a child, parent or sibling)","individuals <VML Logic=greater_equal Unit=years>1</VML> - <VML Logic=lower_equal Unit=years>45</VML> <VL Label=Age Source=DK>old</VL> who have an immediate family member with type 1 diabetes ( such as a child, parent or sibling ) ","[['Age', '>=', 1.0, 'years'], ['Age', '<=', 45.0, 'years']]"
NCT00097292,Inclusion,"individuals 1-20 years old who have an extended family member with type 1 diabetes (such as a cousin, niece, nephew, aunt, uncle, grandparent or half-sibling)","individuals <VML Logic=greater_equal Unit=years>1</VML> - <VML Logic=lower_equal Unit=years>20</VML> <VL Label=Age Source=DK>old</VL> who have an extended family member with type 1 diabetes ( such as a cousin, niece, nephew, aunt, uncle, grandparent or half-sibling ) ","[['Age', '>=', 1.0, 'years'], ['Age', '<=', 20.0, 'years']]"
NCT00100178,Inclusion,be between the ages of 8 and 45 years old,be between the <VL Label=Age Source=DK>ages</VL> <VML Logic=greater_equal Unit=years>8</VML> - <VML Logic=lower_equal Unit=years>45</VML> <VL Label=Age Source=DK>old</VL>,"[['Age', '>=', 8.0, 'years'], ['Age', '<=', 45.0, 'years']]"
NCT00100178,Inclusion,must have stimulated c-peptide levels > 0.2 pmol/ml (measured during an mmtt administered no more than one month prior to the date of randomization),must have stimulated <VL Label=C-peptide Source=DK>c-peptide levels</VL> <VML Logic=greater Unit=pmol/ml>0.2</VML> ( measured during an mmtt administered no more than one month prior to the date of randomization ) ,"[['C-peptide', '>', 0.2, 'pmol/ml']]"
NCT00100178,Inclusion,"the goal of management will be an hba1c of 7.0% for all participants, regardless of age","the goal of management will be an <VL Label=HBA1C Source=DK>hba1c</VL> of <VML Logic=equal Unit=%>7.0</VML> for all participants, regardless of <VL Label=Age Source=DK>age</VL>","[['HBA1C', '=', 7.0, '%']]"
NCT00100178,Inclusion,participants will also be expected to test their blood sugar at least 3-4 times per day,<VL Label=participants will also be expected to test their blood sugar Source=ngram>participants will also be expected to test their blood sugar</VL> <VML Logic=greater_equal Unit=times/day>3</VML> - <VML Logic=greater_equal Unit=times/day>4</VML>,"[['participants will also be expected to test their blood sugar', '>=', '3', 'times/day'], ['participants will also be expected to test their blood sugar', '>=', '4', 'times/day']]"
NCT00100178,Exclusion,have had any live vaccinations in the preceding 6 weeks (e.g,have had any <VL Label=live vaccinations Source=ngram>live vaccinations</VL> <VML Logic=lower_equal Unit=preceding weeks>6</VML> ( e.g,"[['live vaccinations', '<=', '6', 'preceding weeks']]"
NCT00100178,Exclusion,be currently pregnant or 3 months postpartum.,be currently <VL Label=Pregnant Source=DK>pregnant</VL> or <VML Logic=equal Unit=months>3</VML> postpartum.,"[['Pregnant', '=', 3.0, 'months']]"
NCT00100178,Exclusion,be currently nursing or within 6 weeks of having completed nursing.,be <VL Label=currently nursing Source=ngram>currently nursing</VL> or <VML Logic=lower Unit=weeks>6</VML> of having completed nursing.,"[['currently nursing', '<', '6', 'weeks']]"
NCT00105352,Inclusion,informed consent obtained from participants (over 12 years of age) and parents (for participants below 18 years of age),informed consent obtained from participants ( <VML Logic=greater Unit=years>12</VML> of <VL Label=Age Source=DK>age</VL> ) and parents ( for participants <VML Logic=lower Unit=years>18</VML> of <VL Label=Age Source=DK>age</VL> ) ,"[['Age', '>', 12.0, 'years'], ['Age', '<', 18.0, 'years']]"
NCT00105352,Inclusion,age 8 - 35 years at the time of inclusion,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=years>8</VML> - <VML Logic=lower_equal Unit=years>35</VML> at the time of inclusion,"[['Age', '>=', 8.0, 'years'], ['Age', '<=', 35.0, 'years']]"
NCT00105352,Inclusion,body weight > 30 kg,<VL Label=Weight Loss Source=DK>body weight</VL> <VML Logic=greater Unit=kg>30</VML>,"[['Weight Loss', '>', 30.0, 'kg']]"
NCT00105352,Inclusion,duration of diabetes: 1 month to 3* years (*the trialnet coordinating center will monitor fasting c-peptide levels as they are reported to ensure that a wide range of values is included,duration of diabetes: <VML Logic=greater_equal Unit=month>1</VML> - <VML Logic=lower_equal Unit=* years>3</VML> ( *the trialnet coordinating center will monitor <VL Label=C-peptide Source=DK>fasting c-peptide levels</VL> as they are reported to ensure that a wide range of values is included,"[['C-peptide', '<=', 3.0, '* years']]"
NCT00105352,Inclusion,be willing to travel to a trialnet clinical center for a minimum of four separate visits that are spaced 3-10 days apart and be willing to complete the study within a six week period.,be <VL Label=willing to travel to a trialnet clinical center for a greater_equal of four separate visits that are spaced Source=ngram>willing to travel to a trialnet clinical center for a greater_equal of four separate visits that are spaced</VL> <VML Logic=greater_equal Unit=days>3</VML> - <VML Logic=lower_equal Unit=days>10</VML> apart and be willing to complete the study within a six week period.,"[['willing to travel to a trialnet clinical center for a greater_equal of four separate visits that are spaced', '>=', '3', 'days'], ['willing to travel to a trialnet clinical center for a greater_equal of four separate visits that are spaced', '<=', '10', 'days']]"
NCT00105352,Exclusion,febrile illness within the prior 3 days),<VL Label=febrile illness Source=ngram>febrile illness</VL> within the <VML Logic=greater Unit=days>3</VML> ) ,"[['febrile illness', '>', '3', 'days']]"
NCT00107107,Inclusion,the subject has completed the full dosing period in protocol 137-150.,the <VL Label=subject has completed the full dosing period in protocol Source=ngram>subject has completed the full dosing period in protocol</VL> <VML Logic=greater_equal Unit=>137</VML> - <VML Logic=lower_equal Unit=>150</VML> .,"[['subject has completed the full dosing period in protocol', '>=', '137', ''], ['subject has completed the full dosing period in protocol', '<=', '150', '']]"
NCT00108004,Inclusion,the subject has a hba1c of 7.0% to 11.0% at screening.,the subject has a <VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater_equal Unit=%>7.0</VML> - <VML Logic=lower_equal Unit=%>11.0</VML> at screening.,"[['HBA1C', '>=', 7.0, '%'], ['HBA1C', '<=', 11.0, '%']]"
NCT00109434,Inclusion,clinical diagnosis of type 1 diabetes for at least 18 months,<VL Label=clinical diagnosis of type 1 diabetes Source=ngram>clinical diagnosis of type 1 diabetes</VL> for <VML Logic=greater_equal Unit=months>18</VML>,"[['clinical diagnosis of type 1 diabetes', '>=', '18', 'months']]"
NCT00109434,Inclusion,hba1c <10.0% as measured by the dca2000.,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=lower Unit=%>10.0</VML> as measured by the dca2000.,"[['HBA1C', '<', 10.0, '%']]"
NCT00109434,Inclusion,age 10.0 to <18.0 years,<VL Label=Age Source=DK>age</VL> <VML Logic=equal Unit=years>10.0</VML> - <VML Logic=lower Unit=years>18.0</VML>,"[['Age', '=', 10.0, 'years'], ['Age', '<', 18.0, 'years']]"
NCT00109434,Inclusion,weight >36.0 kg,<VL Label=Weight Source=DK>weight</VL> <VML Logic=greater Unit=kg>36.0</VML>,"[['Weight', '>', 36.0, 'kg']]"
NCT00109434,Exclusion,"use of pseudoephedrine 48 hours prior to crc admission (if used in the 48 hours prior to the scheduled second admission, the admission will be deferred)","<VL Label=use of pseudoephedrine Source=ngram>use of pseudoephedrine</VL> <VML Logic=equal Unit=hours>48</VML> prior to crc admission ( if used <VML Logic=lower_equal Unit=hours>48</VML> prior to the scheduled second admission, the admission will be deferred ) ","[['use of pseudoephedrine', '=', '48', 'hours'], ['use of pseudoephedrine', '<=', '48', 'hours']]"
NCT00109434,Exclusion,"severe hypoglycemia resulting in seizure or loss of consciousness in the 2 weeks prior to crc admission (if a severe episode occurs within 2 weeks prior to the scheduled second admission, the admission will be deferred)","<VL Label=severe hypoglycemia resulting in seizure or loss of consciousness Source=ngram>severe hypoglycemia resulting in seizure or loss of consciousness</VL> <VML Logic=lower_equal Unit=weeks>2</VML> prior to crc admission ( if a severe episode occurs <VML Logic=lower Unit=weeks>2</VML> prior to the scheduled second admission, the admission will be deferred ) ","[['severe hypoglycemia resulting in seizure or loss of consciousness', '<=', '2', 'weeks'], ['severe hypoglycemia resulting in seizure or loss of consciousness', '<', '2', 'weeks']]"
NCT00117026,Inclusion,type 1 diabetes (of at least 15 years duration) as assessed by medical history.,<VL Label=type 1 diabetes Source=ngram>type 1 diabetes</VL> ( of <VML Logic=greater_equal Unit=years>15</VML> duration ) as assessed by medical history.,"[['type 1 diabetes', '>=', '15', 'years']]"
NCT00117026,Exclusion,diabetic nephropathy with a creatinine clearance less than 60 cc/min.,diabetic nephropathy with a <VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=lower Unit=>60</VML> cc / min.,"[['Creatinine clearance', '<', 60.0, '']]"
NCT00117026,Exclusion,supplementation with thiamine > 2mg per day and/or alpha-lipoic acid,<VL Label=supplementation with thiamine Source=ngram>supplementation with thiamine</VL> <VML Logic=greater Unit=mg/day>2</VML> and / or alpha-lipoic acid,"[['supplementation with thiamine', '>', '2', 'mg/day']]"
NCT00117780,Inclusion,type 1 diabetes for more than 1 year,<VL Label=type 1 diabetes Source=ngram>type 1 diabetes</VL> for <VML Logic=greater Unit=year>1</VML>,"[['type 1 diabetes', '>', '1', 'year']]"
NCT00117780,Inclusion,hba1c = 7.5% and = 10%,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=equal Unit=%>7.5</VML> and <VML Logic=equal Unit=%>10</VML>,"[['HBA1C', '=', 7.5, '%'], ['HBA1C', '=', 10.0, '%']]"
NCT00118937,Inclusion,hba1c > 8.5% for more than one year prior to enrolment.,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=%>8.5</VML> for more than one year prior to enrolment.,"[['HBA1C', '>', 8.5, '%']]"
NCT00118937,Inclusion,diabetes-duration > 5 years.,<VL Label=diabetes-duration Source=ngram>diabetes-duration</VL> <VML Logic=greater Unit=years>5</VML>.,"[['diabetes-duration', '>', '5', 'years']]"
NCT00118937,Inclusion,age at onset of diabetes < 35 years,<VL Label=Age Source=DK>age</VL> at onset of diabetes <VML Logic=lower Unit=years>35</VML>,"[['Age', '<', 35.0, 'years']]"
NCT00118937,Inclusion,fasting c-peptide < 300 pmol/l,<VL Label=C-peptide Source=DK>fasting c-peptide</VL> <VML Logic=lower Unit=pmol/l>300</VML>,"[['C-peptide', '<', 300.0, 'pmol/l']]"
NCT00118937,Inclusion,age > 18 years at enrolment.,<VL Label=Age Source=DK>age</VL> <VML Logic=greater Unit=years>18</VML> at enrolment.,"[['Age', '>', 18.0, 'years']]"
NCT00118976,Inclusion,diabetic nephropathy (2 out of 3 consecutive 24 hour urinary samples with albumin excretion > 300 mg/24hour and diabetic retinopathy in the absence of signs of other kidney or urinary tract disease) 27 or diabetic glomerulosclerosis verified by biopsy.,<VL Label=diabetic nephropathy Source=ngram>diabetic nephropathy</VL> ( <VML Logic=equal Unit=>2</VML> out of <VML Logic=equal Unit=>3</VML> consecutive <VML Logic=equal Unit=hour>24</VML> urinary samples with albumin excretion <VML Logic=greater Unit=mg>300</VML> / <VML Logic=equal Unit=hour>24</VML> and diabetic retinopathy in the absence of signs of other kidney or urinary tract disease ) <VML Logic=equal Unit=>27</VML> or diabetic glomerulosclerosis verified by biopsy.,"[['diabetic nephropathy', '=', '2', ''], ['diabetic nephropathy', '=', '3', ''], ['diabetic nephropathy', '=', '24', 'hour'], ['diabetic nephropathy', '>', '300', 'mg'], ['diabetic nephropathy', '=', '24', 'hour'], ['diabetic nephropathy', '=', '27', '']]"
NCT00118976,Inclusion,hypertension: blood pressure > 135 mmhg systolic and/or 85 mm hg diastolic repeatedly.,hypertension: <VL Label=BP Source=DK>blood pressure</VL> <VML Logic=greater Unit=mmhg>135</VML> <VL Label=BP-Systolic Source=DK>systolic</VL> and / or <VML Logic=equal Unit=mm hg>85</VML> <VL Label=BP-Diastolic Source=DK>diastolic</VL> repeatedly.,"[['BP', '>', 135.0, 'mmhg'], ['BP-Systolic', '=', 85.0, 'mm hg']]"
NCT00118976,Inclusion,age from 18 to 70 years.,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>70</VML>.,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 70.0, 'years']]"
NCT00118976,Exclusion,age < 18 years or > 70 years.,<VL Label=Age Source=DK>age</VL> <VML Logic=lower Unit=years>18</VML> or <VML Logic=greater Unit=years>70</VML>.,"[['Age', '<', 18.0, 'years'], ['Age', '>', 70.0, 'years']]"
NCT00118976,Exclusion,blood pressure > 180 - 105 mm hg,<VL Label=BP Source=DK>blood pressure</VL> <VML Logic=greater Unit=mm hg>180</VML> - <VML Logic=greater Unit=mm hg>105</VML>,"[['BP', '>', 180.0, 'mm hg'], ['BP', '>', 105.0, 'mm hg']]"
NCT00118976,Exclusion,gfr < 30 ml/min/1.73 m²,<VL Label=gfr Source=ngram>gfr</VL> <VML Logic=lower Unit=ml/min>30</VML> / <VML Logic=equal Unit=>1.73</VML> m²,"[['gfr', '<', '30', 'ml/min'], ['gfr', '=', '1.73', '']]"
NCT00118976,Exclusion,serum potassium > 4.8 mmol/ l,<VL Label=serum potassium result Source=UMLS>serum potassium</VL> <VML Logic=greater Unit=mmol/l>4.8</VML>,"[['serum potassium result', '>', '4.8', 'mmol/l']]"
NCT00118976,Exclusion,chronic use of non steroid inflammatory drugs or aspirin (above 1 g/day),<VL Label=chronic use of non steroid inflammatory drugs or aspirin Source=ngram>chronic use of non steroid inflammatory drugs or aspirin</VL> ( <VML Logic=greater Unit=g/day>1</VML> ) ,"[['chronic use of non steroid inflammatory drugs or aspirin', '>', '1', 'g/day']]"
NCT00119041,Inclusion,2) a1c > 7.0%,2 ) <VL Label=HBA1C Source=DK>a1c</VL> <VML Logic=greater Unit=%>7.0</VML>,"[['HBA1C', '>', 7.0, '%']]"
NCT00119041,Inclusion,or 3) fasting glucose levels > 130 mg/dl,or <VML Logic=equal Unit=>3</VML> ) fasting <VL Label=glucose level - finding Source=UMLS>glucose levels</VL> <VML Logic=greater Unit=mg/dl>130</VML>,"[['glucose level - finding', '=', '3', ''], ['glucose level - finding', '>', '130', 'mg/dl']]"
NCT00119041,Inclusion,and 4) referred to see a consultant and are seen during the active intervention phase,and <VML Logic=equal Unit=>4</VML> ) <VL Label=referred to see a consultant and are seen during the active intervention phase Source=ngram>referred to see a consultant and are seen during the active intervention phase</VL>,"[['referred to see a consultant and are seen during the active intervention phase', '=', '4', '']]"
NCT00119041,Exclusion,"1) primary care obtained at more than one site (based on stop codes with evidence of more than 1 cboc involved in care during the last 6 months) and 2) documented dementia, aphasia and psychosis.","1 ) <VL Label=primary care obtained at more than one site Source=ngram>primary care obtained at more than one site</VL> ( based on stop codes with evidence of <VML Logic=greater Unit=>1</VML> cboc involved in care <VML Logic=lower_equal Unit=last months>6</VML> ) and <VML Logic=equal Unit=>2</VML> ) documented dementia, aphasia and psychosis.","[['primary care obtained at more than one site', '>', '1', ''], ['primary care obtained at more than one site', '<=', '6', 'last months'], ['primary care obtained at more than one site', '=', '2', '']]"
NCT00129259,Inclusion,diagnosis of type 1 diabetes (according to american diabetes association [ada] criteria) within the 8 weeks prior to study entry,diagnosis of type 1 diabetes ( according to american diabetes association [ ada ] criteria ) <VML Logic=lower Unit=weeks>8</VML> prior to <VL Label=Study entry Source=DK>study entry</VL>,"[['Study entry', '<', 8.0, 'weeks']]"
NCT00129259,Inclusion,weigh at least 25 kg (55 lbs),<VL Label=weigh Source=ngram>weigh</VL> <VML Logic=greater_equal Unit=kg>25</VML> ,"[['weigh', '>=', '25', 'kg']]"
NCT00129259,Exclusion,participation in another investigational clinical trial within the 6 weeks prior to study entry,participation in another investigational clinical trial <VML Logic=lower Unit=weeks>6</VML> prior to <VL Label=Study entry Source=DK>study entry</VL>,"[['Study entry', '<', 6.0, 'weeks']]"
NCT00130481,Inclusion,type 1 diabetes mellitus (t1dm) or type 2 diabetes mellitus (t2dm) for more than 1 year,type 1 diabetes mellitus ( t1dm ) or <VL Label=type 2 diabetes mellitus Source=ngram>type 2 diabetes mellitus</VL> ( t2dm ) for <VML Logic=greater Unit=year>1</VML>,"[['type 2 diabetes mellitus', '>', '1', 'year']]"
NCT00130481,Inclusion,age 10-18 years.,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=years>10</VML> - <VML Logic=lower_equal Unit=years>18</VML>.,"[['Age', '>=', 10.0, 'years'], ['Age', '<=', 18.0, 'years']]"
NCT00131755,Inclusion,age between 18-40 years,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>40</VML>,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 40.0, 'years']]"
NCT00131755,Inclusion,c-peptide >0.2 nmol/l,<VL Label=C-peptide Source=DK>c-peptide</VL> <VML Logic=greater Unit=nmol/l>0.2</VML>,"[['C-peptide', '>', 0.2, 'nmol/l']]"
NCT00133809,Inclusion,type 1 diabetes mellitus diagnosed > 5 years previously,<VL Label=type 1 diabetes mellitus diagnosed Source=ngram>type 1 diabetes mellitus diagnosed</VL> <VML Logic=greater Unit=years>5</VML> previously,"[['type 1 diabetes mellitus diagnosed', '>', '5', 'years']]"
NCT00133809,Inclusion,body mass index less than or equal to 26,<VL Label=BMI Source=DK>body mass index</VL> <VML Logic=lower_equal Unit=>26</VML> ,"[['BMI', '<=', 26.0, 'kg/m2']]"
NCT00133809,Inclusion,18 to 65 years of age,<VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>65</VML> of <VL Label=Age Source=DK>age</VL>,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 65.0, 'years']]"
NCT00133809,Inclusion,checking and recording blood sugars at least 3 times per day,<VL Label=checking and recording blood sugars Source=ngram>checking and recording blood sugars</VL> <VML Logic=greater_equal Unit=times/day>3</VML>,"[['checking and recording blood sugars', '>=', '3', 'times/day']]"
NCT00133809,Inclusion,intensive insulin therapy (injecting insulin at least 3 times a day or using an insulin pump),intensive <VL Label=Insulin Source=DK>insulin</VL> therapy ( injecting <VL Label=Insulin Source=DK>insulin</VL> <VML Logic=greater_equal Unit=times/day>3</VML> or using an insulin pump ) ,"[['Insulin', '>=', 3.0, 'times/day']]"
NCT00133809,Inclusion,severe hypoglycemia is defined by: episodes requiring assistance by others and/or hypoglycemic unawareness (the inability to recognize blood glucose < 54 mg/dl),severe hypoglycemia is defined by: episodes requiring assistance by others and / or hypoglycemic unawareness ( the inability to recognize blood <VL Label=Glucose Source=DK>glucose</VL> <VML Logic=lower Unit=mg/dl>54</VML> ) ,"[['Glucose', '<', 3.0, 'mmol/l']]"
NCT00133809,Exclusion,baseline hemoglobin < 11.4 gm/dl in women,<VL Label=baseline hemoglobin Source=ngram>baseline hemoglobin</VL> <VML Logic=lower Unit=gm/dl>11.4</VML> in women,"[['baseline hemoglobin', '<', '11.4', 'gm/dl']]"
NCT00133809,Exclusion,< 12.9 gm/dl in men., <VML Logic=lower Unit=gm/dl>12.9</VML> in <VL Label=men Source=ngram>men</VL>.,"[['men', '<', '12.9', 'gm/dl']]"
NCT00133809,Exclusion,presence of hla panel reactive antibodies > 20%,<VL Label=presence of hla panel reactive antibodies Source=ngram>presence of hla panel reactive antibodies</VL> <VML Logic=greater Unit=%>20</VML>,"[['presence of hla panel reactive antibodies', '>', '20', '%']]"
NCT00133809,Exclusion,evidence of insulin resistance (insulin requirement > 1.2 units/kg/day),evidence of <VL Label=Insulin Source=DK>insulin</VL> resistance ( insulin requirement <VML Logic=greater Unit=units/kg>1.2</VML> / day ) ,"[['Insulin', '>', 1.2, 'units/kg']]"
NCT00135915,Inclusion,type 1 diabetes for > 5 years,<VL Label=type 1 diabetes Source=ngram>type 1 diabetes</VL> for <VML Logic=greater Unit=years>5</VML>,"[['type 1 diabetes', '>', '5', 'years']]"
NCT00135915,Exclusion,type i diabetes < 5 years,<VL Label=type i diabetes Source=ngram>type i diabetes</VL> <VML Logic=lower Unit=years>5</VML>,"[['type i diabetes', '<', '5', 'years']]"
NCT00140543,Inclusion,"male or female patients, of 18 to 55 years of age, with end-stage, c-peptide-negative, type 1-diabetic nephropathy.","male or female patients, <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>55</VML> of <VL Label=Age Source=DK>age</VL>, with end-stage, c-peptide-negative, type 1-diabetic nephropathy.","[['Age', '>=', 18.0, 'years'], ['Age', '<=', 55.0, 'years']]"
NCT00140543,Inclusion,female patients of childbearing age must have a negative pregnancy test and must agree to maintain effective birth control practice throughout the study period (3 years).,female patients of childbearing age must have a <VL Label=pregnancy test negative Source=UMLS>negative pregnancy test</VL> and must agree to maintain effective birth control practice throughout the study period ( <VML Logic=equal Unit=years>3</VML> ) .,"[['pregnancy test negative', '=', '3', 'years']]"
NCT00140543,Exclusion,"patient is known for active liver disease or has significant liver disease, defined by asat and alat serum levels greater than 3 times the upper limit of normal.","<VL Label=patient is known for active liver disease or has significant liver disease Source=ngram>patient is known for active liver disease or has significant liver disease</VL>, defined by asat and alat serum levels <VML Logic=greater Unit=times the upper limit of normal>3</VML>.","[['patient is known for active liver disease or has significant liver disease', '>', '3', 'times the upper limit of normal']]"
NCT00140543,Exclusion,patient has been included in another clinical trial protocol for any investigational drug within 4 weeks prior to randomisation.,<VL Label=patient has been included in another clinical trial protocol for any investigational drug Source=ngram>patient has been included in another clinical trial protocol for any investigational drug</VL> <VML Logic=lower Unit=weeks>4</VML> prior to randomisation.,"[['patient has been included in another clinical trial protocol for any investigational drug', '<', '4', 'weeks']]"
NCT00140543,Exclusion,donor is older than 55 years of age.,donor is <VML Logic=greater Unit=years>55</VML> of <VL Label=Age Source=DK>age</VL>.,"[['Age', '>', 55.0, 'years']]"
NCT00141986,Inclusion,"hla genotypes that increase risk of type 1 diabetes: heterozygous for drb1*03, dqa1*0501, dqb1*0201 / drb1*04, dqa1*03011, dqb1*0302 (drb1*04 ≠ *0403 or related alleles) or homozygous for drb1*03, dqa1*0501, dqb1*0201 or homozygous for drb1*04, dqa1*03011, dqb1*0302 (drb1*04 ≠ *0403 or related alleles).","<VL Label=hla genotypes that increase risk of type 1 diabetes Source=ngram>hla genotypes that increase risk of type 1 diabetes</VL>: heterozygous for drb1*<VML Logic=equal Unit=>03</VML> , dqa1*<VML Logic=equal Unit=>0501</VML> , dqb1*<VML Logic=equal Unit=>0201</VML>  / drb1*<VML Logic=equal Unit=>04</VML> , dqa1*<VML Logic=equal Unit=>03011</VML> , dqb1*<VML Logic=equal Unit=>0302</VML>  ( drb1*<VML Logic=equal Unit=>04</VML> ≠ *<VML Logic=equal Unit=>0403</VML> or related alleles ) or homozygous for drb1*<VML Logic=equal Unit=>03</VML> , dqa1*<VML Logic=equal Unit=>0501</VML> , dqb1*<VML Logic=equal Unit=>0201</VML> or homozygous for drb1*<VML Logic=equal Unit=>04</VML> , dqa1*<VML Logic=equal Unit=>03011</VML> , dqb1*<VML Logic=equal Unit=>0302</VML>  ( drb1*<VML Logic=equal Unit=>04</VML> ≠ *<VML Logic=equal Unit=>0403</VML> or related alleles ) .","[['hla genotypes that increase risk of type 1 diabetes', '=', '03', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '0501', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '0201', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '04', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '03011', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '0302', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '04', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '0403', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '03', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '0501', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '0201', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '04', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '03011', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '0302', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '04', ''], ['hla genotypes that increase risk of type 1 diabetes', '=', '0403', '']]"
NCT00142922,Inclusion,aged 18-65,<VL Label=Age Source=DK>aged</VL> <VML Logic=greater_equal Unit=>18</VML> - <VML Logic=lower_equal Unit=>65</VML> ,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 65.0, 'years']]"
NCT00142922,Inclusion,aged 25-65 years,<VL Label=Age Source=DK>aged</VL> <VML Logic=greater_equal Unit=years>25</VML> - <VML Logic=lower_equal Unit=years>65</VML>,"[['Age', '>=', 25.0, 'years'], ['Age', '<=', 65.0, 'years']]"
NCT00142922,Exclusion,"renal disease, microalbumin >300 ug/mg)","<VL Label=renal disease Source=ngram>renal disease</VL>, microalbumin <VML Logic=greater Unit=ug/mg>300</VML> ) ","[['renal disease', '>', '300', 'ug/mg']]"
NCT00142922,Exclusion,hba1c levels less than 7.0% (normal range 4.0 - 6.0%).,<VL Label=HBA1C Source=DK>hba1c levels</VL> <VML Logic=lower Unit=%>7.0</VML> ( normal <VML Logic=greater_equal Unit=%>4.0</VML> - <VML Logic=lower_equal Unit=%>6.0</VML> ) .,"[['HBA1C', '<', 7.0, '%'], ['HBA1C', '>=', 4.0, '%'], ['HBA1C', '<=', 6.0, '%']]"
NCT00142922,Exclusion,hba1c levels greater than 14.0%,<VL Label=HBA1C Source=DK>hba1c levels</VL> <VML Logic=greater Unit=%>14.0</VML>,"[['HBA1C', '>', 14.0, '%']]"
NCT00142922,Exclusion,"a history of severe, unstable myocardial infarction, congestive heart failure or other severe cardiac disease, severe hypertension (systolic more than 160 mmhg or diastolic 90 mmhg) who may be at risk when mildly increasing physical activity","a history of severe, unstable myocardial infarction, congestive heart failure or other severe cardiac disease, severe hypertension ( <VL Label=BP-Systolic Source=DK>systolic</VL> <VML Logic=greater Unit=mmhg>160</VML> or <VL Label=BP-Diastolic Source=DK>diastolic</VL> <VML Logic=equal Unit=mmhg>90</VML> ) who may be at risk when mildly increasing physical activity","[['BP-Systolic', '>', 160.0, 'mmhg'], ['BP-Diastolic', '=', 90.0, 'mmhg']]"
NCT00143949,Inclusion,type 1 diabetic (dm) for 2-20 yrs,<VL Label=type 1 diabetic Source=ngram>type 1 diabetic</VL> ( dm ) for <VML Logic=greater_equal Unit=yrs>2</VML> - <VML Logic=lower_equal Unit=yrs>20</VML>,"[['type 1 diabetic', '>=', '2', 'yrs'], ['type 1 diabetic', '<=', '20', 'yrs']]"
NCT00143949,Inclusion,type 1 dm onset prior to 45,<VL Label=type 1 dm onset prior Source=ngram>type 1 dm onset prior</VL> to <VML Logic=equal Unit=>45</VML> ,"[['type 1 dm onset prior', '=', '45', '']]"
NCT00143949,Inclusion,"if onset was between ages 31-41, bmi <26","if onset was between <VL Label=Age Source=DK>ages</VL> <VML Logic=greater_equal Unit=>31</VML> - <VML Logic=lower_equal Unit=>41</VML> , <VL Label=BMI Source=DK>bmi</VL> <VML Logic=lower Unit=>26</VML> ","[['Age', '>=', 31.0, 'years'], ['Age', '<=', 41.0, 'years'], ['BMI', '<', 26.0, 'kg/m2']]"
NCT00143949,Inclusion,"onset 41-45, positive gad or ica required","<VL Label=onset Source=ngram>onset</VL> <VML Logic=greater_equal Unit=>41</VML> - <VML Logic=lower_equal Unit=>45</VML> , positive gad or ica required","[['onset', '>=', '41', ''], ['onset', '<=', '45', '']]"
NCT00143949,Inclusion,normoalbuminuric (<20 ug/min on 2 of 3 time overnight urine collections),<VL Label=normoalbuminuric Source=ngram>normoalbuminuric</VL> ( <VML Logic=lower Unit=ug/min>20</VML> on <VML Logic=equal Unit=>2</VML> of <VML Logic=equal Unit=>3</VML> time overnight urine collections ) ,"[['normoalbuminuric', '<', '20', 'ug/min'], ['normoalbuminuric', '=', '2', ''], ['normoalbuminuric', '=', '3', '']]"
NCT00143949,Exclusion,type 1 dm duration longer than 20 yrs,<VL Label=type 1 dm duration longer Source=ngram>type 1 dm duration longer</VL> than <VML Logic=equal Unit=yrs>20</VML>,"[['type 1 dm duration longer', '=', '20', 'yrs']]"
NCT00143949,Exclusion,hypertension (>85 - 135 mmhg),<VL Label=BP Source=DK>hypertension</VL> ( <VML Logic=greater Unit=mmhg>85</VML> - <VML Logic=greater Unit=mmhg>135</VML> ) ,"[['BP', '>', 85.0, 'mmhg'], ['BP', '>', 135.0, 'mmhg']]"
NCT00143949,Exclusion,reduced gfr (<90 ml/min/1.73m2),<VL Label=reduced gfr Source=ngram>reduced gfr</VL> ( <VML Logic=lower Unit=ml/min/1.73m2>90</VML> ) ,"[['reduced gfr', '<', '90', 'ml/min/1.73m2']]"
NCT00143949,Exclusion,pregnancy or females planning pregnancy within 2 years were excluded due to the drugs being used,<VL Label=pregnancy or females planning pregnancy Source=ngram>pregnancy or females planning pregnancy</VL> <VML Logic=lower Unit=years>2</VML> were excluded due to the drugs being used,"[['pregnancy or females planning pregnancy', '<', '2', 'years']]"
NCT00143949,Exclusion,compliance (pt not taking at least 85% of two week placebo were excluded),<VL Label=compliance Source=UMLS>compliance</VL> ( pt not taking <VML Logic=greater_equal Unit=%>85</VML> of two week placebo were excluded ) ,"[['compliance', '>=', '85', '%']]"
NCT00145353,Inclusion,age: 18-60 years,<VL Label=Age Source=DK>age</VL>: <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>60</VML>,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 60.0, 'years']]"
NCT00145353,Inclusion,bmi: 18-27.5,<VL Label=BMI Source=DK>bmi</VL>: <VML Logic=greater_equal Unit=>18</VML> - <VML Logic=lower_equal Unit=>27.5</VML> ,"[['BMI', '>=', 18.0, 'kg/m2'], ['BMI', '<=', 27.5, 'kg/m2']]"
NCT00145353,Inclusion,s-creatinin below 120 μmol/l and normal monofilament examination,<VL Label=s-creatinin Source=ngram>s-creatinin</VL> <VML Logic=lower Unit=>120</VML> μmol / l and normal monofilament examination,"[['s-creatinin', '<', '120', '']]"
NCT00145353,Exclusion,visus > 0.3 evaluated at the latest eye exam.,<VL Label=visus Source=ngram>visus</VL> <VML Logic=greater Unit=>0.3</VML> evaluated at the latest eye exam.,"[['visus', '>', '0.3', '']]"
NCT00145379,Inclusion,patients with type 1 diabetes mellitus treated with insulin 4 times daily.,patients with type 1 diabetes mellitus treated with <VL Label=Insulin Source=DK>insulin</VL> <VML Logic=equal Unit=times daily>4</VML>.,"[['Insulin', '=', 4.0, 'times daily']]"
NCT00145379,Inclusion,age: 18-60 years,<VL Label=Age Source=DK>age</VL>: <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>60</VML>,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 60.0, 'years']]"
NCT00145379,Inclusion,c-peptide <300 pmol/l,<VL Label=C-peptide Source=DK>c-peptide</VL> <VML Logic=lower Unit=pmol/l>300</VML>,"[['C-peptide', '<', 300.0, 'pmol/l']]"
NCT00145379,Inclusion,bmi >/= 25,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater_equal Unit=>25</VML> ,"[['BMI', '>=', 25.0, 'kg/m2']]"
NCT00145379,Inclusion,hba1c >/=8%,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater_equal Unit=%>8</VML>,"[['HBA1C', '>=', 8.0, '%']]"
NCT00145379,Exclusion,"known kidney disease, s-creatinin >100","<VL Label=known kidney disease Source=ngram>known kidney disease</VL>, s-creatinin <VML Logic=greater Unit=>100</VML> ","[['known kidney disease', '>', '100', '']]"
NCT00145379,Exclusion,"liver disease, alat > 50","<VL Label=liver disease Source=ngram>liver disease</VL>, alat <VML Logic=greater Unit=>50</VML> ","[['liver disease', '>', '50', '']]"
NCT00146484,Inclusion,"informed consent from adolescents greater than 16 years of age or if less than 16 years, informed consent from the parent/guardian with assent from the child.","informed consent from adolescents <VML Logic=greater Unit=years>16</VML> of <VL Label=Age Source=DK>age</VL> or if <VML Logic=lower Unit=years>16</VML>, informed consent from the parent / guardian with assent from the child.","[['Age', '>', 16.0, 'years'], ['Age', '<', 16.0, 'years']]"
NCT00147342,Inclusion,clinical diagnosis of type 1 diabetes for at least 18 months (the diagnosis of type 1 diabetes is based on the investigator's judgment,<VL Label=clinical diagnosis of type 1 diabetes Source=ngram>clinical diagnosis of type 1 diabetes</VL> for <VML Logic=greater_equal Unit=months>18</VML> ( the diagnosis of type 1 diabetes is based on the investigator's judgment,"[['clinical diagnosis of type 1 diabetes', '>=', '18', 'months']]"
NCT00147342,Inclusion,hba1c <10.0% (the dca2000 will be used to assess eligibility.),<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=lower Unit=%>10.0</VML> ( the dca2000 will be used to assess eligibility. ) ,"[['HBA1C', '<', 10.0, '%']]"
NCT00147342,Inclusion,age 8.0 to <18.0 years,<VL Label=Age Source=DK>age</VL> <VML Logic=equal Unit=years>8.0</VML> - <VML Logic=lower Unit=years>18.0</VML>,"[['Age', '=', 8.0, 'years'], ['Age', '<', 18.0, 'years']]"
NCT00147342,Inclusion,weight >39.5 kg at reinfusion centers and >46.0 kg at discard centers,<VL Label=Weight Source=DK>weight</VL> <VML Logic=greater Unit=kg>39.5</VML> at reinfusion centers and <VML Logic=greater Unit=kg>46.0</VML> at discard centers,"[['Weight', '>', 39.5, 'kg'], ['Weight', '>', 46.0, 'kg']]"
NCT00147342,Exclusion,"use of pseudoephedrine 48 hours prior to visit (if used in the 48 hours prior to the scheduled visit, the visit will be deferred)","<VL Label=use of pseudoephedrine Source=ngram>use of pseudoephedrine</VL> <VML Logic=equal Unit=hours>48</VML> prior to visit ( if used <VML Logic=lower_equal Unit=hours>48</VML> prior to the scheduled visit, the visit will be deferred ) ","[['use of pseudoephedrine', '=', '48', 'hours'], ['use of pseudoephedrine', '<=', '48', 'hours']]"
NCT00147342,Exclusion,"severe hypoglycemia resulting in seizure or loss of consciousness in the 2 weeks prior to a visit (if a severe episode occurs within 2 weeks prior to the scheduled visit, the visit will be deferred)","<VL Label=severe hypoglycemia resulting in seizure or loss of consciousness Source=ngram>severe hypoglycemia resulting in seizure or loss of consciousness</VL> <VML Logic=lower_equal Unit=weeks>2</VML> prior to a visit ( if a severe episode occurs <VML Logic=lower Unit=weeks>2</VML> prior to the scheduled visit, the visit will be deferred ) ","[['severe hypoglycemia resulting in seizure or loss of consciousness', '<=', '2', 'weeks'], ['severe hypoglycemia resulting in seizure or loss of consciousness', '<', '2', 'weeks']]"
NCT00148538,Inclusion,"male or female, age 16-45 years, a1c 0.066-0.090","male or female, <VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=years>16</VML> - <VML Logic=lower_equal Unit=years>45</VML>, <VL Label=HBA1C Source=DK>a1c</VL> <VML Logic=greater_equal Unit=>0.066</VML> - <VML Logic=lower_equal Unit=>0.090</VML> ","[['Age', '>=', 16.0, 'years'], ['Age', '<=', 45.0, 'years'], ['HBA1C', '>=', 6.6, '%'], ['HBA1C', '<=', 9.0, '%']]"
NCT00148538,Inclusion,"willingness and ability to work closely with the study physicians, nurse and dietitian and follow intensive diabetes therapy including carbohydrate counting, glucose monitoring >= 4 times per day and intensive insulin therapy--either by multiple daily injections (mdi--insulin aspart or lispro before meals and nph or insulin glargine 1-2x/day) or continuous subcutaneous insulin infusion (csii) by pump therapy using insulin aspart or lispro for the duration of involvement in the study","willingness and ability to work closely with the study physicians, nurse and dietitian and follow intensive diabetes therapy including carbohydrate counting, <VL Label=Glucose Source=DK>glucose</VL> monitoring <VML Logic=greater_equal Unit=times/day>4</VML> and intensive <VL Label=Insulin Source=DK>insulin</VL> therapy - either by multiple daily injections ( mdi - insulin aspart or lispro before meals and nph or <VL Label=Insulin Source=DK>insulin glargine</VL> <VML Logic=greater_equal Unit=>1</VML> - <VML Logic=lower_equal Unit=>2</VML> x / day ) or continuous subcutaneous insulin infusion ( csii ) by pump therapy using insulin aspart or lispro for the duration of involvement in the study","[['Glucose', '>=', 4.0, 'times/day'], ['Insulin', '>=', 1.0, 'uiu/ml'], ['Insulin', '<=', 2.0, 'uiu/ml']]"
NCT00148538,Exclusion,participation during the previous 4 months in a regular program of exercise or aerobic sports greater than 2 times per week for at least 20 minutes per session or in any resistance training.,<VL Label=participation Source=ngram>participation</VL> <VML Logic=lower_equal Unit=previous months>4</VML> in a regular program of exercise or aerobic sports <VML Logic=greater Unit=times/week>2</VML> for <VML Logic=greater_equal Unit=minutes>20</VML> per session or in any resistance training.,"[['participation', '<=', '4', 'previous months'], ['participation', '>', '2', 'times/week'], ['participation', '>=', '20', 'minutes']]"
NCT00148538,Exclusion,hypoglycemia unawareness or severe hypoglycemia requiring assistance from another person within the previous 3 months.,<VL Label=hypoglycemia unawareness or severe hypoglycemia requiring assistance from another person Source=ngram>hypoglycemia unawareness or severe hypoglycemia requiring assistance from another person</VL> <VML Logic=lower Unit=previous months>3</VML>.,"[['hypoglycemia unawareness or severe hypoglycemia requiring assistance from another person', '<', '3', 'previous months']]"
NCT00148538,Exclusion,body mass index less than or equal to 32 kg/m2.,<VL Label=BMI Source=DK>body mass index</VL> <VML Logic=lower_equal Unit=kg/m2>32</VML>.,"[['BMI', '<=', 32.0, 'kg/m2']]"
NCT00148538,Exclusion,fasting serum c-peptide less than 0.2 nmol/l.,fasting serum <VL Label=C-peptide Source=DK>c-peptide</VL> <VML Logic=lower Unit=nmol/l>0.2</VML>.,"[['C-peptide', '<', 0.2, 'nmol/l']]"
NCT00148538,Exclusion,recent significant weight change (increase or decrease of 5% of body weight during the two months before enrollment).,recent significant <VL Label=weight change Source=UMLS>weight change</VL> ( increase or decrease of <VML Logic=equal Unit=%>5</VML> of <VL Label=Weight Loss Source=DK>body weight</VL> during the two months before enrollment ) .,"[['Weight Loss', '=', 5.0, '%']]"
NCT00148538,Exclusion,"if age < 18 yr, linear growth of 1cm during the previous year.","if <VL Label=Age Source=DK>age</VL> <VML Logic=lower Unit=yr>18</VML>, linear growth of <VML Logic=equal Unit=cm>1</VML> during the previous year.","[['Age', '<', 18.0, 'yr']]"
NCT00148538,Exclusion,significant renal disease: serum creatinine greater than 200 meq/l,significant renal disease: <VL Label=Creatinine Source=DK>serum creatinine</VL> <VML Logic=greater Unit=>200</VML> meq / l,"[['Creatinine', '>', 2.26, 'mg/dl']]"
NCT00148538,Exclusion,or proteinuria > 1 g/24 hours.,or <VL Label=proteinuria Source=ngram>proteinuria</VL> <VML Logic=greater Unit=g>1</VML> / <VML Logic=equal Unit=hours>24</VML>.,"[['proteinuria', '>', '1', 'g'], ['proteinuria', '=', '24', 'hours']]"
NCT00148538,Exclusion,uncontrolled hypertension: bp > 150 mm hg systolic or > 95 mm hg diastolic in a sitting position.,uncontrolled hypertension: <VL Label=BP Source=DK>bp</VL> <VML Logic=greater Unit=mm hg>150</VML> <VL Label=BP-Systolic Source=DK>systolic</VL> or <VML Logic=greater Unit=mm hg>95</VML> <VL Label=BP-Diastolic Source=DK>diastolic</VL> in a sitting position.,"[['BP', '>', 150.0, 'mm hg'], ['BP-Systolic', '>', 95.0, 'mm hg']]"
NCT00160732,Inclusion,patients must have been diabetic for at least five years and be aged 18 - 58 years.,patients must have been diabetic for greater_equal five years and be <VL Label=Age Source=DK>aged</VL> <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>58</VML>.,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 58.0, 'years']]"
NCT00160732,Inclusion,"hypoglycemic unawareness, with at least one episode in the past two years in which hypoglycemia required the assistance of another person (e.g., family member, emergency medical technician [emt], etc.) and was associated with a fingerstick blood glucose (fsbg) of < 50 mg/dl and prompt recovery after administration of oral glucose, intravenous glucose or glucagon;","hypoglycemic unawareness, with greater_equal one episode in the past two years in which hypoglycemia required the assistance of another person ( e.g., family member, emergency medical technician [ emt ] , etc. ) and was associated with a fingerstick blood <VL Label=Glucose Source=DK>glucose</VL> ( fsbg ) of <VML Logic=lower Unit=mg/dl>50</VML> and prompt recovery after administration of oral <VL Label=Glucose Source=DK>glucose</VL>, intravenous glucose or glucagon;","[['Glucose', '<', 2.78, 'mmol/l']]"
NCT00160732,Exclusion,panel of reactive antibody (pra) > 10%,<VL Label=panel of reactive antibody Source=ngram>panel of reactive antibody</VL> ( pra )  <VML Logic=greater Unit=%>10</VML>,"[['panel of reactive antibody', '>', '10', '%']]"
NCT00160732,Exclusion,creatinine clearance < 80 ml/min,<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=lower Unit=ml/min>80</VML>,"[['Creatinine clearance', '<', 80.0, 'ml/min']]"
NCT00160732,Exclusion,abnormal liver function tests (> 2 times the upper limit of normal as defined by the university of chicago clinical laboratory),<VL Label=abnormal liver function tests Source=ngram>abnormal liver function tests</VL> ( <VML Logic=greater Unit=times the upper limit of normal>2</VML> as defined by the university of chicago clinical laboratory ) ,"[['abnormal liver function tests', '>', '2', 'times the upper limit of normal']]"
NCT00160732,Exclusion,"""the evaluation of renal transplant candidates: clinical practice guidelines,"" american journal of transplantation 1 (supplement 2): 12-22, 2001.","""the <VL Label=evaluation of renal transplant candidates Source=ngram>evaluation of renal transplant candidates</VL>: clinical practice guidelines,"" american journal of transplantation <VML Logic=equal Unit=>1</VML>  ( supplement <VML Logic=equal Unit=>2</VML> ) : <VML Logic=greater_equal Unit=>12</VML> - <VML Logic=lower_equal Unit=>22</VML> , <VML Logic=equal Unit=>2001</VML> .","[['evaluation of renal transplant candidates', '=', '1', ''], ['evaluation of renal transplant candidates', '=', '2', ''], ['evaluation of renal transplant candidates', '>=', '12', ''], ['evaluation of renal transplant candidates', '<=', '22', ''], ['evaluation of renal transplant candidates', '=', '2001', '']]"
NCT00160732,Exclusion,obesity (body mass index [bmi] > 28),obesity ( body mass index [ <VL Label=BMI Source=DK>bmi</VL> ]  <VML Logic=greater Unit=>28</VML> ) ,"[['BMI', '>', 28.0, 'kg/m2']]"
NCT00160732,Exclusion,ejection fraction < 30%,<VL Label=Ejection fraction Source=DK>ejection fraction</VL> <VML Logic=lower Unit=%>30</VML>,"[['Ejection fraction', '<', 30.0, '%']]"
NCT00160732,Exclusion,myocardial infarction (mi) within the past 6 months,<VL Label=Myocardial infarction Source=DK>myocardial infarction</VL> ( mi ) <VML Logic=lower Unit=past months>6</VML>,"[['Myocardial infarction', '<', 6.0, 'past months']]"
NCT00175253,Inclusion,participant must have had type 1 diabetes mellitus for more than 5 years,<VL Label=participant must have had type 1 diabetes mellitus Source=ngram>participant must have had type 1 diabetes mellitus</VL> for <VML Logic=greater Unit=years>5</VML>,"[['participant must have had type 1 diabetes mellitus', '>', '5', 'years']]"
NCT00175253,Inclusion,"diabetes must be complicated by at least 1 of the following situations that persist despite intensive insulin management efforts: (1) reduced awareness of hypoglycemia, as defined by the absence of adequate autonomic symptoms at plasma glucose levels < 3.0 mmol/l, indicated by, 2 or more episodes of severe hypoglycemia requiring third party assistance within 12 months","diabetes must be complicated by <VML Logic=greater_equal Unit=>1</VML> of the following situations that persist despite intensive insulin management efforts: ( 1 ) reduced awareness of hypoglycemia, as defined by the absence of adequate autonomic symptoms at plasma <VL Label=glucose level - finding Source=UMLS>glucose levels</VL> <VML Logic=lower Unit=mmol/l>3.0</VML>, indicated by, <VML Logic=greater_equal Unit=episodes>2</VML> of severe hypoglycemia requiring third party assistance <VML Logic=lower Unit=months>12</VML>","[['glucose level - finding', '>=', '1', ''], ['glucose level - finding', '<', '3.0', 'mmol/l'], ['glucose level - finding', '>=', '2', 'episodes'], ['glucose level - finding', '<', '12', 'months']]"
NCT00175253,Inclusion,"or (2) metabolic instability, characterized by erratic blood glucose levels that interfere with daily activities and or 2 or more hospital visits for diabetic ketoacidosis over the last 12 months.","or ( 2 ) metabolic instability, characterized by erratic <VL Label=finding of blood glucose level Source=UMLS>blood glucose levels</VL> that interfere with daily activities and or <VML Logic=greater_equal Unit=>2</VML> hospital visits for diabetic ketoacidosis <VML Logic=greater Unit=last months>12</VML>.","[['finding of blood glucose level', '>=', '2', ''], ['finding of blood glucose level', '>', '12', 'last months']]"
NCT00175253,Exclusion,bmi > 28 kg/m2 at screening visit,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater Unit=kg/m2>28</VML> at screening visit,"[['BMI', '>', 28.0, 'kg/m2']]"
NCT00175253,Exclusion,creatinine clearance < 65 ml/min/1.73 m2,<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=lower Unit=ml/min/1.73 m2>65</VML>,"[['Creatinine clearance', '<', 65.0, 'ml/min/1.73 m2']]"
NCT00175253,Exclusion,blood creatinine > 150 µmol/l (1.7 mg/dl),blood <VL Label=Creatinine Source=DK>creatinine</VL> <VML Logic=greater Unit=>150</VML> µmol / l ( <VML Logic=equal Unit=mg/dl>1.7</VML> ) ,"[['Creatinine', '>', 1.7, 'mg/dl'], ['Creatinine', '=', 1.7, 'mg/dl']]"
NCT00175253,Exclusion,macroalbuminuria (urinary albumin excretion rate > 300 mg/24h),macroalbuminuria ( urinary <VL Label=albumin excretion rate measurement Source=UMLS>albumin excretion rate</VL> <VML Logic=greater Unit=mg>300</VML> / <VML Logic=equal Unit=h>24</VML> ) ,"[['albumin excretion rate measurement', '>', '300', 'mg'], ['albumin excretion rate measurement', '=', '24', 'h']]"
NCT00175253,Exclusion,baseline hb < 105g/l (<10.5 g/dl) in women or < 130 g/l (<13 g/dl) in men,<VL Label=baseline hb Source=ngram>baseline hb</VL> <VML Logic=lower Unit=g/l>105</VML> ( <VML Logic=lower Unit=g/dl>10.5</VML> ) in women or <VML Logic=lower Unit=g/l>130</VML> ( <VML Logic=lower Unit=g/dl>13</VML> ) in men,"[['baseline hb', '<', '105', 'g/l'], ['baseline hb', '<', '10.5', 'g/dl'], ['baseline hb', '<', '130', 'g/l'], ['baseline hb', '<', '13', 'g/dl']]"
NCT00175253,Exclusion,insulin requirement >1.0 u/kg/day,<VL Label=Insulin Source=DK>insulin</VL> requirement <VML Logic=greater Unit=u/kg>1.0</VML> / day,"[['Insulin', '>', 1.0, 'u/kg']]"
NCT00175253,Exclusion,hba1c >12%,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=%>12</VML>,"[['HBA1C', '>', 12.0, '%']]"
NCT00175253,Exclusion,use of coumadin or other anticoagulant therapy (except aspirin) or subject with pt inr > 1.5,<VL Label=use of coumadin or other anticoagulant therapy Source=ngram>use of coumadin or other anticoagulant therapy</VL> ( except aspirin ) or subject with pt <VML Logic=greater Unit=inr>1.5</VML> ,"[['use of coumadin or other anticoagulant therapy', '>', '1.5', 'inr']]"
NCT00175266,Inclusion,must have type 1 diabetes mellitus for more than 5 years,must have <VL Label=type 1 diabetes mellitus Source=ngram>type 1 diabetes mellitus</VL> for <VML Logic=greater Unit=years>5</VML>,"[['type 1 diabetes mellitus', '>', '5', 'years']]"
NCT00175266,Inclusion,"the complicating situations are (1) reduced awareness of hypoglycemia, as defined by the absence of adequate autonomic symptoms at plasma glucose levels of < 3.0 mmol/l","the complicating situations are ( 1 ) reduced awareness of hypoglycemia, as defined by the absence of adequate autonomic symptoms at plasma <VL Label=glucose level - finding Source=UMLS>glucose levels</VL> of <VML Logic=lower Unit=mmol/l>3.0</VML>","[['glucose level - finding', '<', '3.0', 'mmol/l']]"
NCT00175266,Inclusion,"(2) metabolic lability/instability, characterized by mage >= 11.0 mmol/l and wide swings in blood glucose despite optimal diabetes therapy"," ( 2 ) metabolic lability / instability, characterized by <VL Label=MAGE Source=DK>mage</VL> <VML Logic=greater_equal Unit=mmol/l>11.0</VML> and wide swings in blood <VL Label=Glucose Source=DK>glucose</VL> despite optimal diabetes therapy","[['MAGE', '>=', 11.0, 'mmol/l']]"
NCT00175266,Exclusion,bmi > 28 kg/m2 or body weight > 85 kg at screening visit,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater Unit=kg/m2>28</VML> or <VL Label=Weight Loss Source=DK>body weight</VL> <VML Logic=greater Unit=kg>85</VML> at screening visit,"[['BMI', '>', 28.0, 'kg/m2'], ['Weight Loss', '>', 85.0, 'kg']]"
NCT00175266,Exclusion,positive fasting c-peptide response on assessment (2 positive results),positive <VL Label=C-peptide Source=DK>fasting c-peptide</VL> response on assessment ( <VML Logic=equal Unit=>2</VML> positive results ) ,"[['C-peptide', '=', 2.0, 'ng/ml']]"
NCT00175266,Exclusion,creatinine clearance < 80 ml/min/1.73 m2,<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=lower Unit=ml/min/1.73 m2>80</VML>,"[['Creatinine clearance', '<', 80.0, 'ml/min/1.73 m2']]"
NCT00175266,Exclusion,serum creatinine > 150 µmol/l,<VL Label=Creatinine Source=DK>serum creatinine</VL> <VML Logic=greater Unit=>150</VML> µmol / l,"[['Creatinine', '>', 1.7, 'mg/dl']]"
NCT00175266,Exclusion,macroalbuminuria (urinary albumin excretion rate > 300 mg/24h),macroalbuminuria ( urinary <VL Label=albumin excretion rate measurement Source=UMLS>albumin excretion rate</VL> <VML Logic=greater Unit=mg>300</VML> / <VML Logic=equal Unit=h>24</VML> ) ,"[['albumin excretion rate measurement', '>', '300', 'mg'], ['albumin excretion rate measurement', '=', '24', 'h']]"
NCT00175266,Exclusion,baseline hb < 105g/l in women or < 130 g/l in men,<VL Label=baseline hb Source=ngram>baseline hb</VL> <VML Logic=lower Unit=g/l>105</VML> in women or <VML Logic=lower Unit=g/l>130</VML> in men,"[['baseline hb', '<', '105', 'g/l'], ['baseline hb', '<', '130', 'g/l']]"
NCT00175266,Exclusion,insulin requirement > 1.0 iu/kg/day,<VL Label=Insulin Source=DK>insulin</VL> requirement <VML Logic=greater Unit=iu/kg>1.0</VML> / day,"[['Insulin', '>', 1.0, 'iu/kg']]"
NCT00175266,Exclusion,hba1c > 0.12,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=>0.12</VML> ,"[['HBA1C', '>', 12.0, '%']]"
NCT00175266,Exclusion,"hyperlipidemia (fasting ldl cholesterol > 3.4 mmol/l, treated or untreated","hyperlipidemia ( fasting <VL Label=LDL Cholesterol Source=DK>ldl cholesterol</VL> <VML Logic=greater Unit=mmol/l>3.4</VML>, treated or untreated","[['LDL Cholesterol', '>', 3.4, 'mmol/l']]"
NCT00175266,Exclusion,and/or fasting triglycerides > 2.3 mmol/l),and / or fasting <VL Label=LDL Source=DK>triglycerides</VL> <VML Logic=greater Unit=mmol/l>2.3</VML> ) ,"[['LDL', '>', 41.4, 'mg/dl']]"
NCT00175266,Exclusion,use of coumadin or other anticoagulant therapy (except aspirin) or subject with pt inr > 1.5,<VL Label=use of coumadin or other anticoagulant therapy Source=ngram>use of coumadin or other anticoagulant therapy</VL> ( except aspirin ) or subject with pt <VML Logic=greater Unit=inr>1.5</VML> ,"[['use of coumadin or other anticoagulant therapy', '>', '1.5', 'inr']]"
NCT00179777,Exclusion,the gestational age of the newborn infant is less than 35 weeks.,the gestational <VL Label=Age Source=DK>age</VL> of the newborn infant is <VML Logic=lower Unit=weeks>35</VML>.,"[['Age', '<', 35.0, 'weeks']]"
NCT00179777,Exclusion,the infant is older than 7 days at randomization.,the <VL Label=infant Source=ngram>infant</VL> is <VML Logic=greater Unit=days>7</VML> at randomization.,"[['infant', '>', '7', 'days']]"
NCT00179777,Exclusion,no hla sample drawn before the age of 8 days.,no hla sample drawn before the <VL Label=Age Source=DK>age</VL> of <VML Logic=equal Unit=days>8</VML>.,"[['Age', '=', 8.0, 'days']]"
NCT00184639,Inclusion,bmi maximum 32 kg/m^2,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=lower_equal Unit=kg/m^2>32</VML>,"[['BMI', '<=', 32.0, 'kg/m2']]"
NCT00184639,Inclusion,hba1c > 5.5 % and < 12.0 %,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=%>5.5</VML> and <VML Logic=lower Unit=%>12.0</VML>,"[['HBA1C', '>', 5.5, '%'], ['HBA1C', '<', 12.0, '%']]"
NCT00184665,Inclusion,bmi = 35.0 kg/m2,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=equal Unit=kg/m2>35.0</VML>,"[['BMI', '=', 35.0, 'kg/m2']]"
NCT00184665,Inclusion,hba1c =11.0%,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=equal Unit=%>11.0</VML>,"[['HBA1C', '=', 11.0, '%']]"
NCT00187564,Inclusion,"subjects must be pubertal (defined as tanner stage ii or greater) or post-pubertal, with an upper age limit of 21 years.","subjects must be pubertal ( defined as tanner stage ii or greater ) or post-pubertal, with an upper <VL Label=Age Source=DK>age</VL> limit of <VML Logic=equal Unit=years>21</VML>.","[['Age', '=', 21.0, 'years']]"
NCT00187564,Inclusion,subjects must have diabetes by 1997 ada criteria:,<VL Label=subjects must have diabetes Source=ngram>subjects must have diabetes</VL> by <VML Logic=equal Unit=>1997</VML> ada criteria:,"[['subjects must have diabetes', '=', '1997', '']]"
NCT00187564,Inclusion,"fasting plasma glucose >= 126 mg/dl, or","<VL Label=Glucose Source=DK>fasting plasma glucose</VL> <VML Logic=greater_equal Unit=mg/dl>126</VML>, or","[['Glucose', '>=', 7.0, 'mmol/l']]"
NCT00187564,Inclusion,2 hour postprandial glucose >= 200 mg/dl,<VML Logic=equal Unit=hour>2</VML> postprandial <VL Label=Glucose Source=DK>glucose</VL> <VML Logic=greater_equal Unit=mg/dl>200</VML>,"[['Glucose', '>=', 11.11, 'mmol/l']]"
NCT00187564,Inclusion,"subjects must have history of least one auto-antibody associated with t1d, either glutamic acid decarboxylase (gada) or islet cell autoantigen 512 (ica512) or history of diabetic ketoacidosis.","<VL Label=subjects must have history of least one auto-antibody associated with t1d Source=ngram>subjects must have history of least one auto-antibody associated with t1d</VL>, either glutamic acid decarboxylase ( gada ) or islet cell autoantigen <VML Logic=equal Unit=>512</VML>  ( ica512 ) or history of diabetic ketoacidosis.","[['subjects must have history of least one auto-antibody associated with t1d', '=', '512', '']]"
NCT00187564,Exclusion,"subjects must not have history of eye, kidney or nerve damage 2","<VL Label=subjects must not have history of eye Source=ngram>subjects must not have history of eye</VL>, kidney or nerve damage <VML Logic=equal Unit=>2</VML> ","[['subjects must not have history of eye', '=', '2', '']]"
NCT00190502,Inclusion,body mass index up to 32 kg/m2,<VL Label=BMI Source=DK>body mass index</VL> <VML Logic=lower_equal Unit=kg/m2>32</VML>,"[['BMI', '<=', 32.0, 'kg/m2']]"
NCT00190502,Inclusion,known diagnosis of diabetes of less than 6 weeks,<VL Label=known diagnosis of diabetes Source=ngram>known diagnosis of diabetes</VL> of <VML Logic=lower Unit=weeks>6</VML>,"[['known diagnosis of diabetes', '<', '6', 'weeks']]"
NCT00190502,Inclusion,insulin dose of up to 40 iu per day for no longer than 1 month,<VL Label=Insulin Source=DK>insulin</VL> dose of <VML Logic=lower_equal Unit=iu/day>40</VML> for no longer than <VML Logic=equal Unit=month>1</VML>,"[['Insulin', '<=', 40.0, 'iu/day']]"
NCT00190502,Inclusion,c-peptide level >= 0.3 pmol/ml 4 min,<VL Label=C-peptide Source=DK>c-peptide level</VL> <VML Logic=greater_equal Unit=pmol/ml>0.3</VML> <VML Logic=equal Unit=min>4</VML>,"[['C-peptide', '>=', 0.3, 'pmol/ml']]"
NCT00190502,Inclusion,following intravenous (iv) administration of 1 ml glucagon,<VL Label=following intravenous Source=ngram>following intravenous</VL> ( iv ) administration of <VML Logic=equal Unit=ml>1</VML> glucagon,"[['following intravenous', '=', '1', 'ml']]"
NCT00190502,Inclusion,granulocyte count >= 2 x 10^9/l,<VL Label=granulocyte count Source=ngram>granulocyte count</VL> <VML Logic=greater_equal Unit=>2 x 10</VML> ^9/l,"[['granulocyte count', '>=', '2 x 10', '']]"
NCT00190502,Inclusion,platelet count >= 120 x 10^9/l,<VL Label=platelet count measurement Source=UMLS>platelet count</VL> <VML Logic=greater_equal Unit=>120 x 10</VML> ^9/l,"[['platelet count measurement', '>=', '120 x 10', '']]"
NCT00191581,Inclusion,men and women who have had either type 1 or type 2 diabetes (world health organization[who]classification)for at least 2 months and are between the ages of 18 and 70 (inclusive) at the signing of the informed consent.,men and women who have had either type 1 or type 2 diabetes ( world health organization [ who ] classification ) for <VML Logic=greater_equal Unit=months>2</VML> and are between the <VL Label=Age Source=DK>ages</VL> <VML Logic=greater_equal Unit=>18</VML> - <VML Logic=lower_equal Unit=>70</VML>  ( inclusive ) at the signing of the informed consent.,"[['Age', '>=', 2.0, 'months'], ['Age', '>=', 18.0, 'years'], ['Age', '<=', 70.0, 'years']]"
NCT00191581,Inclusion,have been treated with commercially available human insulin mix 50 - 50 or human insulin mix 30 - 70 twice daily as the only pharmacological treatment for their diabetes for at least 2 months prior to entering the study.,have been treated with commercially available human <VL Label=Insulin Source=DK>insulin</VL> mix <VML Logic=greater_equal Unit=>50</VML> - <VML Logic=lower_equal Unit=>50</VML> or human <VL Label=Insulin Source=DK>insulin</VL> mix <VML Logic=greater_equal Unit=twice daily>30</VML> - <VML Logic=lower_equal Unit=twice daily>70</VML> as the only pharmacological treatment for their diabetes for <VML Logic=greater_equal Unit=months>2</VML> prior to entering the study.,"[['Insulin', '>=', 50.0, 'uiu/ml'], ['Insulin', '<=', 50.0, 'uiu/ml'], ['Insulin', '>=', 30.0, 'twice daily'], ['Insulin', '<=', 70.0, 'twice daily']]"
NCT00191581,Inclusion,have an hba1c between 1.1 and 1.7 times the upper limit of the normal reference rang(inclusive) as determined by a local laboratory within 2 weeks prior to or at visit 1.,have an <VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater_equal Unit=times>1.1</VML> - <VML Logic=lower_equal Unit=times>1.7</VML> the upper limit of the normal reference rang ( inclusive ) as determined by a local laboratory <VML Logic=lower Unit=weeks>2</VML> prior to or at visit 1 .,"[['HBA1C', '>=', 1.1, 'times'], ['HBA1C', '<=', 1.7, 'times']]"
NCT00191581,Exclusion,"{1] have used oral antidiabetic agents, including biguanides, sulfonylureas, glucosidase inhibitors and insulin-sensitivity enhancers within 30 days prior to entry into the study."," { 1 ] have used oral antidiabetic agents, including biguanides, sulfonylureas, glucosidase inhibitors and insulin-sensitivity enhancers <VML Logic=lower Unit=days>30</VML> prior to <VL Label=Study entry Source=DK>entry</VL> into the study.","[['Study entry', '<', 30.0, 'days']]"
NCT00191581,Exclusion,[2] receive a total daily dose of insulin >2 units/kg., [ 2 ] receive a total daily dose of <VL Label=Insulin Source=DK>insulin</VL> <VML Logic=greater Unit=units/kg>2</VML>.,"[['Insulin', '>', 2.0, 'units/kg']]"
NCT00191581,Exclusion,[3] have had more than two episodes of severe hypoglycemia (defined as requiring assistance of another person due to disabling hypoglycemia) within 6 months prior to entry into the study., [ 3 ] have had more than two episodes of severe hypoglycemia ( defined as requiring assistance of another person due to disabling hypoglycemia ) <VML Logic=lower Unit=months>6</VML> prior to <VL Label=Study entry Source=DK>entry</VL> into the study.,"[['Study entry', '<', 6.0, 'months']]"
NCT00191581,Exclusion,[4] have a body mass index >35 kg/m2., [ 4 ] have a <VL Label=BMI Source=DK>body mass index</VL> <VML Logic=greater Unit=kg/m2>35</VML>.,"[['BMI', '>', 35.0, 'kg/m2']]"
NCT00198146,Inclusion,ages 2 to 40 years at diagnosis,<VL Label=Age Source=DK>ages</VL> <VML Logic=greater_equal Unit=years>2</VML> - <VML Logic=lower_equal Unit=years>40</VML> at diagnosis,"[['Age', '>=', 2.0, 'years'], ['Age', '<=', 40.0, 'years']]"
NCT00198146,Inclusion,enroll within 3 months of diagnosis,<VL Label=enroll Source=ngram>enroll</VL> <VML Logic=lower Unit=months>3</VML> of diagnosis,"[['enroll', '<', '3', 'months']]"
NCT00198146,Inclusion,"test positive for at least one of the biochemical autoantibodies (ica-512, gad 65 or iaa) prior to enrolling","<VL Label=test positive for greater_equal one of the biochemical autoantibodies Source=ngram>test positive for greater_equal one of the biochemical autoantibodies</VL> ( ica - 512 , gad <VML Logic=equal Unit=>65</VML> or iaa ) prior to enrolling","[['test positive for greater_equal one of the biochemical autoantibodies', '=', '65', '']]"
NCT00206258,Inclusion,age >12 years < 19 years,<VL Label=Age Source=DK>age</VL> <VML Logic=greater Unit=years>12</VML> <VML Logic=lower Unit=years>19</VML>,"[['Age', '>', 12.0, 'years'], ['Age', '<', 19.0, 'years']]"
NCT00206258,Inclusion,have diabetes for at least 2 years and in good control (hba1c < 8%).,have diabetes for <VML Logic=greater_equal Unit=years>2</VML> and in good control ( <VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=lower Unit=%>8</VML> ) .,"[['HBA1C', '<', 8.0, '%']]"
NCT00206258,Inclusion,hemoglobin equal to or > than 12 g/dl before each study.,<VL Label=hemoglobin equal Source=ngram>hemoglobin equal</VL> or > than <VML Logic=equal Unit=g/dl>12</VML> before each study.,"[['hemoglobin equal', '=', '12', 'g/dl']]"
NCT00206258,Inclusion,weight more than 44 kg.,<VL Label=Weight Source=DK>weight</VL> <VML Logic=greater Unit=kg>44</VML>.,"[['Weight', '>', 44.0, 'kg']]"
NCT00206258,Exclusion,age >18 or < 12 y at the time of study,<VL Label=Age Source=DK>age</VL> <VML Logic=greater Unit=y>18</VML> - <VML Logic=lower Unit=y>12</VML> at the time of study,"[['Age', '>', 18.0, 'y'], ['Age', '<', 12.0, 'y']]"
NCT00206258,Exclusion,"hemoglobin less than 12 g/dl (if before any of the studies the hemoglobin is lower than 12 g/dl, subjects will be excluded from further studies)","<VL Label=hemoglobin Source=ngram>hemoglobin</VL> <VML Logic=lower Unit=g/dl>12</VML> ( if before any of the studies the hemoglobin is <VML Logic=lower Unit=g/dl>12</VML>, subjects will be excluded from further studies ) ","[['hemoglobin', '<', '12', 'g/dl'], ['hemoglobin', '<', '12', 'g/dl']]"
NCT00206258,Exclusion,hgb a1c >8.0 % in a diabetic subject,hgb <VL Label=HBA1C Source=DK>a1c</VL> <VML Logic=greater Unit=%>8.0</VML> in a diabetic subject,"[['HBA1C', '>', 8.0, '%']]"
NCT00206258,Exclusion,weight less than 44 kg,<VL Label=Weight Source=DK>weight</VL> <VML Logic=lower Unit=kg>44</VML>,"[['Weight', '<', 44.0, 'kg']]"
NCT00206297,Inclusion,between 12-21 years of age at the time of enrollment.,<VML Logic=greater_equal Unit=years>12</VML> - <VML Logic=lower_equal Unit=years>21</VML> of <VL Label=Age Source=DK>age</VL> at the time of enrollment.,"[['Age', '>=', 12.0, 'years'], ['Age', '<=', 21.0, 'years']]"
NCT00206297,Inclusion,have been diagnosed with diabetes for at least 2 years and in good control (hba1c less than 8.5%).,have been diagnosed with diabetes for <VML Logic=greater_equal Unit=years>2</VML> and in good control ( <VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=lower Unit=%>8.5</VML> ) .,"[['HBA1C', '<', 8.5, '%']]"
NCT00206297,Inclusion,hemoglobin equal to or > 12 g/dl before each study.,<VL Label=hemoglobin equal Source=ngram>hemoglobin equal</VL> or <VML Logic=greater Unit=g/dl>12</VML> before each study.,"[['hemoglobin equal', '>', '12', 'g/dl']]"
NCT00206297,Inclusion,weight more than 44 kg,<VL Label=Weight Source=DK>weight</VL> <VML Logic=greater Unit=kg>44</VML>,"[['Weight', '>', 44.0, 'kg']]"
NCT00206297,Exclusion,age greater than 22 years or less than 12 years at the time of study,<VL Label=Age Source=DK>age</VL> <VML Logic=greater Unit=years>22</VML> or <VML Logic=lower Unit=years>12</VML> at the time of study,"[['Age', '>', 22.0, 'years'], ['Age', '<', 12.0, 'years']]"
NCT00206297,Exclusion,anemia (hemoglobin less than 12mg/dl),anemia ( <VL Label=hemoglobin Source=ngram>hemoglobin</VL> <VML Logic=lower Unit=mg/dl>12</VML> ) ,"[['hemoglobin', '<', '12', 'mg/dl']]"
NCT00206297,Exclusion,hgb a1c greater than or equal to 8.5 % in a diabetic subject,hgb <VL Label=HBA1C Source=DK>a1c</VL> <VML Logic=greater_equal Unit=%>8.5</VML> in a diabetic subject,"[['HBA1C', '>=', 8.5, '%']]"
NCT00206297,Exclusion,weight less than 44 kg,<VL Label=Weight Source=DK>weight</VL> <VML Logic=lower Unit=kg>44</VML>,"[['Weight', '<', 44.0, 'kg']]"
NCT00206401,Inclusion,age greater than 6 years of age but less than 25 years of age (insulin glargine has been approved for use in children 6 years and older).,<VL Label=Age Source=DK>age</VL> <VML Logic=greater Unit=years>6</VML> of <VL Label=Age Source=DK>age</VL> but <VML Logic=lower Unit=years>25</VML> of age ( <VL Label=Insulin Source=DK>insulin glargine</VL> has been approved for use in children <VML Logic=greater_equal Unit=years>6</VML> ) .,"[['Age', '>', 6.0, 'years'], ['Age', '<', 25.0, 'years']]"
NCT00206401,Inclusion,patients newly diagnosed with t1dm within the past 3 months.,<VL Label=patients newly diagnosed with t1dm Source=ngram>patients newly diagnosed with t1dm</VL> <VML Logic=lower Unit=past months>3</VML>.,"[['patients newly diagnosed with t1dm', '<', '3', 'past months']]"
NCT00206401,Inclusion,"have an hgba1c of less than 9.0%, after the initial run-in period of 3 months.","have an <VL Label=HBA1C Source=DK>hgba1c</VL> of <VML Logic=lower Unit=%>9.0</VML>, after the initial run-in period of <VML Logic=equal Unit=months>3</VML>.","[['HBA1C', '<', 9.0, '%']]"
NCT00206401,Exclusion,age less than 6 years or greater than 25 years.,<VL Label=Age Source=DK>age</VL> <VML Logic=lower Unit=years>6</VML> or <VML Logic=greater Unit=years>25</VML>.,"[['Age', '<', 6.0, 'years'], ['Age', '>', 25.0, 'years']]"
NCT00206401,Exclusion,"hba1c level of greater than 9.0%, after the initial run-in period of 3 months.","<VL Label=HBA1C Source=DK>hba1c level</VL> of <VML Logic=greater Unit=%>9.0</VML>, after the initial run-in period of <VML Logic=equal Unit=months>3</VML>.","[['HBA1C', '>', 9.0, '%']]"
NCT00211510,Inclusion,age 12 - 80 years,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=years>12</VML> - <VML Logic=lower_equal Unit=years>80</VML>,"[['Age', '>=', 12.0, 'years'], ['Age', '<=', 80.0, 'years']]"
NCT00211510,Inclusion,type 1 diabetes mellitus diagnosed at least 1 year ago,<VL Label=type 1 diabetes mellitus diagnosed Source=ngram>type 1 diabetes mellitus diagnosed</VL> <VML Logic=greater_equal Unit=year>1</VML> ago,"[['type 1 diabetes mellitus diagnosed', '>=', '1', 'year']]"
NCT00211510,Inclusion,using insulin infusion pump for past 6 months minimum,using <VL Label=Insulin Source=DK>insulin</VL> infusion pump <VML Logic=lower_equal Unit=past months>6</VML> greater_equal,"[['Insulin', '<=', 6.0, 'past months']]"
NCT00211510,Inclusion,performing minimum 4 blood glucose tests per day,performing <VML Logic=greater_equal Unit=>4</VML> blood <VL Label=Glucose Source=DK>glucose tests</VL> per day,"[['Glucose', '>=', 4.0, '']]"
NCT00211536,Inclusion,hba1c greater than or equal to 7.5%,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater_equal Unit=%>7.5</VML>,"[['HBA1C', '>=', 7.5, '%']]"
NCT00211536,Inclusion,capability and willingness to perform self-monitoring of blood glucose at least four times daily for 9 months of the study and 7 times daily for 3 months of the study,capability and willingness to perform self-monitoring of blood <VL Label=Glucose Source=DK>glucose</VL> greater_equal four times daily for <VML Logic=equal Unit=months>9</VML> of the study and <VML Logic=equal Unit=times daily>7</VML> for <VML Logic=equal Unit=months>3</VML> of the study,"[['Glucose', '=', 7.0, 'times daily']]"
NCT00211536,Exclusion,the subject's insulin usage exceeds 66 units per day.,the subject's <VL Label=Insulin Source=DK>insulin</VL> usage exceeds <VML Logic=equal Unit=units/day>66</VML>.,"[['Insulin', '=', 66.0, 'units/day']]"
NCT00211536,Exclusion,reside at or plan to travel to elevations above 8000 feet during the study period (commercial airline travel is acceptable),<VL Label=reside at or plan to travel to elevations Source=ngram>reside at or plan to travel to elevations</VL> <VML Logic=greater Unit=>8000</VML> feet during the study period ( commercial airline travel is acceptable ) ,"[['reside at or plan to travel to elevations', '>', '8000', '']]"
NCT00211536,Exclusion,the subject has previously enrolled in or participated in an investigational drug or device study within the preceding 4 weeks,the <VL Label=subject has previously enrolled in or participated in an investigational drug or device study Source=ngram>subject has previously enrolled in or participated in an investigational drug or device study</VL> <VML Logic=lower Unit=preceding weeks>4</VML>,"[['subject has previously enrolled in or participated in an investigational drug or device study', '<', '4', 'preceding weeks']]"
NCT00211536,Exclusion,has plans for activities which require them to go 25 feet below sea level,has <VL Label=plans for activities which require them to go Source=ngram>plans for activities which require them to go</VL> <VML Logic=equal Unit=>25</VML> feet below sea level,"[['plans for activities which require them to go', '=', '25', '']]"
NCT00212329,Inclusion,8-35 years of age at time of first visit,<VML Logic=greater_equal Unit=years>8</VML> - <VML Logic=lower_equal Unit=years>35</VML> of <VL Label=Age Source=DK>age</VL> at time of first visit,"[['Age', '>=', 8.0, 'years'], ['Age', '<=', 35.0, 'years']]"
NCT00212329,Inclusion,weigh > 40 kg (88 lbs) at time of first visit,<VL Label=weigh Source=ngram>weigh</VL> <VML Logic=greater Unit=kg>40</VML> at time of first visit,"[['weigh', '>', '40', 'kg']]"
NCT00214214,Inclusion,"adult subjects ages 18-35, with new onset type 1 diabetes mellitus (within 2-12 weeks of diagnosis), one or more islet autoantibody to gad, ia2, iaa or islet cell cytoplasmic antibody (ica) within 2 weeks of diabetes diagnosis.","adult subjects <VL Label=Age Source=DK>ages</VL> <VML Logic=greater_equal Unit=>18</VML> - <VML Logic=lower_equal Unit=>35</VML> , with new onset type 1 diabetes mellitus ( <VML Logic=lower Unit=weeks>2</VML> - <VML Logic=lower Unit=weeks>12</VML> of diagnosis ) , one or more islet autoantibody to gad, ia2, iaa or islet cell cytoplasmic antibody ( ica ) <VML Logic=lower Unit=weeks>2</VML> of diabetes diagnosis.","[['Age', '>=', 18.0, 'years'], ['Age', '<=', 35.0, 'years'], ['Age', '<', 2.0, 'weeks'], ['Age', '<', 12.0, 'weeks'], ['Age', '<', 2.0, 'weeks']]"
NCT00214214,Exclusion,subjects under 18 years of age or over 35 years of age.,subjects <VML Logic=lower Unit=years>18</VML> of <VL Label=Age Source=DK>age</VL> or <VML Logic=greater Unit=years>35</VML> of <VL Label=Age Source=DK>age</VL>.,"[['Age', '<', 18.0, 'years'], ['Age', '>', 35.0, 'years']]"
NCT00214214,Exclusion,individuals will be considered to have thrombocytopenia if they have a platelet count <100000 platelets/mm2 or <3000 wbc/ml.,individuals will be considered to have thrombocytopenia if they have a <VL Label=platelet count measurement Source=UMLS>platelet count</VL> <VML Logic=lower Unit=platelets>100000</VML> / mm2 or <VML Logic=lower Unit=wbc/ml>3000</VML>.,"[['platelet count measurement', '<', '100000', 'platelets'], ['platelet count measurement', '<', '3000', 'wbc/ml']]"
NCT00214253,Inclusion,"16 type i insulin-dependent diabetic subjects ages 18-60,(8 who have received a prior kidney or liver transplant and have stable renal function and 8 who have labile glucose regulation and who have failed a trial of intensive exogenous insulin therapy and who have preserved native renal function)","<VML Logic=equal Unit=>16</VML> type i <VL Label=Insulin Source=DK>insulin</VL>-dependent diabetic subjects <VL Label=Age Source=DK>ages</VL> <VML Logic=greater_equal Unit=>18</VML> - <VML Logic=lower_equal Unit=>60</VML> , ( <VML Logic=equal Unit=>8</VML> who have received a prior kidney or liver transplant and have stable renal function and <VML Logic=equal Unit=>8</VML> who have labile glucose regulation and who have failed a trial of intensive exogenous insulin therapy and who have preserved native renal function ) ","[['Insulin', '=', 16.0, 'uiu/ml'], ['Age', '>=', 18.0, 'years'], ['Age', '<=', 60.0, 'years'], ['Age', '=', 8.0, 'years'], ['Age', '=', 8.0, 'years']]"
NCT00214253,Exclusion,hgba1c >12%,<VL Label=HBA1C Source=DK>hgba1c</VL> <VML Logic=greater Unit=%>12</VML>,"[['HBA1C', '>', 12.0, '%']]"
NCT00214253,Exclusion,creatinine clearance < 80 ml/minute or macroalbuminuria > 0.3 gm/24 hrs;,<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=lower Unit=ml/minute>80</VML> or macroalbuminuria <VML Logic=greater Unit=gm>0.3</VML> / <VML Logic=equal Unit=>24</VML> hrs;,"[['Creatinine clearance', '<', 80.0, 'ml/minute'], ['Creatinine clearance', '=', 24.0, '']]"
NCT00214253,Exclusion,presence of panel reactive antibodies >20%,<VL Label=presence of panel reactive antibodies Source=ngram>presence of panel reactive antibodies</VL> <VML Logic=greater Unit=%>20</VML>,"[['presence of panel reactive antibodies', '>', '20', '%']]"
NCT00223613,Exclusion,age above 15 years,<VL Label=Age Source=DK>age</VL> <VML Logic=greater Unit=years>15</VML>,"[['Age', '>', 15.0, 'years']]"
NCT00226902,Inclusion,aged 18-80 years,<VL Label=Age Source=DK>aged</VL> <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>80</VML>,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 80.0, 'years']]"
NCT00226902,Inclusion,"patients receiving either conventional haemodialysis 3-4 x week, for a duration of > 6 months or peritoneal dialysis for a duration >6 months","<VL Label=patients receiving either conventional haemodialysis Source=ngram>patients receiving either conventional haemodialysis</VL> <VML Logic=greater_equal Unit=x week>3</VML> - <VML Logic=lower_equal Unit=x week>4</VML>, for a duration of <VML Logic=greater Unit=months>6</VML> or peritoneal dialysis for a duration <VML Logic=greater Unit=months>6</VML>","[['patients receiving either conventional haemodialysis', '>=', '3', 'x week'], ['patients receiving either conventional haemodialysis', '<=', '4', 'x week'], ['patients receiving either conventional haemodialysis', '>', '6', 'months'], ['patients receiving either conventional haemodialysis', '>', '6', 'months']]"
NCT00226902,Inclusion,stable dialysis access for at least 3 months (permcath / ptfe / avf),<VL Label=stable dialysis access Source=ngram>stable dialysis access</VL> for <VML Logic=greater_equal Unit=months>3</VML> ( permcath / ptfe / avf ) ,"[['stable dialysis access', '>=', '3', 'months']]"
NCT00226902,Inclusion,"on erythropoietin and iron therapy, with stable [hb] x 2 months (105 - 135g/l)","on <VL Label=erythropoietin and iron therapy Source=ngram>erythropoietin and iron therapy</VL>, with stable [ hb ] x <VML Logic=equal Unit=months>2</VML> ( <VML Logic=greater_equal Unit=g/l>105</VML> - <VML Logic=lower_equal Unit=g/l>135</VML> ) ","[['erythropoietin and iron therapy', '=', '2', 'months'], ['erythropoietin and iron therapy', '>=', '105', 'g/l'], ['erythropoietin and iron therapy', '<=', '135', 'g/l']]"
NCT00226902,Exclusion,pre dialysis sbp> 180 mmhg on > 2 times within a 2 week period,pre dialysis <VL Label=BP-Systolic Source=DK>sbp</VL> <VML Logic=greater Unit=mmhg>180</VML> on <VML Logic=greater Unit=times>2</VML> within a <VML Logic=equal Unit=week>2</VML> period,"[['BP-Systolic', '>', 180.0, 'mmhg'], ['BP-Systolic', '>', 2.0, 'times']]"
NCT00226902,Exclusion,between dialysis weight gain > 5% of body weight (if evident > 2 times/ 2 week period),between dialysis <VL Label=Weight Source=DK>weight</VL> gain <VML Logic=greater Unit=%>5</VML> of <VL Label=Weight Loss Source=DK>body weight</VL> ( if evident <VML Logic=greater Unit=times>2</VML> / <VML Logic=equal Unit=week>2</VML> period ) ,"[['Weight Loss', '>', 5.0, '%'], ['Weight Loss', '>', 2.0, 'times']]"
NCT00226902,Exclusion,unstable cardiac function: ischaemic or non ischaemic events requiring modification of therapy or admission to hospital within 3 months of study start: according to clinical discretion,unstable cardiac function: <VL Label=ischaemic or non ischaemic events requiring modification of therapy or admission to hospital Source=ngram>ischaemic or non ischaemic events requiring modification of therapy or admission to hospital</VL> <VML Logic=lower Unit=months>3</VML> of study start: according to clinical discretion,"[['ischaemic or non ischaemic events requiring modification of therapy or admission to hospital', '<', '3', 'months']]"
NCT00226902,Exclusion,"planned operative procedures within 6 months of study start (including transplant, cabg, ptca, vascular surgery)","planned operative procedures <VML Logic=lower Unit=months>6</VML> of study start ( including transplant, cabg, ptca, vascular <VL Label=Surgery Source=DK>surgery</VL> ) ","[['Surgery', '<', 6.0, 'months']]"
NCT00226902,Exclusion,known hypo-responsiveness to ert (>200u/kg/wk),<VL Label=known hypo-responsiveness to ert Source=ngram>known hypo-responsiveness to ert</VL> ( <VML Logic=greater Unit=u/kg>200</VML> / wk ) ,"[['known hypo-responsiveness to ert', '>', '200', 'u/kg']]"
NCT00226902,Exclusion,inadequate dialysis (pru < 65% or kt/v < 1.2),<VL Label=inadequate dialysis Source=ngram>inadequate dialysis</VL> ( pru <VML Logic=lower Unit=%>65</VML> or kt / <VML Logic=lower Unit=v>1.2</VML> ) ,"[['inadequate dialysis', '<', '65', '%'], ['inadequate dialysis', '<', '1.2', 'v']]"
NCT00226902,Exclusion,participation in investigational study within last 3 months,<VL Label=participation in investigational study within last Source=ngram>participation in investigational study within last</VL> <VML Logic=equal Unit=months>3</VML>,"[['participation in investigational study within last', '=', '3', 'months']]"
NCT00229658,Inclusion,have a1c <=9.0% within 3 months of study enrollment,have <VL Label=HBA1C Source=DK>a1c</VL> <VML Logic=lower_equal Unit=%>9.0</VML> <VML Logic=lower Unit=months>3</VML> of study enrollment,"[['HBA1C', '<=', 9.0, '%']]"
NCT00229658,Exclusion,have experienced recurrent patient-ascertained severe hypoglycemia requiring assistance during the past 6 months,have <VL Label=experienced recurrent patient-ascertained severe hypoglycemia requiring assistance Source=ngram>experienced recurrent patient-ascertained severe hypoglycemia requiring assistance</VL> <VML Logic=lower_equal Unit=past months>6</VML>,"[['experienced recurrent patient-ascertained severe hypoglycemia requiring assistance', '<=', '6', 'past months']]"
NCT00229658,Exclusion,have been treated with symlin within 3 months prior to study start,have been <VL Label=treated with symlin Source=ngram>treated with symlin</VL> <VML Logic=lower Unit=months>3</VML> prior to study start,"[['treated with symlin', '<', '3', 'months']]"
NCT00239148,Inclusion,currently self monitoring blood glucose levels at least 3 times per day,currently self monitoring <VL Label=finding of blood glucose level Source=UMLS>blood glucose levels</VL> <VML Logic=greater_equal Unit=times/day>3</VML>,"[['finding of blood glucose level', '>=', '3', 'times/day']]"
NCT00239148,Inclusion,no episodes of severe hypoglycemia for 60 days prior to screening,no <VL Label=episodes of severe hypoglycemia Source=ngram>episodes of severe hypoglycemia</VL> for <VML Logic=equal Unit=days>60</VML> prior to screening,"[['episodes of severe hypoglycemia', '=', '60', 'days']]"
NCT00239148,Inclusion,body mass index within the range 19-30 kg/m2,<VL Label=BMI Source=DK>body mass index</VL> within the <VML Logic=greater_equal Unit=kg/m2>19</VML> - <VML Logic=lower_equal Unit=kg/m2>30</VML>,"[['BMI', '>=', 19.0, 'kg/m2'], ['BMI', '<=', 30.0, 'kg/m2']]"
NCT00239148,Inclusion,patient cannot live alone during the treatment phase and up to 1 month in follow-up,<VL Label=patient cannot live alone during the treatment phase Source=ngram>patient cannot live alone during the treatment phase</VL> and <VML Logic=lower_equal Unit=month>1</VML> in follow-up,"[['patient cannot live alone during the treatment phase', '<=', '1', 'month']]"
NCT00239148,Exclusion,serum creatine superior or equal to 2.0 mg/dl,<VL Label=serum creatine Source=ngram>serum creatine</VL> <VML Logic=greater_equal Unit=mg/dl>2.0</VML>,"[['serum creatine', '>=', '2.0', 'mg/dl']]"
NCT00252720,Inclusion,male or female aged 18 - 55 years with type 1 diabetes diagnosed before age of 36 years and in need for continuous insulin treatment within 1 year of diagnosis of diabetes are included.,male or female <VL Label=Age Source=DK>aged</VL> <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>55</VML> with type 1 diabetes diagnosed before <VL Label=Age Source=DK>age</VL> of <VML Logic=equal Unit=years>36</VML> and in need for continuous <VL Label=Insulin Source=DK>insulin</VL> treatment <VML Logic=lower Unit=year>1</VML> of diagnosis of diabetes are included.,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 55.0, 'years'], ['Age', '=', 36.0, 'years']]"
NCT00252720,Inclusion,duration of diabetes for > 1 year and < 20 years with stable diabetic therapy within last 6 months.,<VL Label=duration of diabetes Source=ngram>duration of diabetes</VL> for <VML Logic=greater Unit=year>1</VML> and <VML Logic=lower Unit=years>20</VML> with stable diabetic therapy within last <VML Logic=equal Unit=months>6</VML>.,"[['duration of diabetes', '>', '1', 'year'], ['duration of diabetes', '<', '20', 'years'], ['duration of diabetes', '=', '6', 'months']]"
NCT00252720,Inclusion,"patients with untreated resting mean sitting sbp < 130 mmhg, mean sitting dbp < 85 mmhg and with retinal photograph grading level > 20 - 10 up to < 47 - 47 (on etdrs severity scale).","patients with untreated resting mean sitting <VL Label=BP-Systolic Source=DK>sbp</VL> <VML Logic=lower Unit=mmhg>130</VML>, mean sitting <VL Label=BP-Diastolic Source=DK>dbp</VL> <VML Logic=lower Unit=mmhg>85</VML> and with retinal photograph grading level <VML Logic=greater Unit=>20</VML> - <VML Logic=greater Unit=>10</VML> lower_equal <VML Logic=lower Unit=>47</VML> - <VML Logic=lower Unit=>47</VML>  ( on etdrs severity scale ) .","[['BP-Systolic', '<', 130.0, 'mmhg'], ['BP-Diastolic', '<', 85.0, 'mmhg'], ['BP-Diastolic', '>', 20.0, 'mm/hg'], ['BP-Diastolic', '>', 10.0, 'mm/hg'], ['BP-Diastolic', '<', 47.0, 'mm/hg'], ['BP-Diastolic', '<', 47.0, 'mm/hg']]"
NCT00252733,Inclusion,type 1 diabetes diagnosed before age of 36 years and in need for continuous insulin treatment within 1 year of diagnosis of diabetes are included.,type 1 diabetes diagnosed before <VL Label=Age Source=DK>age</VL> of <VML Logic=equal Unit=years>36</VML> and in need for continuous <VL Label=Insulin Source=DK>insulin</VL> treatment <VML Logic=lower Unit=year>1</VML> of diagnosis of diabetes are included.,"[['Age', '=', 36.0, 'years']]"
NCT00252733,Inclusion,duration of diabetes for > 1 year and < 15 years with stable diabetic therapy within last 6 months.,<VL Label=duration of diabetes Source=ngram>duration of diabetes</VL> for <VML Logic=greater Unit=year>1</VML> and <VML Logic=lower Unit=years>15</VML> with stable diabetic therapy within last <VML Logic=equal Unit=months>6</VML>.,"[['duration of diabetes', '>', '1', 'year'], ['duration of diabetes', '<', '15', 'years'], ['duration of diabetes', '=', '6', 'months']]"
NCT00252733,Inclusion,"patients with untreated resting mean sitting sbp < 130 mmhg, mean sitting dbp < 85 mmhg and with retinal photograph grading level 10 - 10 (on etdrs severity scale).","patients with untreated resting mean sitting <VL Label=BP-Systolic Source=DK>sbp</VL> <VML Logic=lower Unit=mmhg>130</VML>, mean sitting <VL Label=BP-Diastolic Source=DK>dbp</VL> <VML Logic=lower Unit=mmhg>85</VML> and with retinal photograph grading level <VML Logic=greater_equal Unit=>10</VML> - <VML Logic=lower_equal Unit=>10</VML>  ( on etdrs severity scale ) .","[['BP-Systolic', '<', 130.0, 'mmhg'], ['BP-Diastolic', '<', 85.0, 'mmhg'], ['BP-Diastolic', '>=', 10.0, 'mm/hg'], ['BP-Diastolic', '<=', 10.0, 'mm/hg']]"
NCT00254501,Inclusion,age 18 or older,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=>18</VML>,"[['Age', '>=', 18.0, 'years']]"
NCT00260234,Inclusion,male or non-pregnant non-lactating female subjects > 20 years of age,male or non-pregnant non-lactating female subjects <VML Logic=greater Unit=years>20</VML> of <VL Label=Age Source=DK>age</VL>,"[['Age', '>', 20.0, 'years']]"
NCT00260234,Inclusion,diagnosed with insulin-dependent type i diabetes for at least 20 years,<VL Label=diagnosed with insulin-dependent type i diabetes Source=ngram>diagnosed with insulin-dependent type i diabetes</VL> for <VML Logic=greater_equal Unit=years>20</VML>,"[['diagnosed with insulin-dependent type i diabetes', '>=', '20', 'years']]"
NCT00260234,Inclusion,bmi less than 28 kg/m2,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=lower Unit=kg/m2>28</VML>,"[['BMI', '<', 28.0, 'kg/m2']]"
NCT00260234,Inclusion,insulin requirement less than or equal to 0.7 u/kg/day,<VL Label=Insulin Source=DK>insulin</VL> requirement <VML Logic=lower_equal Unit=u/kg>0.7</VML> / day,"[['Insulin', '<=', 0.7, 'u/kg']]"
NCT00260234,Inclusion,hba1c greater than or equal to 7.0 %,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater_equal Unit=%>7.0</VML>,"[['HBA1C', '>=', 7.0, '%']]"
NCT00260234,Inclusion,serum c-peptide concentration less than or equal to 0.5 ng/ml stimulated by an ogtt,serum <VL Label=C-peptide Source=DK>c-peptide</VL> concentration <VML Logic=lower_equal Unit=ng/ml>0.5</VML> stimulated by an <VL Label=Glucose Source=DK>ogtt</VL>,"[['C-peptide', '<=', 0.5, 'ng/ml']]"
NCT00260234,Exclusion,serum c-peptide greater than 0.5 ng/ml stimulated by ogtt,serum <VL Label=C-peptide Source=DK>c-peptide</VL> <VML Logic=greater Unit=ng/ml>0.5</VML> stimulated by <VL Label=Glucose Source=DK>ogtt</VL>,"[['C-peptide', '>', 0.5, 'ng/ml']]"
NCT00260234,Exclusion,sustained hypertension greater than or equal to 100 mmhg diastolic and/or greater than or equal to 160 mmhg systolic,sustained <VL Label=BP Source=DK>hypertension</VL> <VML Logic=greater_equal Unit=mmhg>100</VML> <VL Label=BP-Diastolic Source=DK>diastolic</VL> and / or <VML Logic=greater_equal Unit=mmhg>160</VML> <VL Label=BP-Systolic Source=DK>systolic</VL>,"[['BP', '>=', 100.0, 'mmhg'], ['BP-Diastolic', '>=', 160.0, 'mmhg']]"
NCT00260234,Exclusion,significant renal dysfunction as indicated by gfr less than 80 ml/min/1.73 m2 and/or urinary albumin greater than 500 µg/ml,<VL Label=significant renal dysfunction as indicated by gfr Source=ngram>significant renal dysfunction as indicated by gfr</VL> <VML Logic=lower Unit=ml/min/1.73 m2>80</VML> and / or urinary albumin <VML Logic=greater Unit=>500</VML> µg / ml,"[['significant renal dysfunction as indicated by gfr', '<', '80', 'ml/min/1.73 m2'], ['significant renal dysfunction as indicated by gfr', '>', '500', '']]"
NCT00260234,Exclusion,significant liver dysfunction as indicated by alt or ast more than 3x the upper limit of normal,significant liver dysfunction as indicated by alt or <VL Label=AST Source=DK>ast</VL> <VML Logic=greater Unit=x the upper limit of normal>3</VML>,"[['AST', '>', 3.0, 'x the upper limit of normal']]"
NCT00265473,Inclusion,age 18 to 65 years of age.,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>65</VML> of <VL Label=Age Source=DK>age</VL>.,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 65.0, 'years']]"
NCT00265473,Inclusion,clinical history compatible with type 1 diabetes with onset of disease at <40 years of age and insulin-dependence for > 5 years at the time of enrollment.,clinical history compatible with type 1 diabetes with onset of disease at <VML Logic=lower Unit=years>40</VML> of <VL Label=Age Source=DK>age</VL> and insulin-dependence for <VML Logic=greater Unit=years>5</VML> at the time of enrollment.,"[['Age', '<', 40.0, 'years'], ['Age', '>', 5.0, 'years']]"
NCT00265473,Inclusion,absent stimulated c-peptide (<0.3ng/ml) in response to a mixed meal tolerance test.,absent stimulated <VL Label=C-peptide Source=DK>c-peptide</VL> ( <VML Logic=lower Unit=ng/ml>0.3</VML> ) in response to a mixed meal tolerance test.,"[['C-peptide', '<', 0.3, 'ng/ml']]"
NCT00265473,Inclusion,"such management must be under the direction of an endocrinologist, diabetologist or diabetes specialist with at least 3 clinical evaluations during the previous 12 months.","such <VL Label=management must be under the direction of an endocrinologist Source=ngram>management must be under the direction of an endocrinologist</VL>, diabetologist or diabetes specialist with <VML Logic=greater_equal Unit=>3</VML> clinical evaluations <VML Logic=lower_equal Unit=previous months>12</VML>.","[['management must be under the direction of an endocrinologist', '>=', '3', ''], ['management must be under the direction of an endocrinologist', '<=', '12', 'previous months']]"
NCT00265473,Inclusion,"at least one episode of severe hypoglycemia in the past 3 years defined as an event with symptoms compatible with hypoglycemia in which the subject required the assistance of another person and which was associated with either a blood glucose level < 50 mg/dl or prompt recovery after oral carbohydrate, intravenous glucose or glucagon administration).","greater_equal one episode of severe hypoglycemia <VML Logic=lower_equal Unit=past years>3</VML> defined as an event with symptoms compatible with hypoglycemia in which the subject required the assistance of another person and which was associated with either a <VL Label=finding of blood glucose level Source=UMLS>blood glucose level</VL> <VML Logic=lower Unit=mg/dl>50</VML> or prompt recovery after oral carbohydrate, intravenous glucose or glucagon administration ) .","[['finding of blood glucose level', '<=', '3', 'past years'], ['finding of blood glucose level', '<', '50', 'mg/dl']]"
NCT00265473,Exclusion,bmi >27 kg/m2 or patient weight <= 50kg.,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater Unit=kg/m2>27</VML> or patient <VL Label=Weight Source=DK>weight</VL> <VML Logic=lower_equal Unit=kg>50</VML>.,"[['BMI', '>', 27.0, 'kg/m2'], ['Weight', '<=', 50.0, 'kg']]"
NCT00265473,Exclusion,insulin requirement of > 0.8 iu/kg/day or 50 iu/day.,<VL Label=Insulin Source=DK>insulin</VL> requirement of <VML Logic=greater Unit=iu/kg>0.8</VML> / day or <VML Logic=equal Unit=iu/day>50</VML>.,"[['Insulin', '>', 0.8, 'iu/kg'], ['Insulin', '=', 50.0, 'iu/day']]"
NCT00265473,Exclusion,hba1c >10%.,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=%>10</VML>.,"[['HBA1C', '>', 10.0, '%']]"
NCT00265473,Exclusion,estimated glomerular filtration rate <70 ml/min/1.73 m2 for females and <80 ml/min/1.73 m2 for males,<VL Label=estimated glomerular filtration rate Source=ngram>estimated glomerular filtration rate</VL> <VML Logic=lower Unit=ml/min/1.73 m2>70</VML> for females and <VML Logic=lower Unit=ml/min/1.73 m2>80</VML> for males,"[['estimated glomerular filtration rate', '<', '70', 'ml/min/1.73 m2'], ['estimated glomerular filtration rate', '<', '80', 'ml/min/1.73 m2']]"
NCT00265473,Exclusion,presence or history of macroalbuminuria (>300mg/d).,<VL Label=presence or history of macroalbuminuria Source=ngram>presence or history of macroalbuminuria</VL> ( <VML Logic=greater Unit=mg/d>300</VML> ) .,"[['presence or history of macroalbuminuria', '>', '300', 'mg/d']]"
NCT00265473,Exclusion,presence or history of panel-reactive anti-hla antibodies >20% by flow cytometry.,presence or history of panel-reactive anti-hla antibodies <VML Logic=greater Unit=%>20</VML> by <VL Label=flow Source=UMLS>flow</VL> cytometry.,"[['flow', '>', '20', '%']]"
NCT00265473,Exclusion,"females: positive pregnancy test, presently breast-feeding or unwillingness to use effective contraceptive measures for the duration of the study and 3 months after discontinuation","females: <VL Label=positive pregnancy test Source=UMLS>positive pregnancy test</VL>, presently breast-feeding or unwillingness to use effective contraceptive measures for the duration of the study and <VML Logic=equal Unit=months>3</VML> after discontinuation","[['positive pregnancy test', '=', '3', 'months']]"
NCT00265473,Exclusion,males: intent to procreate during the duration of the study or within 3 months after discontinuation or unwillingness to use effective measures of contraception.,males: <VL Label=intent to procreate during the duration of the study Source=ngram>intent to procreate during the duration of the study</VL> or <VML Logic=lower Unit=months>3</VML> after discontinuation or unwillingness to use effective measures of contraception.,"[['intent to procreate during the duration of the study', '<', '3', 'months']]"
NCT00265473,Exclusion,"hyperlipidemia despite medical therapy (fasting ldl cholesterol > 130 mg/dl, treated or untreated","hyperlipidemia despite medical therapy ( fasting <VL Label=LDL Cholesterol Source=DK>ldl cholesterol</VL> <VML Logic=greater Unit=mg/dl>130</VML>, treated or untreated","[['LDL Cholesterol', '>', 130.0, 'mg/dl']]"
NCT00265473,Exclusion,and/or fasting triglycerides > 200 mg/dl).,and / or fasting <VL Label=LDL Source=DK>triglycerides</VL> <VML Logic=greater Unit=mg/dl>200</VML> ) .,"[['LDL', '>', 200.0, 'mg/dl']]"
NCT00265473,Exclusion,use of any other investigational agents within 4 weeks of participation.,<VL Label=use of any other investigational agents Source=ngram>use of any other investigational agents</VL> <VML Logic=lower Unit=weeks>4</VML> of participation.,"[['use of any other investigational agents', '<', '4', 'weeks']]"
NCT00265473,Exclusion,administration of live attenuated vaccine(s) within 2 months of enrollment.,<VL Label=administration of live attenuated vaccine Source=ngram>administration of live attenuated vaccine</VL> ( s ) <VML Logic=lower Unit=months>2</VML> of enrollment.,"[['administration of live attenuated vaccine', '<', '2', 'months']]"
NCT00271284,Inclusion,"with type 1 diabetes (defined as a concentration of c-peptide < 0.1 nmol//l and a fasting blood glucose of >= 1.26 g/l), diagnosed not less than 5 years previously","with type 1 diabetes ( defined as a concentration of <VL Label=C-peptide Source=DK>c-peptide</VL> <VML Logic=lower Unit=nmol>0.1</VML> / / l and a <VL Label=Glucose Source=DK>fasting blood glucose</VL> of <VML Logic=greater_equal Unit=g/l>1.26</VML> ) , diagnosed <VML Logic=greater_equal Unit=years>5</VML> previously","[['C-peptide', '<', 0.1, 'nmol'], ['Glucose', '>=', 9.76, 'mmol/l']]"
NCT00271284,Inclusion,with an hba1c level of <= 8.5% at the inclusion visit,with an <VL Label=HBA1C Source=DK>hba1c level</VL> of <VML Logic=lower_equal Unit=%>8.5</VML> at the inclusion visit,"[['HBA1C', '<=', 8.5, '%']]"
NCT00271284,Inclusion,able to eat 3 regular daily meals on the days for recording the blood glucose cycle and similarly as much as possible on other days throughout the length of the study,able to eat <VML Logic=equal Unit=regular daily>3</VML> meals on the days for recording the blood <VL Label=Glucose Source=DK>glucose</VL> cycle and similarly as much as possible on other days throughout the length of the study,"[['Glucose', '=', 3.0, 'regular daily']]"
NCT00271284,Exclusion,recent history of severe hypoglycaemia (at least 2 events in the 6 months prior to inclusion),<VL Label=recent history of severe hypoglycaemia Source=ngram>recent history of severe hypoglycaemia</VL> ( <VML Logic=greater_equal Unit=events>2</VML> <VML Logic=lower_equal Unit=months>6</VML> prior to inclusion ) ,"[['recent history of severe hypoglycaemia', '>=', '2', 'events'], ['recent history of severe hypoglycaemia', '<=', '6', 'months']]"
NCT00271284,Exclusion,an episode of acidocetosis in the 3 months prior to inclusion,an <VL Label=episode of acidocetosis Source=ngram>episode of acidocetosis</VL> <VML Logic=lower_equal Unit=months>3</VML> prior to inclusion,"[['episode of acidocetosis', '<=', '3', 'months']]"
NCT00271284,Exclusion,"proliferating retinopathy, defined as having required treatment by surgery or photocoagulation, in the 6 months prior to visit 1 or non-stabilised (rapidly developing) retinopathy which may require photocoagulation or surgery","proliferating retinopathy, defined as having required treatment by <VL Label=Surgery Source=DK>surgery</VL> or photocoagulation, <VML Logic=lower_equal Unit=months>6</VML> prior to visit 1 or non-stabilised ( rapidly developing ) retinopathy which may require photocoagulation or <VL Label=Surgery Source=DK>surgery</VL>","[['Surgery', '<=', 6.0, 'months']]"
NCT00271284,Exclusion,"altered hepatic function (ast or alt >= 2.5 x normal, in the initial measurements)","altered hepatic function ( ast or <VL Label=ALT Source=DK>alt</VL> <VML Logic=greater_equal Unit=>2.5</VML> x normal, in the initial measurements ) ","[['ALT', '>=', 2.5, 'iu/l']]"
NCT00271284,Exclusion,altered renal function (plasma creatinine > 1.5 mg/dl),altered renal function ( plasma <VL Label=Creatinine Source=DK>creatinine</VL> <VML Logic=greater Unit=mg/dl>1.5</VML> ) ,"[['Creatinine', '>', 1.5, 'mg/dl']]"
NCT00271284,Exclusion,history of cancer in the last 5 years,<VL Label=history of cancer Source=ngram>history of cancer</VL> <VML Logic=lower_equal Unit=last years>5</VML>,"[['history of cancer', '<=', '5', 'last years']]"
NCT00271284,Exclusion,treatment by another product undergoing development during the 3 months prior to inclusion in the trial,<VL Label=treatment by another product undergoing development Source=ngram>treatment by another product undergoing development</VL> <VML Logic=lower_equal Unit=months>3</VML> prior to inclusion in the trial,"[['treatment by another product undergoing development', '<=', '3', 'months']]"
NCT00272090,Inclusion,"hba1c <= 9 % (measured by central lab, with dcct aligned standard method)","<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=lower_equal Unit=%>9</VML> ( measured by central lab, with dcct aligned standard method ) ","[['HBA1C', '<=', 9.0, '%']]"
NCT00272090,Inclusion,fasting c-peptide <= 0.1nmol/l with fbg >126 mg/dl,<VL Label=C-peptide Source=DK>fasting c-peptide</VL> <VML Logic=lower_equal Unit=nmol/l>0.1</VML> with <VL Label=Glucose Source=DK>fbg</VL> <VML Logic=greater Unit=mg/dl>126</VML>,"[['C-peptide', '<=', 0.1, 'nmol/l'], ['Glucose', '>', 7.0, 'mmol/l']]"
NCT00272090,Inclusion,body mass index (bmi) < 30 kg/m2,body mass index ( <VL Label=BMI Source=DK>bmi</VL> )  <VML Logic=lower Unit=kg/m2>30</VML>,"[['BMI', '<', 30.0, 'kg/m2']]"
NCT00272090,Exclusion,type 1 diabetic patients with total insulin dose >= 1 iu/kg/day,type <VML Logic=equal Unit=diabetic patients>1</VML> with <VL Label=total Insulin Source=DK>total insulin</VL> dose <VML Logic=greater_equal Unit=iu/kg>1</VML> / day,"[['total Insulin', '=', '1', 'diabetic patients'], ['total Insulin', '>=', '1', 'iu/kg']]"
NCT00272090,Exclusion,serum creatinine > 1.5 mg/dl or history of renal transplantation or current renal dialysis,<VL Label=Creatinine Source=DK>serum creatinine</VL> <VML Logic=greater Unit=mg/dl>1.5</VML> or history of renal transplantation or current renal dialysis,"[['Creatinine', '>', 1.5, 'mg/dl']]"
NCT00272090,Exclusion,clinical evidence of active liver disease or serum alt/ast 2 times the upper limit of the normal range,clinical evidence of active liver disease or serum alt / <VL Label=AST Source=DK>ast</VL> <VML Logic=equal Unit=times>2</VML> the upper limit of the normal range,"[['AST', '=', 2.0, 'times']]"
NCT00272090,Exclusion,long lasting (> 2 weeks) treatment with systemic glucocorticoid therapy,<VL Label=long lasting Source=ngram>long lasting</VL> ( <VML Logic=greater Unit=weeks>2</VML> ) treatment with systemic glucocorticoid therapy,"[['long lasting', '>', '2', 'weeks']]"
NCT00272090,Exclusion,blood donation of more than 500 ml during the previous 3 months for males or 6 months for females,<VL Label=blood donation Source=ngram>blood donation</VL> of <VML Logic=greater Unit=ml>500</VML> <VML Logic=lower_equal Unit=previous months>3</VML> for males or <VML Logic=equal Unit=months>6</VML> for females,"[['blood donation', '>', '500', 'ml'], ['blood donation', '<=', '3', 'previous months'], ['blood donation', '=', '6', 'months']]"
NCT00272090,Exclusion,smoker for previous 3 months,<VL Label=smoker Source=ngram>smoker</VL> <VML Logic=lower_equal Unit=previous months>3</VML>,"[['smoker', '<=', '3', 'previous months']]"
NCT00272090,Exclusion,receipt of an experimental drug or use of an experimental device within the 30 days prior to study entry.,receipt of an experimental drug or use of an experimental device <VML Logic=lower Unit=days>30</VML> prior to <VL Label=Study entry Source=DK>study entry</VL>.,"[['Study entry', '<', 30.0, 'days']]"
NCT00273286,Inclusion,age 9.0 to <14.5.,<VL Label=Age Source=DK>age</VL> <VML Logic=equal Unit=>9.0</VML> to <VML Logic=lower Unit=>14.5</VML> .,"[['Age', '=', 9.0, 'years'], ['Age', '<', 14.5, 'years']]"
NCT00273286,Inclusion,type 1 diabetes diagnosis (diagnosed by ada criteria) for a minimum of 1 year for the main subgroup or 3 months for the recent onset subgroup.,type 1 diabetes diagnosis ( <VL Label=diagnosed by ada criteria Source=ngram>diagnosed by ada criteria</VL> ) for a greater_equal of <VML Logic=equal Unit=year>1</VML> for the main subgroup or <VML Logic=equal Unit=months>3</VML> for the recent onset subgroup.,"[['diagnosed by ada criteria', '=', '1', 'year'], ['diagnosed by ada criteria', '=', '3', 'months']]"
NCT00273286,Inclusion,insulin dose greater than or equal to 0.5 u/kg/day for the main subgroup or 0.2 u/kg/day for the recent onset subgroup,<VL Label=Insulin Source=DK>insulin</VL> dose <VML Logic=greater_equal Unit=u/kg>0.5</VML> / day for the main subgroup or <VML Logic=equal Unit=u/kg>0.2</VML> / day for the recent onset subgroup,"[['Insulin', '>=', 0.5, 'u/kg'], ['Insulin', '=', 0.2, 'u/kg']]"
NCT00273286,Inclusion,most recent a1c is >6.0% and <13.0%,most recent <VL Label=HBA1C Source=DK>a1c</VL> is <VML Logic=greater Unit=%>6.0</VML> and <VML Logic=lower Unit=%>13.0</VML>,"[['HBA1C', '>', 6.0, '%'], ['HBA1C', '<', 13.0, '%']]"
NCT00273286,Inclusion,<12.0% for those diagnosed for less than 1 year., <VML Logic=lower Unit=%>12.0</VML> for those <VL Label=diagnosed Source=ngram>diagnosed</VL> for <VML Logic=lower Unit=year>1</VML>.,"[['diagnosed', '<', '12.0', '%'], ['diagnosed', '<', '1', 'year']]"
NCT00273286,Inclusion,"child lives in geographically stable home, no multiple foster homes, boarding school or institutions expected in next 2 years.","<VL Label=child lives in geographically stable home Source=ngram>child lives in geographically stable home</VL>, no multiple foster homes, boarding school or institutions expected <VML Logic=lower_equal Unit=next years>2</VML>.","[['child lives in geographically stable home', '<=', '2', 'next years']]"
NCT00273286,Inclusion,"the same 1 or 2 adult caregivers have accompanied the child to every diabetes clinic visit in the past year and at least 1 caregiver agrees to participate in all aspects of the protocol (single-parent families, blended families and separated parents will be eligible).","the same <VML Logic=equal Unit=>1</VML> or <VML Logic=equal Unit=>2</VML> <VL Label=adult caregivers have accompanied the child to every diabetes clinic visit in the past year Source=ngram>adult caregivers have accompanied the child to every diabetes clinic visit in the past year</VL> and <VML Logic=greater_equal Unit=>1</VML> caregiver agrees to participate in all aspects of the protocol ( single-parent families, blended families and separated parents will be eligible ) .","[['adult caregivers have accompanied the child to every diabetes clinic visit in the past year', '=', '1', ''], ['adult caregivers have accompanied the child to every diabetes clinic visit in the past year', '=', '2', ''], ['adult caregivers have accompanied the child to every diabetes clinic visit in the past year', '>=', '1', '']]"
NCT00273286,Inclusion,child had at least 2 clinic visits within last 12 months.,<VL Label=child Source=ngram>child</VL> had <VML Logic=greater_equal Unit=>2</VML> clinic visits within last <VML Logic=equal Unit=months>12</VML>.,"[['child', '>=', '2', ''], ['child', '=', '12', 'months']]"
NCT00273286,Inclusion,parent and child willing to come to clinic every 3 months for duration (2 years) of study.,<VL Label=parent and child willing to come to clinic Source=ngram>parent and child willing to come to clinic</VL> every <VML Logic=equal Unit=months>3</VML> for duration ( <VML Logic=equal Unit=years>2</VML> ) of study.,"[['parent and child willing to come to clinic', '=', '3', 'months'], ['parent and child willing to come to clinic', '=', '2', 'years']]"
NCT00273286,Exclusion,history of anti-psychotic medications for the past 6 months.,<VL Label=history of anti-psychotic medications Source=ngram>history of anti-psychotic medications</VL> for <VML Logic=equal Unit=past months>6</VML>.,"[['history of anti-psychotic medications', '=', '6', 'past months']]"
NCT00273286,Exclusion,"those who have been in an intervention arm of a trial of a behavioral, psychological or psychoeducational intervention and concluded their study follow-up within the past 12 months are also ineligible to participate","those who have been in an intervention arm of a trial of a behavioral, <VL Label=psychological or psychoeducational intervention and concluded their study follow-up Source=ngram>psychological or psychoeducational intervention and concluded their study follow-up</VL> <VML Logic=lower Unit=past months>12</VML> are also ineligible to participate","[['psychological or psychoeducational intervention and concluded their study follow-up', '<', '12', 'past months']]"
NCT00273286,Exclusion,family has plans to re-locate out of area within the next 2 years of the study.,<VL Label=family has plans to re-locate out of area Source=ngram>family has plans to re-locate out of area</VL> <VML Logic=lower Unit=next years>2</VML> of the study.,"[['family has plans to re-locate out of area', '<', '2', 'next years']]"
NCT00273286,Exclusion,participating caretaker has been hospitalized in past 6 months for mental disorder.,<VL Label=participating caretaker has been hospitalized Source=ngram>participating caretaker has been hospitalized</VL> <VML Logic=lower_equal Unit=past months>6</VML> for mental disorder.,"[['participating caretaker has been hospitalized', '<=', '6', 'past months']]"
NCT00273286,Exclusion,"those who have been in an intervention arm of a trial of a behavioral, psychological or psychoeducational intervention and concluded their study follow-up within the past 12 months are also ineligible to participate","those who have been in an intervention arm of a trial of a behavioral, <VL Label=psychological or psychoeducational intervention and concluded their study follow-up Source=ngram>psychological or psychoeducational intervention and concluded their study follow-up</VL> <VML Logic=lower Unit=past months>12</VML> are also ineligible to participate","[['psychological or psychoeducational intervention and concluded their study follow-up', '<', '12', 'past months']]"
NCT00273286,Exclusion,the family must reside within 90 miles (one-way) of the clinic (main or satellite) or agree to meet at a mutually agreed upon closer location for conduct of the home assessment.,the <VL Label=family must reside Source=ngram>family must reside</VL> <VML Logic=lower Unit=miles>90</VML> ( one-way ) of the clinic ( main or satellite ) or agree to meet at a mutually agreed upon closer location for conduct of the home assessment.,"[['family must reside', '<', '90', 'miles']]"
NCT00276250,Inclusion,male and female patients age 18 to 65 years of age,male and female patients <VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>65</VML> of <VL Label=Age Source=DK>age</VL>,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 65.0, 'years']]"
NCT00276250,Inclusion,clinical history compatible with type 1 diabetes with onset of disease at <40 years of age and insulin-dependence for >5 years at the time of enrollment.,clinical history compatible with type 1 diabetes with onset of disease at <VML Logic=lower Unit=years>40</VML> of <VL Label=Age Source=DK>age</VL> and insulin-dependence for <VML Logic=greater Unit=years>5</VML> at the time of enrollment.,"[['Age', '<', 40.0, 'years'], ['Age', '>', 5.0, 'years']]"
NCT00276250,Inclusion,body mass index less than or equal to 26,<VL Label=BMI Source=DK>body mass index</VL> <VML Logic=lower_equal Unit=>26</VML> ,"[['BMI', '<=', 26.0, 'kg/m2']]"
NCT00276250,Inclusion,18 to 65 years of age,<VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>65</VML> of <VL Label=Age Source=DK>age</VL>,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 65.0, 'years']]"
NCT00276250,Inclusion,absent stimulated c-peptide (<0.3ng/ml) in response to a mixed meal tolerance test (boost® 6 ml/kg body weight to a maximum of 360 ml,absent stimulated <VL Label=C-peptide Source=DK>c-peptide</VL> ( <VML Logic=lower Unit=ng/ml>0.3</VML> ) in response to a mixed meal tolerance test ( boost® <VML Logic=equal Unit=ml/kg>6</VML> <VL Label=Weight Loss Source=DK>body weight</VL> to a lower_equal of <VML Logic=equal Unit=ml>360</VML>,"[['C-peptide', '<', 0.3, 'ng/ml'], ['C-peptide', '=', 6.0, 'ml/kg']]"
NCT00276250,Inclusion,another product with equivalent caloric and nutrient content may be substituted for boost) measured at 90min after the end of consumption.,<VL Label=another product with equivalent caloric and nutrient content may be substituted for boost Source=ngram>another product with equivalent caloric and nutrient content may be substituted for boost</VL> ) measured at <VML Logic=equal Unit=min>90</VML> after the end of consumption.,"[['another product with equivalent caloric and nutrient content may be substituted for boost', '=', '90', 'min']]"
NCT00276250,Inclusion,checking and recording blood sugars at least 3 times per day,<VL Label=checking and recording blood sugars Source=ngram>checking and recording blood sugars</VL> <VML Logic=greater_equal Unit=times/day>3</VML>,"[['checking and recording blood sugars', '>=', '3', 'times/day']]"
NCT00276250,Inclusion,"such management must be under the direction of an endocrinologist, diabetologist or diabetes specialist with at least 3 clinical evaluations during the previous 12 months.","such <VL Label=management must be under the direction of an endocrinologist Source=ngram>management must be under the direction of an endocrinologist</VL>, diabetologist or diabetes specialist with <VML Logic=greater_equal Unit=>3</VML> clinical evaluations <VML Logic=lower_equal Unit=previous months>12</VML>.","[['management must be under the direction of an endocrinologist', '>=', '3', ''], ['management must be under the direction of an endocrinologist', '<=', '12', 'previous months']]"
NCT00276250,Inclusion,"at least one episode of severe hypoglycemia in the past 3 years defined as an event with symptoms compatible with hypoglycemia in which the subject required the assistance of another person and which was associated with either a blood glucose level <50 mg/dl [2.8 mmol/l] or prompt recovery after oral carbohydrate, intravenous glucose or glucagon administration).","greater_equal one episode of severe hypoglycemia <VML Logic=lower_equal Unit=past years>3</VML> defined as an event with symptoms compatible with hypoglycemia in which the subject required the assistance of another person and which was associated with either a <VL Label=finding of blood glucose level Source=UMLS>blood glucose level</VL> <VML Logic=lower Unit=mg/dl>50</VML> [ <VML Logic=equal Unit=mmol/l>2.8</VML> ] or prompt recovery after oral carbohydrate, intravenous glucose or glucagon administration ) .","[['finding of blood glucose level', '<=', '3', 'past years'], ['finding of blood glucose level', '<', '50', 'mg/dl'], ['finding of blood glucose level', '=', '2.8', 'mmol/l']]"
NCT00276250,Inclusion,reduced awareness of hypoglycemia as defined by a clarke score of 4 or more and a hypo score greater than or equal to the 90th percentile (1047) within the last 6 months prior to randomization,<VL Label=reduced awareness of hypoglycemia as defined by a clarke score Source=ngram>reduced awareness of hypoglycemia as defined by a clarke score</VL> of <VML Logic=greater_equal Unit=>4</VML> and a hypo score greater_equal the 90th percentile ( 1047 ) <VML Logic=lower Unit=last months>6</VML> prior to randomization,"[['reduced awareness of hypoglycemia as defined by a clarke score', '>=', '4', ''], ['reduced awareness of hypoglycemia as defined by a clarke score', '<', '6', 'last months']]"
NCT00276250,Inclusion,or marked glycemic lability characterized by wide swings in blood glucose despite optimal diabetes therapy and defined by a glycemic lability index (li) score greater than or equal to the 90th percentile (433 mm2/h/wk) within the last 6 months prior to randomization,or marked glycemic lability characterized by wide swings in blood <VL Label=Glucose Source=DK>glucose</VL> despite optimal diabetes therapy and defined by a glycemic lability index ( li ) score greater_equal the 90th percentile ( <VML Logic=equal Unit=>433</VML> mm2 / h / wk ) <VML Logic=lower Unit=last months>6</VML> prior to randomization,"[['Glucose', '=', 24.06, 'mmol/l'], ['Glucose', '<', 6.0, 'last months']]"
NCT00276250,Inclusion,or a composite of a clarke score of 4 or more and a hypo score greater than or equal to the 75th percentile (423) and a li greater than of equal to the 75th percentile (329) within the last 6 months prior to randomization.,or a <VL Label=composite of a clarke score Source=ngram>composite of a clarke score</VL> of <VML Logic=greater_equal Unit=>4</VML> and a hypo score greater_equal the 75th percentile ( 423 ) and a li greater than of equal the 75th percentile ( 329 ) <VML Logic=lower Unit=last months>6</VML> prior to randomization.,"[['composite of a clarke score', '>=', '4', ''], ['composite of a clarke score', '<', '6', 'last months']]"
NCT00276250,Exclusion,left ventricular ejection fraction < 30%,<VL Label=left ventricular ejection fraction Source=UMLS>left ventricular ejection fraction</VL> <VML Logic=lower Unit=%>30</VML>,"[['left ventricular ejection fraction', '<', '30', '%']]"
NCT00276250,Exclusion,measured glomerular filtration rate using iohexol <70 ml/min/1.73 m2 for females and <80 ml/min/1.73 m2 for males (or a 24 hr,measured glomerular filtration rate using iohexol <VML Logic=lower Unit=ml/min/1.73 m2>70</VML> for females and <VML Logic=lower Unit=ml/min/1.73 m2>80</VML> for males ( or a <VML Logic=equal Unit=>24</VML> <VL Label=heart rate Source=UMLS>hr</VL>,"[['heart rate', '<', '70', 'ml/min/1.73 m2'], ['heart rate', '<', '80', 'ml/min/1.73 m2'], ['heart rate', '=', '24', '']]"
NCT00276250,Exclusion,creatinine clearance with participants allergic to iodine <85ml/min/1.73m2).,<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> with participants allergic to iodine <VML Logic=lower Unit=ml/min>85</VML> / <VML Logic=equal Unit=m2>1.73</VML> ) .,"[['Creatinine clearance', '<', 85.0, 'ml/min']]"
NCT00276250,Exclusion,macroalbuminuria (urinary protein excretion rate >300 mg/24h),macroalbuminuria ( urinary <VL Label=Protein Source=DK>protein</VL> excretion rate <VML Logic=greater Unit=mg>300</VML> / <VML Logic=equal Unit=h>24</VML> ) ,"[['Protein', '>', 300.0, 'mg']]"
NCT00276250,Exclusion,"lymphopenia (<1000/l), neutropenia (<1500/l) or thrombocytopenia (platelets <100000/ l).","lymphopenia ( <VML Logic=lower Unit=/l>1000</VML> ) , neutropenia ( <VML Logic=lower Unit=/l>1500</VML> ) or thrombocytopenia ( <VL Label=Platelets Source=DK>platelets</VL> <VML Logic=lower Unit=/l>100000</VML> ) .","[['Platelets', '<', 1000.0, '/l'], ['Platelets', '<', 1500.0, '/l'], ['Platelets', '<', 100000.0, '/l']]"
NCT00276250,Exclusion,"hyperlipidemia (fasting ldl cholesterol >130 mg/dl, treated or untreated","hyperlipidemia ( fasting <VL Label=LDL Cholesterol Source=DK>ldl cholesterol</VL> <VML Logic=greater Unit=mg/dl>130</VML>, treated or untreated","[['LDL Cholesterol', '>', 130.0, 'mg/dl']]"
NCT00276250,Exclusion,and/or fasting triglycerides >300 mg/dl),and / or fasting <VL Label=LDL Source=DK>triglycerides</VL> <VML Logic=greater Unit=mg/dl>300</VML> ) ,"[['LDL', '>', 300.0, 'mg/dl']]"
NCT00276250,Exclusion,history of malignancy (except squamous or basal cell skin carcinoma) within the previous 5 years,history of malignancy ( <VL Label=except squamous or basal cell skin carcinoma Source=ngram>except squamous or basal cell skin carcinoma</VL> ) <VML Logic=lower Unit=previous years>5</VML>,"[['except squamous or basal cell skin carcinoma', '<', '5', 'previous years']]"
NCT00276250,Exclusion,presence of hla panel reactive antibodies >20%,<VL Label=presence of hla panel reactive antibodies Source=ngram>presence of hla panel reactive antibodies</VL> <VML Logic=greater Unit=%>20</VML>,"[['presence of hla panel reactive antibodies', '>', '20', '%']]"
NCT00276250,Exclusion,evidence of insulin resistance (insulin requirements >0.8 units/kg/day),evidence of <VL Label=Insulin Source=DK>insulin</VL> resistance ( insulin requirements <VML Logic=greater Unit=units/kg>0.8</VML> / day ) ,"[['Insulin', '>', 0.8, 'units/kg']]"
NCT00276250,Exclusion,"hyperlipidemia despite medical therapy (fasting ldl cholesterol >130 mg/dl, treated or untreated","hyperlipidemia despite medical therapy ( fasting <VL Label=LDL Cholesterol Source=DK>ldl cholesterol</VL> <VML Logic=greater Unit=mg/dl>130</VML>, treated or untreated","[['LDL Cholesterol', '>', 130.0, 'mg/dl']]"
NCT00276250,Exclusion,and/or fasting triglycerides >200 mg/dl).,and / or fasting <VL Label=LDL Source=DK>triglycerides</VL> <VML Logic=greater Unit=mg/dl>200</VML> ) .,"[['LDL', '>', 200.0, 'mg/dl']]"
NCT00276250,Exclusion,use of any other investigational agents within 4 weeks of participation.,<VL Label=use of any other investigational agents Source=ngram>use of any other investigational agents</VL> <VML Logic=lower Unit=weeks>4</VML> of participation.,"[['use of any other investigational agents', '<', '4', 'weeks']]"
NCT00276250,Exclusion,"any coagulopathy or medical condition requiring long-term anticoagulant therapy (e.g., warfarin) after transplantation (low-dose aspirin treatment is allowed) or patients with an inr >1.5.","any <VL Label=coagulopathy or medical condition requiring long-term anticoagulant therapy Source=ngram>coagulopathy or medical condition requiring long-term anticoagulant therapy</VL> ( e.g., warfarin ) after transplantation ( low-dose aspirin treatment is allowed ) or patients with an <VML Logic=greater Unit=inr>1.5</VML> .","[['coagulopathy or medical condition requiring long-term anticoagulant therapy', '>', '1.5', 'inr']]"
NCT00276250,Exclusion,"for female participants: positive pregnancy test, presently breast-feeding or unwillingness to use effective contraceptive measures for the duration of the study and 3 months after discontinuation","for female participants: <VL Label=positive pregnancy test Source=UMLS>positive pregnancy test</VL>, presently breast-feeding or unwillingness to use effective contraceptive measures for the duration of the study and <VML Logic=equal Unit=months>3</VML> after discontinuation","[['positive pregnancy test', '=', '3', 'months']]"
NCT00276250,Exclusion,for male participants: intent to procreate during the duration of the study or within 3 months after discontinuation or unwillingness to use effective measures of contraception,for male participants: <VL Label=intent to procreate during the duration of the study Source=ngram>intent to procreate during the duration of the study</VL> or <VML Logic=lower Unit=months>3</VML> after discontinuation or unwillingness to use effective measures of contraception,"[['intent to procreate during the duration of the study', '<', '3', 'months']]"
NCT00276393,Inclusion,"type 1 diabetes, hba1c < 7.8%, who have had prior instruction in a complex insulin program and presently using a mdi insulin program with basal insulin preparations of glargine or ultralente and humalog as the short acting insulin, should be free of hepatorenal abnormalities and hypoglycemia unawareness","type 1 diabetes, <VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=lower Unit=%>7.8</VML>, who have had prior instruction in a complex <VL Label=Insulin Source=DK>insulin</VL> program and presently using a mdi insulin program with basal insulin preparations of glargine or ultralente and humalog as the short acting insulin, should be free of hepatorenal abnormalities and hypoglycemia unawareness","[['HBA1C', '<', 7.8, '%']]"
NCT00278980,Inclusion,subjects who have a duration of type 1 diabetes of more than 5 yrs,<VL Label=subjects who have a duration of type 1 diabetes Source=ngram>subjects who have a duration of type 1 diabetes</VL> of <VML Logic=greater Unit=yrs>5</VML>,"[['subjects who have a duration of type 1 diabetes', '>', '5', 'yrs']]"
NCT00278980,Inclusion,"subjects who have diabetic distal symmetric neuropathy, according to the criteria defined at the san antonio conference on diabetic neuropathy 1988","subjects who have diabetic distal symmetric neuropathy, <VL Label=according to the criteria defined at the san antonio conference on diabetic neuropathy Source=ngram>according to the criteria defined at the san antonio conference on diabetic neuropathy</VL> <VML Logic=equal Unit=>1988</VML> ","[['according to the criteria defined at the san antonio conference on diabetic neuropathy', '=', '1988', '']]"
NCT00279305,Inclusion,between the ages of 8 and 45 years,between the <VL Label=Age Source=DK>ages</VL> <VML Logic=greater_equal Unit=years>8</VML> - <VML Logic=lower_equal Unit=years>45</VML>,"[['Age', '>=', 8.0, 'years'], ['Age', '<=', 45.0, 'years']]"
NCT00279305,Inclusion,must have stimulated c-peptide levels of at least 0.2 pmol/ml measured during a mixed meal tolerance test (mmtt) within one month of randomization,must have stimulated <VL Label=C-peptide Source=DK>c-peptide levels</VL> of <VML Logic=greater_equal Unit=pmol/ml>0.2</VML> measured during a mixed meal tolerance test ( mmtt ) within one month of randomization,"[['C-peptide', '>=', 0.2, 'pmol/ml']]"
NCT00279318,Inclusion,newborns are less than 4 months of age,newborns are <VML Logic=lower Unit=months>4</VML> of <VL Label=Age Source=DK>age</VL>,"[['Age', '<', 4.0, 'months']]"
NCT00283218,Inclusion,diagnosed type 1 diabetes before the age of 40 and on insulin treatment within one year of diagnosis.,diagnosed type 1 diabetes before the <VL Label=Age Source=DK>age</VL> of <VML Logic=equal Unit=>40</VML> and on <VL Label=Insulin Source=DK>insulin</VL> treatment within one year of diagnosis.,"[['Age', '=', 40.0, 'years']]"
NCT00283218,Inclusion,total insulin demand >= 0.5 iu/kg/24 hrs,<VL Label=total Insulin Source=DK>total insulin</VL> demand <VML Logic=greater_equal Unit=iu/kg>0.5</VML> / <VML Logic=equal Unit=>24</VML> hrs,"[['total Insulin', '>=', '0.5', 'iu/kg'], ['total Insulin', '=', '24', '']]"
NCT00283218,Inclusion,hba1c between 7% and 12 % (both values included).,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater_equal Unit=%>7</VML> - <VML Logic=lower_equal Unit=%>12</VML> ( both values included ) .,"[['HBA1C', '>=', 7.0, '%'], ['HBA1C', '<=', 12.0, '%']]"
NCT00283218,Inclusion,age >= 18 years.,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=years>18</VML>.,"[['Age', '>=', 18.0, 'years']]"
NCT00283218,Inclusion,bmi between 18 and 35 kg /m2 (including both values).,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater_equal Unit=kg/m2>18</VML> - <VML Logic=lower_equal Unit=kg/m2>35</VML> ( including both values ) .,"[['BMI', '>=', 18.0, 'kg/m2'], ['BMI', '<=', 35.0, 'kg/m2']]"
NCT00283218,Exclusion,"heart: unstable angina pectoris, ami < 12 months or heart insufficiency classified according to nyha iii-iv","heart: <VL Label=unstable angina pectoris Source=ngram>unstable angina pectoris</VL>, ami <VML Logic=lower Unit=months>12</VML> or heart insufficiency classified according to nyha iii-iv","[['unstable angina pectoris', '<', '12', 'months']]"
NCT00283218,Exclusion,"blood pressure: severe uncontrolled hypertension with bp > 180 - 110 mmhg, sitting","blood pressure: severe uncontrolled hypertension with <VL Label=BP Source=DK>bp</VL> <VML Logic=greater Unit=mmhg>180</VML> - <VML Logic=greater Unit=mmhg>110</VML>, sitting","[['BP', '>', 180.0, 'mmhg'], ['BP', '>', 110.0, 'mmhg']]"
NCT00283218,Exclusion,kidneys: impaired renal function corresponding to serum-creatinin > 150 μmol/l according to the local laboratory.,kidneys: <VL Label=impaired renal function corresponding to serum-creatinin Source=ngram>impaired renal function corresponding to serum-creatinin</VL> <VML Logic=greater Unit=>150</VML> μmol / l according to the local laboratory.,"[['impaired renal function corresponding to serum-creatinin', '>', '150', '']]"
NCT00284232,Inclusion,"hba1c 8% or higher, less than 1.5% variation within last year","<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater_equal Unit=%>8</VML>, <VML Logic=lower Unit=%>1.5</VML> variation within last year","[['HBA1C', '>=', 8.0, '%']]"
NCT00284232,Inclusion,age 18-70,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=>18</VML> - <VML Logic=lower_equal Unit=>70</VML> ,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 70.0, 'years']]"
NCT00284232,Inclusion,stable weight (<5kg variation last year),stable <VL Label=Weight Source=DK>weight</VL> ( <VML Logic=lower Unit=kg>5</VML> variation last year ) ,"[['Weight', '<', 5.0, 'kg']]"
NCT00285194,Inclusion,persistently poor glucose control (as defined by hgba1c>10% at the end of six months of intensive management efforts with the diabetes care team);,persistently poor glucose control ( as defined by <VL Label=HBA1C Source=DK>hgba1c</VL> <VML Logic=greater Unit=%>10</VML> at the end of six months of intensive management efforts with the diabetes care team ) ;,"[['HBA1C', '>', 10.0, '%']]"
NCT00285194,Inclusion,age 18 and older,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=>18</VML>,"[['Age', '>=', 18.0, 'years']]"
NCT00285194,Exclusion,age less than 18 years,<VL Label=Age Source=DK>age</VL> <VML Logic=lower Unit=years>18</VML>,"[['Age', '<', 18.0, 'years']]"
NCT00285194,Exclusion,bmi greater than 26 kg/m2 for male and females,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater Unit=kg/m2>26</VML> for male and females,"[['BMI', '>', 26.0, 'kg/m2']]"
NCT00285194,Exclusion,waist-to-hip ratio 0.80 (female) and 0.95 (male),<VL Label=waist-to-hip ratio Source=ngram>waist-to-hip ratio</VL> <VML Logic=equal Unit=>0.80</VML>  ( female ) and <VML Logic=equal Unit=>0.95</VML>  ( male ) ,"[['waist-to-hip ratio', '=', '0.80', ''], ['waist-to-hip ratio', '=', '0.95', '']]"
NCT00285194,Exclusion,insulin requirement of greater than 0.7 iu/kg/day,<VL Label=Insulin Source=DK>insulin</VL> requirement of <VML Logic=greater Unit=iu/kg>0.7</VML> / day,"[['Insulin', '>', 0.7, 'iu/kg']]"
NCT00285194,Exclusion,hba1c greater than 12%,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=%>12</VML>,"[['HBA1C', '>', 12.0, '%']]"
NCT00285194,Exclusion,macroalbuminuria (urinary albumin excretion greater than 300 mg/24hrs),macroalbuminuria ( <VL Label=urinary albumin excretion Source=ngram>urinary albumin excretion</VL> <VML Logic=greater Unit=mg>300</VML> / <VML Logic=equal Unit=>24</VML> hrs ) ,"[['urinary albumin excretion', '>', '300', 'mg'], ['urinary albumin excretion', '=', '24', '']]"
NCT00285194,Exclusion,"creatinine clearance greater than 85 ml/min/1.73 m2 in females, greater than 95 ml/min/1.73 m2 in males","<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=greater Unit=ml/min/1.73 m2>85</VML> in females, <VML Logic=greater Unit=ml/min/1.73 m2>95</VML> in males","[['Creatinine clearance', '>', 85.0, 'ml/min/1.73 m2'], ['Creatinine clearance', '>', 95.0, 'ml/min/1.73 m2']]"
NCT00285194,Exclusion,serum creatinine greater than 1.2 mg/dl,<VL Label=Creatinine Source=DK>serum creatinine</VL> <VML Logic=greater Unit=mg/dl>1.2</VML>,"[['Creatinine', '>', 1.2, 'mg/dl']]"
NCT00285194,Exclusion,presence of history of panel-reactive anti-hla antibodies greater than 10%,<VL Label=presence of history of panel-reactive anti-hla antibodies Source=ngram>presence of history of panel-reactive anti-hla antibodies</VL> <VML Logic=greater Unit=%>10</VML>,"[['presence of history of panel-reactive anti-hla antibodies', '>', '10', '%']]"
NCT00285194,Exclusion,karnofsky performance score greater than 70,<VL Label=Karnofsky Source=DK>karnofsky</VL> performance score <VML Logic=greater Unit=>70</VML> ,"[['Karnofsky', '>', 70.0, '']]"
NCT00285194,Exclusion,baseline hgb greater than 11.7 g/dl,baseline <VL Label=cygb gene Source=UMLS>hgb</VL> <VML Logic=greater Unit=g/dl>11.7</VML>,"[['cygb gene', '>', '11.7', 'g/dl']]"
NCT00285194,Exclusion,lymphopenia (greater than 1000/l) or leukopenia (greater than 4000 total leukocytes/l) or an absolute cd4+ count <500/l,lymphopenia ( <VML Logic=greater Unit=/l>1000</VML> ) or leukopenia ( <VML Logic=greater Unit=>4000</VML> total leukocytes / l ) or an <VL Label=absolute Cd4+ Source=DK>absolute cd4</VL>+ count <VML Logic=lower Unit=/l>500</VML>,"[['absolute Cd4+', '>', '1000', '/l'], ['absolute Cd4+', '>', '4000', ''], ['absolute Cd4+', '<', '500', '/l']]"
NCT00285194,Exclusion,thrombocytopenia greater than 150 x 109/l,<VL Label=Thrombocytopenia Source=DK>thrombocytopenia</VL> <VML Logic=greater Unit=/l>150 x 109</VML>,"[['Thrombocytopenia', '>', 16350.0, '/l']]"
NCT00285194,Exclusion,use of warfarin or other anticoagulant therapy (except aspirin) or patient with pt-inr greater than 1.5,<VL Label=use of warfarin or other anticoagulant therapy Source=ngram>use of warfarin or other anticoagulant therapy</VL> ( except aspirin ) or patient with pt-<VML Logic=greater Unit=inr>1.5</VML> ,"[['use of warfarin or other anticoagulant therapy', '>', '1.5', 'inr']]"
NCT00285194,Exclusion,"hyperlipidemia (fasting ldl cholesterol greater than 130 mg/dl, treated or untreated","hyperlipidemia ( fasting <VL Label=LDL Cholesterol Source=DK>ldl cholesterol</VL> <VML Logic=greater Unit=mg/dl>130</VML>, treated or untreated","[['LDL Cholesterol', '>', 130.0, 'mg/dl']]"
NCT00285194,Exclusion,and/or fasting triglycerides greater than 200 mg/dl),and / or fasting <VL Label=LDL Source=DK>triglycerides</VL> <VML Logic=greater Unit=mg/dl>200</VML> ) ,"[['LDL', '>', 200.0, 'mg/dl']]"
NCT00285233,Inclusion,persistently poor glucose control (as defined by hgba1c>10% at the end of six months of intensive management efforts with the diabetes care team);,persistently poor glucose control ( as defined by <VL Label=HBA1C Source=DK>hgba1c</VL> <VML Logic=greater Unit=%>10</VML> at the end of six months of intensive management efforts with the diabetes care team ) ;,"[['HBA1C', '>', 10.0, '%']]"
NCT00285233,Inclusion,age 18 and older,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=>18</VML>,"[['Age', '>=', 18.0, 'years']]"
NCT00285233,Exclusion,presence of history of panel-reactive anti-hla antibodies (>10%).,<VL Label=presence of history of panel-reactive anti-hla antibodies Source=ngram>presence of history of panel-reactive anti-hla antibodies</VL> ( <VML Logic=greater Unit=%>10</VML> ) .,"[['presence of history of panel-reactive anti-hla antibodies', '>', '10', '%']]"
NCT00285233,Exclusion,creatinine clearance <60 ml/min/m2.,<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=lower Unit=ml/min>60</VML> / m2.,"[['Creatinine clearance', '<', 60.0, 'ml/min']]"
NCT00285233,Exclusion,history of malignancy within 5 years.,<VL Label=history of malignancy Source=ngram>history of malignancy</VL> <VML Logic=lower Unit=years>5</VML>.,"[['history of malignancy', '<', '5', 'years']]"
NCT00285233,Exclusion,serological evidence of infection with hiv or hbsag or hcvab positive within the previous 12 months prior to transplantation.,<VL Label=serological evidence of infection with hiv or hbsag or hcvab positive Source=ngram>serological evidence of infection with hiv or hbsag or hcvab positive</VL> <VML Logic=lower Unit=previous months>12</VML> prior to transplantation.,"[['serological evidence of infection with hiv or hbsag or hcvab positive', '<', '12', 'previous months']]"
NCT00286624,Inclusion,age 18 or older,<VL Label=Age Source=DK>age</VL> <VML Logic=greater_equal Unit=>18</VML>,"[['Age', '>=', 18.0, 'years']]"
NCT00286624,Exclusion,age less than 18 years.,<VL Label=Age Source=DK>age</VL> <VML Logic=lower Unit=years>18</VML>.,"[['Age', '<', 18.0, 'years']]"
NCT00286624,Exclusion,bmi >26 kg/m2.,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater Unit=kg/m2>26</VML>.,"[['BMI', '>', 26.0, 'kg/m2']]"
NCT00286624,Exclusion,insulin requirement of > 50 iu per day.,<VL Label=Insulin Source=DK>insulin</VL> requirement of <VML Logic=greater Unit=iu/day>50</VML>.,"[['Insulin', '>', 50.0, 'iu/day']]"
NCT00286624,Exclusion,creatinine clearance < 60 ml/min/1.73 m2 for females and 70 ml/min/1.73 m2 for males.,<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=lower Unit=ml/min/1.73 m2>60</VML> for females and <VML Logic=equal Unit=ml/min/1.73 m2>70</VML> for males.,"[['Creatinine clearance', '<', 60.0, 'ml/min/1.73 m2'], ['Creatinine clearance', '=', 70.0, 'ml/min/1.73 m2']]"
NCT00286624,Exclusion,"serum creatinine >1.3 mg/dl for females, >1.5 mg/dl for males.","<VL Label=Creatinine Source=DK>serum creatinine</VL> <VML Logic=greater Unit=mg/dl>1.3</VML> for females, <VML Logic=greater Unit=mg/dl>1.5</VML> for males.","[['Creatinine', '>', 1.3, 'mg/dl'], ['Creatinine', '>', 1.5, 'mg/dl']]"
NCT00286624,Exclusion,presence of history of panel-reactive anti-hla antibodies >10%.,<VL Label=presence of history of panel-reactive anti-hla antibodies Source=ngram>presence of history of panel-reactive anti-hla antibodies</VL> <VML Logic=greater Unit=%>10</VML>.,"[['presence of history of panel-reactive anti-hla antibodies', '>', '10', '%']]"
NCT00286624,Exclusion,baseline hgb < 11.7 g/dl in females or < 13 g/dl in males,baseline <VL Label=cygb gene Source=UMLS>hgb</VL> <VML Logic=lower Unit=g/dl>11.7</VML> in females or <VML Logic=lower Unit=g/dl>13</VML> in males,"[['cygb gene', '<', '11.7', 'g/dl'], ['cygb gene', '<', '13', 'g/dl']]"
NCT00286624,Exclusion,lymphopenia (<1000/microl) or leukopenia (<3000 total leukocytes/microl) or an absolute cd4+ count <500/microl,lymphopenia ( <VML Logic=lower Unit=>1000</VML> / microl ) or leukopenia ( <VML Logic=lower Unit=>3000</VML> total leukocytes / microl ) or an <VL Label=absolute Cd4+ Source=DK>absolute cd4</VL>+ count <VML Logic=lower Unit=>500</VML> / microl,"[['absolute Cd4+', '<', '1000', ''], ['absolute Cd4+', '<', '3000', ''], ['absolute Cd4+', '<', '500', '']]"
NCT00286624,Exclusion,or platelets <150000/microl,or <VML Logic=lower Unit=platelets>150000</VML> / <VL Label=microl Source=ngram>microl</VL>,"[['microl', '<', '150000', 'platelets']]"
NCT00286624,Exclusion,history of coagulopathy or medical condition requiring long-term anticoagulant therapy after transplantation or patient with inr >1.5.,<VL Label=history of coagulopathy or medical condition requiring long-term anticoagulant therapy after transplantation or patient Source=ngram>history of coagulopathy or medical condition requiring long-term anticoagulant therapy after transplantation or patient</VL> with <VML Logic=greater Unit=inr>1.5</VML> .,"[['history of coagulopathy or medical condition requiring long-term anticoagulant therapy after transplantation or patient', '>', '1.5', 'inr']]"
NCT00286624,Exclusion,"hyperlipidemia (fasting ldl cholesterol > 130 mg/dl, treated or untreated","hyperlipidemia ( fasting <VL Label=LDL Cholesterol Source=DK>ldl cholesterol</VL> <VML Logic=greater Unit=mg/dl>130</VML>, treated or untreated","[['LDL Cholesterol', '>', 130.0, 'mg/dl']]"
NCT00286624,Exclusion,and/or fasting triglycerides > 200 mg/dl).,and / or fasting <VL Label=LDL Source=DK>triglycerides</VL> <VML Logic=greater Unit=mg/dl>200</VML> ) .,"[['LDL', '>', 200.0, 'mg/dl']]"
NCT00286962,Inclusion,"intermediate or poor glycemic control, defined as hba1c >= 7.5% and/or >= 5 incidents of hypoglycemia a week.","intermediate or poor glycemic control, defined as <VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater_equal Unit=%>7.5</VML> and / or <VML Logic=greater_equal Unit=incidents>5</VML> of hypoglycemia a week.","[['HBA1C', '>=', 7.5, '%']]"
NCT00286962,Exclusion,renal function impairment: creatinin >= 150 micromol/l or a creatinin clearance < 50 ml/min,renal function impairment: creatinin <VML Logic=greater_equal Unit=micromol/l>150</VML> or a creatinin <VL Label=clearance Source=UMLS>clearance</VL> <VML Logic=lower Unit=ml/min>50</VML>,"[['clearance', '>=', '150', 'micromol/l'], ['clearance', '<', '50', 'ml/min']]"
NCT00286962,Exclusion,myocardial infarction within the last 12 months,<VL Label=Myocardial infarction Source=DK>myocardial infarction</VL> <VML Logic=lower Unit=last months>12</VML>,"[['Myocardial infarction', '<', 12.0, 'last months']]"
NCT00286962,Exclusion,"participation in other trials, involving investigational products within 30 days prior to trial entry.","participation in other trials, involving investigational products <VML Logic=lower Unit=days>30</VML> prior to trial <VL Label=Study entry Source=DK>entry</VL>.","[['Study entry', '<', 30.0, 'days']]"
NCT00286962,Exclusion,plans to engage in activities which require them to go below 25 feet below sea level.,<VL Label=plans to engage in activities which require them to go Source=ngram>plans to engage in activities which require them to go</VL> <VML Logic=lower Unit=>25</VML> feet below sea level.,"[['plans to engage in activities which require them to go', '<', '25', '']]"
NCT00290979,Inclusion,"men or women with type 1 diabetes mellitus, an hba1c range of >=6.0 - =<11.0% and on a basal-bolus insulin regimen","men or women with type 1 diabetes mellitus, an <VL Label=HBA1C Source=DK>hba1c</VL> range of <VML Logic=greater_equal Unit=>6.0</VML> -  <VML Logic=lower_equal Unit=%>11.0</VML> and on a basal-bolus <VL Label=Insulin Source=DK>insulin</VL> regimen","[['HBA1C', '>=', 6.0, '%'], ['HBA1C', '<=', 11.0, '%']]"
NCT00290979,Exclusion,subjects who received oral or intravenous corticosteroid within 4 weeks prior to informed consent,<VL Label=subjects who received oral or intravenous corticosteroid Source=ngram>subjects who received oral or intravenous corticosteroid</VL> <VML Logic=lower Unit=weeks>4</VML> prior to informed consent,"[['subjects who received oral or intravenous corticosteroid', '<', '4', 'weeks']]"
NCT00290979,Exclusion,subjects who were treated with another investigational product within 12 weeks prior to informed consent,<VL Label=subjects who were treated with another investigational product Source=ngram>subjects who were treated with another investigational product</VL> <VML Logic=lower Unit=weeks>12</VML> prior to informed consent,"[['subjects who were treated with another investigational product', '<', '12', 'weeks']]"
NCT00290979,Exclusion,"female subjects who are possibly pregnant [female subjects of reproductive potential who have serum human chorionic gonadotropin (hcg) level > 0.7 miu/ml as determined by central laboratory, srl medisearch inc., during screening phase]","female subjects who are possibly <VL Label=Pregnant Source=DK>pregnant</VL> [ female subjects of reproductive potential who have serum human chorionic gonadotropin ( hcg ) level <VML Logic=greater Unit=>0.7</VML> miu / ml as determined by central laboratory, srl medisearch inc., during screening phase ] ","[['Pregnant', '>', 0.7, '']]"
NCT00290979,Exclusion,subjects with diabetic retinopathy who received surgical treatments (laser photocoagulation or vitrectomy) within 24 weeks prior to informed consent or who are expected to have these surgical treatments during the study period,<VL Label=subjects with diabetic retinopathy who received surgical treatments Source=ngram>subjects with diabetic retinopathy who received surgical treatments</VL> ( laser photocoagulation or vitrectomy ) <VML Logic=lower Unit=weeks>24</VML> prior to informed consent or who are expected to have these surgical treatments during the study period,"[['subjects with diabetic retinopathy who received surgical treatments', '<', '24', 'weeks']]"
NCT00290979,Exclusion,"subjects with impaired hepatic function (sgot or sgpt ³=<80 iu/l determined by central laboratory, srl medisearch inc., during screening phase) or impaired renal function (serum creatinine =<2.0 mg/dl determined by central laboratory, srl medisearch inc., during screening phase)","subjects with impaired hepatic function ( sgot or <VL Label=ALT Source=DK>sgpt</VL> ³ <VML Logic=lower_equal Unit=iu/l>80</VML> determined by central laboratory, srl medisearch inc., during screening phase ) or impaired renal function ( <VL Label=Creatinine Source=DK>serum creatinine</VL> <VML Logic=lower_equal Unit=mg/dl>2.0</VML> determined by central laboratory, srl medisearch inc., during screening phase ) ","[['ALT', '<=', 80.0, 'iu/l'], ['Creatinine', '<=', 2.0, 'mg/dl']]"
NCT00291772,Inclusion,13-22 years of age at the time of enrollment.,<VML Logic=greater_equal Unit=years>13</VML> - <VML Logic=lower_equal Unit=years>22</VML> of <VL Label=Age Source=DK>age</VL> at the time of enrollment.,"[['Age', '>=', 13.0, 'years'], ['Age', '<=', 22.0, 'years']]"
NCT00291772,Inclusion,have been diagnosed with diabetes for at least 1 year and in good control (hba1c less than or equal to 8.5%).,have been diagnosed with diabetes for <VML Logic=greater_equal Unit=year>1</VML> and in good control ( <VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=lower_equal Unit=%>8.5</VML> ) .,"[['HBA1C', '<=', 8.5, '%']]"
NCT00291772,Inclusion,hemoglobin equal to or greater than 12 g/dl before each study.,<VL Label=hemoglobin Source=ngram>hemoglobin</VL> <VML Logic=greater_equal Unit=g/dl>12</VML> before each study.,"[['hemoglobin', '>=', '12', 'g/dl']]"
NCT00291772,Inclusion,weight more than 44 kg,<VL Label=Weight Source=DK>weight</VL> <VML Logic=greater Unit=kg>44</VML>,"[['Weight', '>', 44.0, 'kg']]"
NCT00291772,Exclusion,age greater than 23 years or less than 13 years at the time of study,<VL Label=Age Source=DK>age</VL> <VML Logic=greater Unit=years>23</VML> or <VML Logic=lower Unit=years>13</VML> at the time of study,"[['Age', '>', 23.0, 'years'], ['Age', '<', 13.0, 'years']]"
NCT00291772,Exclusion,anemia (hemoglobin less than 12mg/dl),anemia ( <VL Label=hemoglobin Source=ngram>hemoglobin</VL> <VML Logic=lower Unit=mg/dl>12</VML> ) ,"[['hemoglobin', '<', '12', 'mg/dl']]"
NCT00291772,Exclusion,hgb a1c greater than 8.5 % in a diabetic subject,hgb <VL Label=HBA1C Source=DK>a1c</VL> <VML Logic=greater Unit=%>8.5</VML> in a diabetic subject,"[['HBA1C', '>', 8.5, '%']]"
NCT00291772,Exclusion,weight less than 44 kg,<VL Label=Weight Source=DK>weight</VL> <VML Logic=lower Unit=kg>44</VML>,"[['Weight', '<', 44.0, 'kg']]"
NCT00297401,Inclusion,hemoglobin a1c between 6 and 10%,<VL Label=HBA1C Source=DK>hemoglobin a1c</VL> <VML Logic=greater_equal Unit=%>6</VML> - <VML Logic=lower_equal Unit=%>10</VML>,"[['HBA1C', '>=', 6.0, '%'], ['HBA1C', '<=', 10.0, '%']]"
NCT00297401,Inclusion,"have evidence of early diabetic renal disease as determined by creatinine clearance more than 80 ml/minute, urine albumin to creatinine ratio of more than 3.0 and urinary albumin levels consistent with the diagnosis of diabetic nephropathy (more than 20 mg/mmol for men and more than 28 mg/mmol for women)","have evidence of early diabetic renal disease as determined by <VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=greater Unit=ml/minute>80</VML>, urine albumin to <VL Label=Creatinine ratio Source=DK>creatinine ratio</VL> of <VML Logic=greater Unit=>3.0</VML> and urinary <VL Label=albumin level Source=UMLS>albumin levels</VL> consistent with the diagnosis of diabetic nephropathy ( <VML Logic=greater Unit=mg/mmol>20</VML> for men and <VML Logic=greater Unit=mg/mmol>28</VML> for women ) ","[['Creatinine clearance', '>', 80.0, 'ml/minute'], ['albumin level', '>', '20', 'mg/mmol'], ['albumin level', '>', '28', 'mg/mmol']]"
NCT00297401,Exclusion,"have poorly controlled diabetes, chronic liver disease, clinical jaundice, and/or elevation of liver-related laboratory results, have chronic renal failure on dialysis, have received a kidney transplant or have a moderate to severe kidney disease, have previous history of myocardial infarction, stroke, claudication or amputation, have cancer and are currently receiving chemotherapy or plan to receive chemotherapy in the next 6 months and woman of childbearing potential despite actively practicing birth control by using a medically accepted device or therapy.","have poorly controlled diabetes, chronic liver disease, clinical jaundice, and / or elevation of liver-related laboratory results, have chronic renal failure on dialysis, have received a kidney transplant or have a moderate to severe kidney disease, have previous history of <VL Label=Myocardial infarction Source=DK>myocardial infarction</VL>, stroke, claudication or amputation, have cancer and are currently receiving chemotherapy or plan to receive chemotherapy <VML Logic=lower_equal Unit=next months>6</VML> and woman of childbearing potential despite actively practicing birth control by using a medically accepted device or therapy.","[['Myocardial infarction', '<=', 6.0, 'next months']]"
NCT00297401,Exclusion,"are being treated or intending to start treatment during the trial with excluded drugs: topical or oral carbonic anhydrase inhibitors and require more than 2 weeks of treatment with drugs known to strongly inhibit cytochrome p450 3a4 (cyp3a4), including but not limited to, delavirdine, fluconazole, itraconazole, indinavir, ketoconazole mibefradil, nelfinavir, ritonavir and saquinavir.","are being <VL Label=treated or intending to start treatment during the trial with excluded drugs Source=ngram>treated or intending to start treatment during the trial with excluded drugs</VL>: topical or oral carbonic anhydrase inhibitors and require <VML Logic=greater Unit=weeks>2</VML> of treatment with drugs known to strongly inhibit cytochrome p450 <VML Logic=equal Unit=>3</VML> a4 ( cyp3a4 ) , including but not limited to, delavirdine, fluconazole, itraconazole, indinavir, ketoconazole mibefradil, nelfinavir, ritonavir and saquinavir.","[['treated or intending to start treatment during the trial with excluded drugs', '>', '2', 'weeks'], ['treated or intending to start treatment during the trial with excluded drugs', '=', '3', '']]"
NCT00297583,Inclusion,type 1 diabetes (as defined by the world health organization) for at least 2 years,type 1 diabetes ( as <VL Label=defined by the world health organization Source=ngram>defined by the world health organization</VL> ) for <VML Logic=greater_equal Unit=years>2</VML>,"[['defined by the world health organization', '>=', '2', 'years']]"
NCT00297583,Inclusion,hba1c <= 10.0 %,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=lower_equal Unit=%>10.0</VML>,"[['HBA1C', '<=', 10.0, '%']]"
NCT00297583,Inclusion,"c-peptide < 0.05 nmol/l, based on fasting c-peptide level","<VL Label=C-peptide Source=DK>c-peptide</VL> <VML Logic=lower Unit=nmol/l>0.05</VML>, based on <VL Label=C-peptide Source=DK>fasting c-peptide level</VL>","[['C-peptide', '<', 0.05, 'nmol/l']]"
NCT00297583,Inclusion,body mass index (bmi) <= 30 kg/m²,body mass index ( <VL Label=BMI Source=DK>bmi</VL> )  <VML Logic=lower_equal Unit=kg>30</VML> / m²,"[['BMI', '<=', 30.0, 'kg/m2']]"
NCT00297583,Inclusion,women not of childbearing potential (surgically sterile or postmenopausal for more than 2 years) or not pregnant and agreed to use a reliable contraceptive measure for the duration of the study.,women not of childbearing potential ( surgically sterile or postmenopausal for <VML Logic=greater Unit=years>2</VML> ) or not <VL Label=Pregnant Source=DK>pregnant</VL> and agreed to use a reliable contraceptive measure for the duration of the study.,"[['Pregnant', '>', 2.0, 'years']]"
NCT00297583,Inclusion,receipt of any investigational drug within the last 30 days prior to this trial,<VL Label=receipt of any investigational drug Source=ngram>receipt of any investigational drug</VL> <VML Logic=lower Unit=last days>30</VML> prior to this trial,"[['receipt of any investigational drug', '<', '30', 'last days']]"
NCT00297583,Inclusion,total daily insulin dose >= 1.4 iu/kg,total daily <VL Label=Insulin Source=DK>insulin</VL> dose <VML Logic=greater_equal Unit=iu/kg>1.4</VML>,"[['Insulin', '>=', 1.4, 'iu/kg']]"
NCT00297583,Inclusion,serum insulin antibody level > 20 u/ml determined at screening visit,<VL Label=serum insulin measurement Source=UMLS>serum insulin</VL> antibody level <VML Logic=greater Unit=u/ml>20</VML> determined at screening visit,"[['serum insulin measurement', '>', '20', 'u/ml']]"
NCT00297583,Inclusion,smokers > 10 cigarettes per day or equivalent,<VL Label=smokers Source=ngram>smokers</VL> <VML Logic=greater Unit=cigarettes/day>10</VML> or equivalent,"[['smokers', '>', '10', 'cigarettes/day']]"
NCT00297583,Inclusion,"active proliferative diabetic retinopathy, as defined by the application of focal or panretinal photocoagulation or vitrectomy, in the 6 months prior to visit 1 or any other unstable (rapidly progressing) retinopathy that may require surgical treatment (including laser photocoagulation) during the study","active proliferative diabetic retinopathy, as <VL Label=defined by the application of focal or panretinal photocoagulation or vitrectomy Source=ngram>defined by the application of focal or panretinal photocoagulation or vitrectomy</VL>, <VML Logic=lower_equal Unit=months>6</VML> prior to visit 1 or any other unstable ( rapidly progressing ) retinopathy that may require surgical treatment ( including laser photocoagulation ) during the study","[['defined by the application of focal or panretinal photocoagulation or vitrectomy', '<=', '6', 'months']]"
NCT00297583,Inclusion,myocardial infarction within the last 12 months,<VL Label=Myocardial infarction Source=DK>myocardial infarction</VL> <VML Logic=lower Unit=last months>12</VML>,"[['Myocardial infarction', '<', 12.0, 'last months']]"
NCT00297583,Inclusion,biochemical signs of hepatic or renal diseases as indicated by alanine aminotransferase and/or alkaline phosphatase >= 2 times and/or creatinine >= 1.5 times the upper limit of the normal reference range for the age group or current renal dialysis,biochemical signs of hepatic or renal diseases as indicated by <VL Label=ALT Source=DK>alanine aminotransferase</VL> and / or alkaline phosphatase <VML Logic=greater_equal Unit=times>2</VML> and / or <VL Label=Creatinine Source=DK>creatinine</VL> <VML Logic=greater_equal Unit=times>1.5</VML> the upper limit of the normal reference range for the <VL Label=Age Source=DK>age</VL> group or current renal dialysis,"[['ALT', '>=', 2.0, 'times'], ['Creatinine', '>=', 1.5, 'times']]"
NCT00297583,Inclusion,"anemia as indicated by hemoglobin < 6.2 mmol/l or clinically relevant iron deficiency as indicated by low ferritin levels in men (< 34 ng/ml) and women (premenopausal < 22 ng/ml, menopausal < 13 ng/ml)","anemia as indicated by hemoglobin <VML Logic=lower Unit=mmol/l>6.2</VML> or clinically relevant iron deficiency as indicated by low <VL Label=ferritin level Source=UMLS>ferritin levels</VL> in men ( <VML Logic=lower Unit=ng/ml>34</VML> ) and women ( premenopausal <VML Logic=lower Unit=ng/ml>22</VML>, menopausal <VML Logic=lower Unit=ng/ml>13</VML> ) ","[['ferritin level', '<', '6.2', 'mmol/l'], ['ferritin level', '<', '34', 'ng/ml'], ['ferritin level', '<', '22', 'ng/ml'], ['ferritin level', '<', '13', 'ng/ml']]"
NCT00297583,Inclusion,donation of blood (>500 ml) during the previous 3 months prior to the screening visit or during the duration of the study,<VL Label=donation of blood Source=ngram>donation of blood</VL> ( <VML Logic=greater Unit=ml>500</VML> ) <VML Logic=lower_equal Unit=previous months>3</VML> prior to the screening visit or during the duration of the study,"[['donation of blood', '>', '500', 'ml'], ['donation of blood', '<=', '3', 'previous months']]"
NCT00297635,Exclusion,patients unwilling to perform at least 4 blood glucose self-tests will be ineligible for participation in this study,patients unwilling to perform <VML Logic=greater_equal Unit=>4</VML> blood <VL Label=Glucose Source=DK>glucose</VL> self-tests will be ineligible for participation in this study,"[['Glucose', '>=', 4.0, '']]"
NCT00298740,Inclusion,people with type 1 diabetes previously implanted with the minimed implantable pump model 2000 at johns hopkins may join this study.,<VL Label=people with type 1 diabetes previously implanted with the minimed implantable pump model Source=ngram>people with type 1 diabetes previously implanted with the minimed implantable pump model</VL> <VML Logic=equal Unit=>2000</VML> at johns hopkins may join this study.,"[['people with type 1 diabetes previously implanted with the minimed implantable pump model', '=', '2000', '']]"
NCT00298740,Exclusion,anyone not previously implanted with the minimed implantable pump model 2000 at johns hopkins.,<VL Label=anyone not previously implanted with the minimed implantable pump model Source=ngram>anyone not previously implanted with the minimed implantable pump model</VL> <VML Logic=equal Unit=>2000</VML> at johns hopkins.,"[['anyone not previously implanted with the minimed implantable pump model', '=', '2000', '']]"
NCT00303134,Inclusion,"such management must be monitored in close cooperation with an endocrinologist or primary care physician, as defined by at least three contacts during the previous 12 months","such <VL Label=management must be monitored in close cooperation with an endocrinologist or primary care physician Source=ngram>management must be monitored in close cooperation with an endocrinologist or primary care physician</VL>, as defined by greater_equal three contacts <VML Logic=lower_equal Unit=previous months>12</VML>","[['management must be monitored in close cooperation with an endocrinologist or primary care physician', '<=', '12', 'previous months']]"
NCT00303134,Inclusion,"reduced awareness of hypoglycemia, as defined by the absence of adequate autonomic symptoms at plasma glucose levels of < 54 mg/dl, b","reduced awareness of hypoglycemia, as defined by the absence of adequate autonomic symptoms at plasma <VL Label=glucose level - finding Source=UMLS>glucose levels</VL> of <VML Logic=lower Unit=mg/dl>54</VML>, b","[['glucose level - finding', '<', '54', 'mg/dl']]"
NCT00303134,Inclusion,"metabolic lability/instability, characterized by two or more episodes of severe hypoglycemia and which is associated with a blood glucose below 54 mg/dl or two or more hospital visits for diabetic ketoacidosis over the last year, c","metabolic lability / instability, characterized by two or more episodes of severe hypoglycemia and which is associated with a blood <VL Label=Glucose Source=DK>glucose</VL> <VML Logic=lower Unit=mg/dl>54</VML> or two or more hospital visits for diabetic ketoacidosis over the last year, c","[['Glucose', '<', 3.0, 'mmol/l']]"
NCT00303134,Exclusion,bmi > 26 kg/m2,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater Unit=kg/m2>26</VML>,"[['BMI', '>', 26.0, 'kg/m2']]"
NCT00303134,Exclusion,"c-peptide response to arginine stimulation (5 gm i.v.) (any c-peptide >= 0.3 ng/ml at 2, 3, 4, 5, 7 and 10 min post-infusion)","<VL Label=C-peptide Source=DK>c-peptide</VL> response to arginine stimulation ( <VML Logic=equal Unit=gm>5</VML> i.v. )  ( any <VL Label=C-peptide Source=DK>c-peptide</VL> <VML Logic=greater_equal Unit=ng/ml>0.3</VML> at <VML Logic=equal Unit=>2</VML> , <VML Logic=equal Unit=>3</VML> , <VML Logic=equal Unit=>4</VML> , <VML Logic=equal Unit=>5</VML> , <VML Logic=equal Unit=min>7</VML> - <VML Logic=equal Unit=min>10</VML> post-infusion ) ","[['C-peptide', '=', 5.0, 'gm'], ['C-peptide', '>=', 0.3, 'ng/ml'], ['C-peptide', '=', 2.0, 'ng/ml'], ['C-peptide', '=', 3.0, 'ng/ml'], ['C-peptide', '=', 4.0, 'ng/ml'], ['C-peptide', '=', 5.0, 'ng/ml']]"
NCT00303134,Exclusion,age less than 18 or greater than 65 years,<VL Label=Age Source=DK>age</VL> <VML Logic=lower Unit=years>18</VML> - <VML Logic=greater Unit=years>65</VML>,"[['Age', '<', 18.0, 'years'], ['Age', '>', 65.0, 'years']]"
NCT00303134,Exclusion,creatinine clearance <80 ml/min/1.73 m2,<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=lower Unit=ml/min/1.73 m2>80</VML>,"[['Creatinine clearance', '<', 80.0, 'ml/min/1.73 m2']]"
NCT00303134,Exclusion,serum creatinine >1.6 mg/dl,<VL Label=Creatinine Source=DK>serum creatinine</VL> <VML Logic=greater Unit=mg/dl>1.6</VML>,"[['Creatinine', '>', 1.6, 'mg/dl']]"
NCT00303134,Exclusion,macroalbuminuria (urinary albumin excretion rate >300 mg/24h),macroalbuminuria ( urinary <VL Label=albumin excretion rate measurement Source=UMLS>albumin excretion rate</VL> <VML Logic=greater Unit=mg>300</VML> / <VML Logic=equal Unit=h>24</VML> ) ,"[['albumin excretion rate measurement', '>', '300', 'mg'], ['albumin excretion rate measurement', '=', '24', 'h']]"
NCT00303134,Exclusion,baseline hb <10.5 gm/dl in women or <13 gm/dl in men,<VL Label=baseline hb Source=ngram>baseline hb</VL> <VML Logic=lower Unit=gm/dl>10.5</VML> in women or <VML Logic=lower Unit=gm/dl>13</VML> in men,"[['baseline hb', '<', '10.5', 'gm/dl'], ['baseline hb', '<', '13', 'gm/dl']]"
NCT00303134,Exclusion,(an initial lft test panel with any values >1.5 times upper limits of normal will exclude a patient, ( an <VL Label=initial lft test panel with any values Source=ngram>initial lft test panel with any values</VL> <VML Logic=greater Unit=times upper limits of normal>1.5</VML> will exclude a patient,"[['initial lft test panel with any values', '>', '1.5', 'times upper limits of normal']]"
NCT00303134,Exclusion,"a re-test for any values between normal and 1.5 times normal should be made and if the values remain elevated above normal limits, the patient will be excluded.)","a <VL Label=re-test for any values between normal Source=ngram>re-test for any values between normal</VL> and <VML Logic=equal Unit=times>1.5</VML> normal should be made and if the values remain elevated above normal limits, the patient will be excluded. ) ","[['re-test for any values between normal', '=', '1.5', 'times']]"
NCT00303134,Exclusion,evidence of sensitization on pra (determined by demonstration of positive results for anti-hla antibodies using solid phase immunoassay with soluble hla class i molecules as a target or a general pra panel with reactivity >20%),evidence of sensitization on pra ( <VL Label=determined by demonstration of positive results for anti-hla antibodies using solid phase immunoassay with soluble hla class i molecules as a target or a general pra panel with reactivity Source=ngram>determined by demonstration of positive results for anti-hla antibodies using solid phase immunoassay with soluble hla class i molecules as a target or a general pra panel with reactivity</VL> <VML Logic=greater Unit=%>20</VML> ) ,"[['determined by demonstration of positive results for anti-hla antibodies using solid phase immunoassay with soluble hla class i molecules as a target or a general pra panel with reactivity', '>', '20', '%']]"
NCT00303134,Exclusion,insulin requirement >0.7 iu/kg/day,<VL Label=Insulin Source=DK>insulin</VL> requirement <VML Logic=greater Unit=iu/kg>0.7</VML> / day,"[['Insulin', '>', 0.7, 'iu/kg']]"
NCT00303134,Exclusion,hba1c >12%,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=%>12</VML>,"[['HBA1C', '>', 12.0, '%']]"
NCT00303134,Exclusion,inability to reach the study hospital for transplantation within 24 hrs of notification,<VL Label=inability to reach the study hospital for transplantation Source=ngram>inability to reach the study hospital for transplantation</VL> <VML Logic=lower Unit=>24</VML> hrs of notification,"[['inability to reach the study hospital for transplantation', '<', '24', '']]"
NCT00303134,Exclusion,untreated hyperlipidemia (fasting ldl cholesterol >130 mg/dl and/or fasting triglycerides >200 mg/dl),untreated hyperlipidemia ( fasting <VL Label=LDL Cholesterol Source=DK>ldl cholesterol</VL> <VML Logic=greater Unit=mg/dl>130</VML> and / or fasting <VL Label=LDL Source=DK>triglycerides</VL> <VML Logic=greater Unit=mg/dl>200</VML> ) ,"[['LDL Cholesterol', '>', 130.0, 'mg/dl'], ['LDL', '>', 200.0, 'mg/dl']]"
NCT00303134,Exclusion,treated hyperlipidemia that is uncontrolled (fasting ldl cholesterol >130 mg/dl,treated hyperlipidemia that is uncontrolled ( fasting <VL Label=LDL Cholesterol Source=DK>ldl cholesterol</VL> <VML Logic=greater Unit=mg/dl>130</VML>,"[['LDL Cholesterol', '>', 130.0, 'mg/dl']]"
NCT00303134,Exclusion,and/or fasting triglycerides >200 mg/dl),and / or fasting <VL Label=LDL Source=DK>triglycerides</VL> <VML Logic=greater Unit=mg/dl>200</VML> ) ,"[['LDL', '>', 200.0, 'mg/dl']]"
NCT00303134,Exclusion,use of coumadin or other anticoagulant therapy (except aspirin) or subject with pt/inr >1.5,<VL Label=use of coumadin or other anticoagulant therapy Source=ngram>use of coumadin or other anticoagulant therapy</VL> ( except aspirin ) or subject with <VML Logic=greater Unit=pt/inr>1.5</VML> ,"[['use of coumadin or other anticoagulant therapy', '>', '1.5', 'pt/inr']]"
NCT00304538,Inclusion,glycosylated hemoglobin (hba1c) <=8.0%,glycosylated hemoglobin ( <VL Label=HBA1C Source=DK>hba1c</VL> )  <VML Logic=lower_equal Unit=%>8.0</VML>,"[['HBA1C', '<=', 8.0, '%']]"
NCT00304538,Inclusion,total daily insulin requirement of <=1 unit/kg of body weight,total daily <VL Label=Insulin Source=DK>insulin</VL> requirement of <VML Logic=lower_equal Unit=unit/kg>1</VML> of <VL Label=Weight Loss Source=DK>body weight</VL>,"[['Weight Loss', '<=', 1.0, 'unit/kg']]"
NCT00304538,Inclusion,fasting c-peptide level of <1.0 ng/ml (<330 pmol/l) (may be done at screening or may be taken from subject’s medical record if performed within the past 12 months),<VL Label=C-peptide Source=DK>fasting c-peptide level</VL> of <VML Logic=lower Unit=ng/ml>1.0</VML> ( <VML Logic=lower Unit=pmol/l>330</VML> )  ( may be done at screening or may be taken from subject’s medical record if performed <VML Logic=lower Unit=past months>12</VML> ) ,"[['C-peptide', '<', 1.0, 'ng/ml'], ['C-peptide', '<', 330.0, 'pmol/l'], ['C-peptide', '<', 12.0, 'past months']]"
NCT00304538,Inclusion,body mass index (bmi) <=25.5 kg/m2 and body weight over past 6 months within ± 5%,body mass index ( <VL Label=BMI Source=DK>bmi</VL> )  <VML Logic=lower_equal Unit=kg/m2>25.5</VML> and <VL Label=Weight Loss Source=DK>body weight</VL> over past <VML Logic=equal Unit=months>6</VML> within ± <VML Logic=equal Unit=%>5</VML>,"[['BMI', '<=', 25.5, 'kg/m2'], ['Weight Loss', '=', 5.0, '%']]"
NCT00304538,Inclusion,serum chemistry results within normal limits except for liver enzymes [aspartate transaminase (ast) and alanine transaminase (alt)] which must be within 2.5 times upper limit of normal (uln) and creatinine which must be <1.6 mg/dl,serum chemistry results within normal limits except for liver enzymes [ aspartate transaminase ( ast ) and alanine transaminase ( <VL Label=ALT Source=DK>alt</VL> ) ] which must be <VML Logic=lower Unit=times upper limit of normal>2.5</VML> ( uln ) and <VL Label=Creatinine Source=DK>creatinine</VL> which must be <VML Logic=lower Unit=mg/dl>1.6</VML>,"[['ALT', '<', 2.5, 'times upper limit of normal'], ['Creatinine', '<', 1.6, 'mg/dl']]"
NCT00304538,Exclusion,participation in a clinical trial with or use of an investigational agent within 30 days of study visit 1.,<VL Label=participation in a clinical trial with or use of an investigational agent Source=ngram>participation in a clinical trial with or use of an investigational agent</VL> <VML Logic=lower Unit=days>30</VML> of study visit 1 .,"[['participation in a clinical trial with or use of an investigational agent', '<', '30', 'days']]"
NCT00304538,Exclusion,history of any malignancy within 3 years except for basal cell skin cancer,<VL Label=history of any malignancy Source=ngram>history of any malignancy</VL> <VML Logic=lower Unit=years>3</VML> except for basal cell skin cancer,"[['history of any malignancy', '<', '3', 'years']]"
NCT00305344,Exclusion,"fever >38.5 c, vomiting, diarrhea, wheezing or crackles).","<VL Label=Fever Source=DK>fever</VL> <VML Logic=greater Unit=>38.5</VML> c, vomiting, diarrhea, wheezing or crackles ) .","[['Fever', '>', 38.5, 'degree']]"
NCT00306098,Inclusion,patients between 18 and 65 years of age,patients <VML Logic=greater_equal Unit=years>18</VML> - <VML Logic=lower_equal Unit=years>65</VML> of <VL Label=Age Source=DK>age</VL>,"[['Age', '>=', 18.0, 'years'], ['Age', '<=', 65.0, 'years']]"
NCT00306098,Inclusion,patients with type 1 diabetes mellitus for more than 5 years duration,<VL Label=patients with type 1 diabetes mellitus Source=ngram>patients with type 1 diabetes mellitus</VL> for <VML Logic=greater Unit=years>5</VML> duration,"[['patients with type 1 diabetes mellitus', '>', '5', 'years']]"
NCT00306098,Inclusion,poor diabetes control (hba1c>8% or >2 visits/yr to hospital for treatment of ketoacidosis) despite intensive insulin therapy,poor diabetes control ( <VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=%>8</VML> - <VML Logic=greater Unit=%>2</VML> visits / yr to hospital for treatment of ketoacidosis ) despite intensive <VL Label=Insulin Source=DK>insulin</VL> therapy,"[['HBA1C', '>', 8.0, '%'], ['HBA1C', '>', 2.0, '%']]"
NCT00306098,Inclusion,body mass index (bmi) <=26,body mass index ( <VL Label=BMI Source=DK>bmi</VL> )  <VML Logic=lower_equal Unit=>26</VML> ,"[['BMI', '<=', 26.0, 'kg/m2']]"
NCT00306098,Exclusion,c-peptide > 0.3ng/ml basal or stimulated;,<VL Label=C-peptide Source=DK>c-peptide</VL> <VML Logic=greater Unit=ng/ml>0.3</VML> basal or stimulated;,"[['C-peptide', '>', 0.3, 'ng/ml']]"
NCT00306098,Exclusion,hba1c >12%;,<VL Label=HBA1C Source=DK>hba1c</VL> <VML Logic=greater Unit=%>12</VML>;,"[['HBA1C', '>', 12.0, '%']]"
NCT00306098,Exclusion,creatinine clearance <60;,<VL Label=Creatinine clearance Source=DK>creatinine clearance</VL> <VML Logic=lower Unit=>60</VML> ;,"[['Creatinine clearance', '<', 60.0, '']]"
NCT00306098,Exclusion,serum creatinine consistently >1.6 mg/dl;,<VL Label=Creatinine Source=DK>serum creatinine</VL> consistently <VML Logic=greater Unit=mg/dl>1.6</VML>;,"[['Creatinine', '>', 1.6, 'mg/dl']]"
NCT00306098,Exclusion,macroalbuminuria >300mg albumin in 24 hours;,<VL Label=macroalbuminuria Source=ngram>macroalbuminuria</VL> <VML Logic=greater Unit=mg>300</VML> albumin <VML Logic=lower_equal Unit=hours>24</VML>;,"[['macroalbuminuria', '>', '300', 'mg'], ['macroalbuminuria', '<=', '24', 'hours']]"
NCT00306098,Exclusion,presence of panel reactive antibodies (pra) >20%;,<VL Label=presence of panel reactive antibodies Source=ngram>presence of panel reactive antibodies</VL> ( pra )  <VML Logic=greater Unit=%>20</VML>;,"[['presence of panel reactive antibodies', '>', '20', '%']]"
NCT00306098,Exclusion,anemia (hemoglobin <12.0);,anemia ( <VL Label=hemoglobin Source=ngram>hemoglobin</VL> <VML Logic=lower Unit=>12.0</VML> ) ;,"[['hemoglobin', '<', '12.0', '']]"
NCT00306098,Exclusion,hyperlipidemia (fasting serum triglycerides >200mg/dl and/or fasting serum cholesterol >240 mg/dl and/or fasting ldl cholesterol >140 mg/dl);,hyperlipidemia ( fasting serum <VL Label=LDL Source=DK>triglycerides</VL> <VML Logic=greater Unit=mg/dl>200</VML> and / or fasting serum <VL Label=LDL Cholesterol Source=DK>cholesterol</VL> <VML Logic=greater Unit=mg/dl>240</VML> and / or fasting <VL Label=LDL Cholesterol Source=DK>ldl cholesterol</VL> <VML Logic=greater Unit=mg/dl>140</VML> ) ;,"[['LDL', '>', 200.0, 'mg/dl'], ['LDL Cholesterol', '>', 240.0, 'mg/dl'], ['LDL Cholesterol', '>', 140.0, 'mg/dl']]"
NCT00306098,Exclusion,bmi above 26;,<VL Label=BMI Source=DK>bmi</VL> <VML Logic=greater Unit=>26</VML> ;,"[['BMI', '>', 26.0, 'kg/m2']]"
NCT00306098,Exclusion,prostate specific antigen (psa) >4;,<VL Label=prostate specific antigen Source=ngram>prostate specific antigen</VL> ( psa )  <VML Logic=greater Unit=>4</VML> ;,"[['prostate specific antigen', '>', '4', '']]"
NCT00306098,Exclusion,"alcohol abuse, substance abuse or smoking within the previous 6 months","alcohol abuse, substance abuse or <VL Label=Smoking Source=DK>smoking</VL> <VML Logic=lower Unit=previous months>6</VML>","[['Smoking', '<', 6.0, 'previous months']]"
NCT00306098,Exclusion,insulin requirement >1u/kg/day and any condition or any circumstance that makes it unsafe to undergo an islet cell transplant.,<VL Label=Insulin Source=DK>insulin</VL> requirement <VML Logic=greater Unit=u/kg>1</VML> / day and any condition or any circumstance that makes it unsafe to undergo an islet cell transplant.,"[['Insulin', '>', 1.0, 'u/kg']]"
